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Summary 
DNA is under constant attack by various genotoxins from the environment or from 
within the cell. To preserve genome integrity and prevent propagation of mutations 
into progeny, a major goal is to recognize genotoxic stress and to respond in an 
appropriate manner. The cellular response to a specific genotoxic stress is regulated 
by different enzymes, which fine-tune a sophisticated network of intracellular 
signaling cascades. Understanding the complexity of genotoxic stress-induced 
signaling events in cells could assist the development of new treatment strategies for 
the therapy of tumors. 
The aims of this thesis were to understand i) the resistance of human primary 
fibroblasts towards high doses of ionizing radiation (IR) and ii) the mechanism of 
ARTD1 activation upon oxidative stress. Based on a kinetic network analysis by 
protein microarrays, we observed IR-induced phosphorylation of PKC family 
members, which fostered pro-survival signaling of human fibroblasts via CREB and 
Bad phosphorylation. Inhibition or knockdown of PKC family members induced a 
transition from IR-induced senescence to apoptosis, which was accompanied by p53 
and Bad stabilization, cleavage of ARTD1 and enhanced DNA fragmentation, and 
thus indicated a PKC-dependent molecular survival mechanism. A similar network 
analysis in combination with an inhibitor screen was employed to identify positive 
and negative regulators of poly-ADP-ribose (PAR) formation upon H2O2. Validation 
of candidates revealed enhanced and reduced activation of ARTD1 by CaMKIIδ and 
the calcium-independent PKCδ, respectively. Importantly, PAR formation was 
abolished upon the depletion of calcium-dependent PKC family members (e.g., 
PKCα), thus revealing a dual role of PKC in regulating ARTD1 activity upon H2O2 
exposure. Finally, we confirmed that oxidative stress activates PLC and subsequently 
IP3R/RYR receptors and thereby leads to calcium release from the ER, which is 
required for PAR formation. Chelation of calcium not only prevented PAR formation, 
but also reduced DNA single-strand break formation, indicating a correlation between 
calcium-dependent PAR formation and DNA damage.  
In summary, these studies highlighted the importance of cytoplasmic signaling at the 
forefront of the response to irradiation and oxidative stress. The activation of the 
nuclear genotoxic stress response and the regulation of cell fate thus rely on these 
signal responses.   
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Zusammenfassung 
DNA ist ständig den schädigenden Einflüssen genotoxischer Substanzen aus der 
Umwelt und der Zelle ausgesetzt. Um die Integrität des Genoms zu wahren und die 
Vererbung von Mutationen zu verhindern, ist es das Ziel genotoxische Stressfaktoren 
zu erkennen und darauf entsprechend zu antworten. Die Antwort auf genotoxischen 
Stress ist durch die Aktivierung eines ausgeklügelten Netzwerks von verschiedenen 
Signalkaskaden gesteuert. Das Verständnis der Komplexität der Signalvermittlung als 
Antwort auf genotoxischen Stress ist für die Entwicklung neuer Behandlungs-
strategien für die Therapie von Tumoren von Bedeutung.   
Die wichtigsten Ziele dieser Dissertation waren das Verständnis i) der Radioresistenz 
humaner, primärer Fibroblasten als Antwort auf hohe Dosen ionisierender Strahlung 
(IS) und ii) des Mechanismus der Aktivierung von ARTD1 als Antwort auf 
oxidativen Stress. Basierend auf der kinetischen Netzwerkanalyse konnten wir die IS-
abhängige Phosphorylierung von Mitgliedern der PKC Familie beobachten, welche 
das Überleben der humanen Fibroblasten mittels Phosphorylierung von CREB und 
Bad förderten. Die Inhibierung oder Reduktion von PKCs hat zu einer Verschiebung 
der Antwort auf Bestrahlung von Seneszenz zum Zelltod geführt. Für diese 
Veränderung waren die Stabilisierung von p53 und Bad, die Spaltung von ARTD1 
und die Fragmentierung von DNA ausschlaggebend. Basierend auf der 
Netzwerkanalyse und einem pharmakologischen Screen haben wir positive und 
negative Regulatoren der poly-ADP-ribose (PAR) Bildung als Antwort auf oxidativen 
Stress entdeckt. Funktionelle Validierung der Kandidaten hat ergeben, dass ARTD1 
durch CaMKIIδ und PKCδ positiv und negativ reguliert wird. Ausschlaggebend 
konnten wir mit Hilfe der Reduktion von Kalzium-abhängigen PKC Mitgliedern 
(PKCα) die Inhibierung und damit duale Regulierung der ARTD1 Aktivität durch 
PKC zeigen. Schlussendlich haben wir funktionell bestätigt, dass oxidativer Stress 
zum Kalziumausstrom aus dem ER mittels PLC und IP3R/RYR führt, was eine 
Voraussetzung für die PAR Bildung war. Die Komplexierung von Kalzium hat nicht 
nur zur Inhibierung von PAR, sondern auch zur Reduktion von Einzelstrang-Brüchen 
der DNA geführt. 
Zusammenfassend haben diese Studien die Bedeutung zytoplasmatischer Signalwege 
als erste Antwort auf zellulären Stress durch Bestrahlung oder oxidativen Stress 
herausgestellt. Die Aktivierung der nukleären, genotoxischen Stressantwort und die 
Regulation des Zellzustands hängt somit entscheidend von diesen Signalkaskaden ab. 
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Abbreviations 
 
53BP1   Tumor suppressor p53-binding protein 1 
ADP   Adenosine diphosphate 
ADPR   Adenosine diphosphate ribose 
AIF   Apoptosis inducing factor 
ARTD1  ADP-ribosyltransferase Diphtheria toxin-like 1  
ASK1   Apoptosis signal-regulating kinase 1   
JNK   c-Jun N-terminal kinase 
ATF4   Activating transcription factor 4     
ATF6   Activating transcription factor 6 
ATM   Ataxiatelangiectasia mutated   
ATP   Adenosine-5'-triphosphate 
ATR   Ataxia telangiectasia and Rad3-related protein 
Bad   BCL2-associated agonist of cell death 
Bak   BCL2-antagonist/killer 1 
Bcl-2   B-cell lymphoma 2 
BER   Base excision repair 
BIM   Bisindolylmaleimide 
BiP   Binding immunoglobulin protein 
BRCA1  Breast cancer type 1 susceptibility protein 
cADPR  Cyclic adenosine diphosphate ribose 
CaM   Calmodulin (Ca2+-modulated protein) 
CaMKII  Ca2+/calmodulin-dependent protein kinases II   
CD38   Cluster of differentiation 38 
CDK   Cyclin-dependent kinases 
Chk1/2  Checkpoint kinase-1/2  
CICR   Ca2+ induced Ca2+ release 
CREB   Cyclic AMP-responsive element-binding protein  
Cys   Cysteine  
DAG   Diacylglycerol 
DDR   DNA damage response 
DNA   Deoxyribonucleic acid 
DNA-PK  DNA-dependent protein kinase 
DNA-PKcs  DNA-dependent protein kinase, catalytic subunit 
DSB   DNA double-strand break   
ECM   Extracellular matrix 
ER   Endoplasmic reticulum 
ERAD   Endoplasmic-reticulum-associated protein degradation 
ERK   Extracellular-signal regulated kinase  
ERO1   ER oxidoreductin 1 
GAPDH  Glycerinaldehyd-3-phosphat-Dehydrogenase 
NER   Nucleotide excision repair 
Glu   Glutamate  
GPCR   G protein-coupled receptor  
GPX   Glutathione peroxidase 
GRP78  78 kDa glucose-regulated protein 
GS-lyation  Glutathionylation     
GSSG   Glutathione disulfide (oxidized) 
GSH   Glutathione (reduced) 
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GST   Glutathione S-transferase 
H2A.X   H2A histone family, member X 
H2O2   Hydrogen peroxide 
H3   H3 histone 
HO   Hydroxyl 
HR   Homologous recombination     
InsP3R  Inositol trisphosphate receptor 
IP3   Inositol trisphosphate 
IP3R   Inositol trisphosphate receptor 
IR   Ionizing radiation 
KO    Knockout 
Lys   Lysine  
MAPK   Mitogen-activated protein kinases 
MDC1   Mediator of DNA damage checkpoint protein 1 
MEK   Dual specificity mitogen-activated protein kinase kinase 1 
Met   Methionine 
MRN   Mre11, Rad50 and Nbs1 
mTOR   Mammalian target of rapamycin   
mTORC2  Mammalian target of rapamycin complex 2 
NAADP  Nicotinic acid adenine dinucleotide phosphate  
NAD+/NADH  Nicotinamide adenine dinucleotide  
NADP+/NADPH Nicotinamide adenine dinucleotide phosphate   
NF-κB   Nuclear factor kappa-light-chain-enhancer of activated B cells 
NHEJ   Non-homologous end joining  
NMDA  N-methyl-D-aspartate 
NO   Nitric oxide 
NO3-   Nitrate 
O2-   Superoxide 
PAR   Poly-Adenosine diphosphate ribose 
PDI   Protein disulfide isomerase 
PDK1   3-phosphoinositide-dependent protein kinase    
PHD   Plant Homeo Domain 
PI-3   Phosphatidylinositide 3   
PI3K   Phosphatidylinositol 3- and 4-kinase 
PIKK   Phosphatidylinositol 3-kinase-related kinase 
PIP2   Phosphatidylinositol 4,5-bisphosphate  
PIP3   Phosphatidylinositol (3,4,5)-trisphosphate 
PKB   Protein kinase B 
PKC   Protein Kinase C   
PLC   Phospholipase C 
PMA   Phorbol-12-myristat-13-acetat 
Pol   Polymerase    
PS   Phosphatidylserine 
PTB   Phosphotyrosine-binding domain 
PTM   Posttranslational modification 
PTP   Protein tyrosine phosphatase  
RAS   Rat sarcoma   
Rb   Retinoblastoma 
RNA   Ribonucleic acid 
RNA Pol II  RNA-Polymerase II  
ROS   reactive oxygen species 
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RTK   Receptor tyrosine kinase 
RYR   Ryanodine receptor    
SERCA  Sarcoplasmic reticulum 
SH2/3   Src Homology 2/3 
SOD   Superoxide dismutase  
SSB   Single-strand break 
STAT   Signal Transducer and Activator of Transcription 
TCA cycle  Tricarboxylic acid cycle    
TCR   Transcription coupled repair 
TLS   Translesion synthesis 
TRPM2 Transient receptor potential cation channel, subfamily 
M, member 2 
Trx   Thioredoxin 
TrxR   Thioredoxin reductase 
Tyr   Tyrosine 
UPR   Unfolded protein response 
UV   Ultraviolet 
VDAC   Voltage-dependent anion channel  
Zn2+   Zinc 
γH2A.X  Gamma-H2A histone family, member X   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  	  	  
  7	  
1. Introduction 
 
1.1 Signaling 	  
 
Higher organisms are constantly exposed to environmental (extrinsic) and 
endogenous (intrinsic) changes. They need to react to these changes in a fast and 
appropriate (reproducible) manner. Signaling is a cellular language which was 
optimized through evolution for exactly those purposes (1). Cells communicate via 
receptor mediated signaling over short (paracrine signaling) or long (endocrine 
signaling) distances. Cellular signaling events depend on second messengers, 
allosteric mechanisms, positive and negative regulatory events, as well as the 
subcellular localization of molecules. One important mechanism to pass the signal on 
is by regulated modification of proteins with chemical groups (posttranslational 
modifications) during or after their synthesis. Phosphorylation is an important 
posttranslational modification of proteins, during which they receive a phosphate 
group. This phosphate group is able to change the protein structure due to its highly 
negative charge, and in the case of enzymes it can affect their catalytic activity (2, 3).  
Once transduced into the cell, the signal must be propagated into the nucleus to allow 
the cell to react on the extracellular stimulus by activating gene transcription. Gene 
transcription is a way to transform the signaling into molecular building blocks, such 
as proteins or RNAs, which are essentially required for a physiological response to 
the stimuli.  
Feedback loops are an important feature of cellular signaling allowing the fine-tuning 
of the system (4). There are two general types of feedback mechanisms. The first one 
relies on the presence of components which undergo posttranslational modifications 
for immediate modification of the output (5). The second relies on newly synthesized 
components (induced early genes / delayed early genes) for better temporal system 
control and robustness (1). 
 
1.1.1 Principles of cellular kinase signaling 	  
To coordinate and integrate highly complex cellular process decisions including cell 
growth, proliferation, differentiation and apoptosis, multicellular organisms have 
developed sophisticated networks based on phosphorylation events of proteins in all 
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cellular compartments from the cellular membrane to the nucleus (6). Extracellular 
stimuli are perceived at the cell membrane via receptor protein-tyrosine kinases 
(RPTKs or shortly RTKs). RTKs are integral trans-membrane fusion proteins 
consisting of a highly variable extracellular domain and a conserved cytoplasmic 
protein kinase domain (7). Extracellular or environmental signals in form of peptide- 
or steroid-based ligands stimulate the activity of RTKs by direct interaction with the 
extracellular-ligand binding domain (e.g., regulation of blood sugar through activation 
of the insulin receptor (RTK) by insulin (ligand)) (8). Ligand binding induces 
dimerization of the RTK leading to its enzymatic activation and auto-phosphorylation 
of Tyr residues outside the kinase domain in its cytoplasmic region (9). 
Phosphorylated Tyr is an important mark to further stimulate a cascade which is 
mediated by protein-protein interactions via SH2/3 or PTB domain-containing 
adaptors (10). Adaptor proteins recruit effector proteins to the RTK in a 
phosphorylation dependent manner, for instance, cellular kinases which in turn 
become active and initiate a phosphorylation cascade. In the case of mitogen activated 
protein kinase (MAPK) signaling, multiple phosphorylation events result in the 
activation of a terminal kinase (ERK, p38 or JNK) which translocates into the nucleus 
and drives gene expression (11). A vast number of nuclear transcription factors 
regulates the physiological outcome of the different MAPK circuits, ranging from cell 
growth, division, proliferation, cell cycle arrest and apoptosis (12). Signal 
transduction can also be achieved via signaling molecules which contain 
phospholipid-binding domains (PHD, pleckstrin homology domain), as in the case of 
protein kinase B (PKB, also called AKT) activation by the phosphoinositide-
dependent kinase-1 (PDK1) (13). Recruitment of AKT and PDK1 to the cell 
membrane via their PHD domains brings PDK1 in close proximity to AKT, leading to 
AKT activation by phosphorylation through PDK1 (14). Alternatively, signal 
transduction can be achieved by direct or indirect activation of transcription factors in 
the cytoplasm as in the case of STAT or NF-κB signaling, or through phospholipid-
derived second messengers and receptor induced cytoplasmic and nuclear calcium 
(Ca2+) shifts (15-17) (see 1.4). 
 
1.1.2 Evolution of regulatory mechanisms of kinase signaling 	  
In the course of the evolution from unicellular to multicellular organisms, signal 
transduction evolved into a multilayered highly interconnected system that allows 
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higher organisms to quickly adapt to environmental signals (18). One crucial event 
was the evolution of RTKs, which are exclusively found in multicellular organisms 
and are believed to be a product of repeated gene fusion events between primordial 
binding proteins and intracellular tyrosine kinases. To reach the full complexity of 
multicellular signaling networks, RTKs and cellular signaling molecules encountered 
duplication of their encoding genes, allowing the expression of slightly different 
proteins, which resulted in dense interconnections (formation of hubs or nodes) and 
novel regulatory mechanisms such as feedback loops (19). The modular composition 
of molecules is another way to involve the same protein for different changing 
environments. One example is the utilization of PI3 kinases for mediating metabolic 
signaling in response to insulin and at the same time for activating cell proliferation in 
response to growth factors in one and the same cell, a process which can only be 
achieved by tethering PI3K via different adaptor proteins to different RTKs (6). 
Modularity enables thus reutilization of genetic circuits (PI3K signaling) in different 
biological settings (metabolism vs. proliferation). The much larger number of 
different RTKs in vertebrates (58) as compared to nematodes (12) indicates how 
higher organisms managed to evolve complex multilayered and interconnected 
signaling networks at a comparable genome size. 
 
1.1.3 Regulation of signaling by Protein kinase C (PKC) 	  
An important kinase, which is modulated by Ca2+ and PLC-dependent generation of 
diacylglycerol (DAG, also called DG), is the protein kinase C (PKC). The PKC 
family comprises 10 members, which are classified into three groups based on their 
domain composition (20). PKCα, -βI/II and -γ belong to the conventional group, 
PKCδ, -ε, -η and -θ to the novel group, and finally PKCζ and -ι to the atypical group 
(Fig. 1). The basic structure is composed of a N-terminal regulatory domain followed 
by the kinase and carboxyterminal (CT) domain. The regulatory domain is subdivided 
into the C1 and C2 domain, which can bind DAG or Ca2+, respectively (Fig. 1). The 
regulatory domain is the basis for distinguishing different PKC groups and determines 
the activation pattern: conventional PKCs are potently induced by Ca2+ and DAG, 
novel PKCs by DAG, and atypical PKCs lacking the C1 and C2 domains are activated 
by an independent mechanism (20). For complete activation all groups are matured by 
PDK1-dependent phosphorylation in the activation loop of the catalytic domain (21), 
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and the mammalian target of rapamycin 2 (mTORC2) kinase complex phosphorylates 
PKCs in the CT domain (22). Interestingly, in absence of maturation PKCs undergo 
complete proteolytic degradation, pointing at a tightly regulated mechanism of 
preventing signal transduction leakage (22, 23). A mature PKC can be eventually 
fully activated by secondary messengers. Signal-dependent increase in cytosolic Ca2+  
mediated by IP3-dependent store depletion of the ER (see chapter 1.4) is bound by the 
C2 domain of conventional PKCs (α-γ) and leads to their translocation to the cell 
membrane (24). At the cell membrane its C1 domain interacts with membrane-bound 
DAG, which has been generated trough stimulus dependent PIP3 cleavage by PLC. 
Mature and activated PKC is subsequently able to target substrate proteins by 
phosphorylation.  
 
 
Figure 1. Protein kinase C (PKC) family members.  A: Domain structure of PKC family members, 
showing pseudosubstrate (green rectangle), C1 domain [orange rectangle; Y/W switch that determines 
affinity for diacylglycerol (DG)-containing membranes depicted by circle in C1B domain], C2 domain 
[yellow rectangle; basic patch that governs binding to PIP2 (phosphatidylinositol-4,5-bisphosphate), 
marked by oval with ++], connecting hinge segment, kinase domain (cyan), and carboxyl-terminal tail 
(CT; dark blue rectangle). The 3 priming phosphorylations in the kinase domain and CT are indicated 
with numbering for PKCβII, PKCε, and PKCζ (note atypical PKC isozymes have Glu at phosphor-
acceptor position of hydrophobic motif). B: Dependence of PKC members on C1 domain cofactors, 
DG, and phosphatidylserine (PS) and C2 domain cofactors Ca2+ and PIP2. (Adapted from (20)) 
 
In contrast, novel PKCs (δ-θ) do not require Ca2+ for their translocation to the 
membrane because the loss of a C2 domain improved the affinity of their C1 domain 
towards DAG, thus making the novel PKC group independent of Ca2+ (25). 
Negative regulation of PKCs is achieved by proteolytic degradation upon sustained 
stimulation (26). In vitro such degradation can be mimicked by prolonged activation 
with phorbol-esters such as phorbol 12-myristate 13-acetate (PMA) (27, 28). The 
presence of PMA on one hand activates PKCs by mimicking the presence of DAG. 
Prolonged activation, on the other hand induces dephosphorylation of the PKC’s 
priming phosphate groups, leading to quick proteolytic degradation.  
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Cellular processes regulated by PKC signaling have been widely studied using small 
molecule ATP-competitive inhibitors, including the Bisindolylmaleimide (BIM) class 
of highly potent (nM range) and selective inhibitors (29). Interestingly, inhibition of 
PKCs by ATP competitive inhibitors such as BIM-1 (GF109203X) led to retention 
and even increase of the phosphorylation at the priming sites (30). One possible 
explanation is the increased protein stability in the presence of PKC inhibitors leading 
to increased priming, therefore also suggesting an induced-fit model of PKC priming 
in presence of ATP bound in the catalytic cleft. As mentioned above, priming is 
crucial for full activation of PKC, however, the substitution of ATP by ATP-
competitive inhibitors is preventing any downstream signaling due to the absence of 
ATP as a substrate.   
 
1.2 Genotoxic stress 
 
Cells are constantly harmed by DNA damaging agents from external and endogenous 
sources and must protect their genetic information in order to assure faithful 
reproduction and genomic stability, otherwise this would lead to malignancies such as 
cancer (31) (see also 1.2.4). Typical genome hazards from external sources include 
UV and ionizing radiation (IR), as well as anthropogenic release of chemicals into the 
environment (e.g., cigarette smoke is responsible for the majority of lung cancers in 
man and women in the US) (32). Endogenous sources include byproducts of aerobic 
metabolism such as ROS (superoxide anions, hydroxyl radicals and hydrogen 
peroxide) derived from oxidative respiration and lipid peroxidation, as well as 
spontaneous disintegration of DNA bonds and replication errors under physiological 
conditions (31). Genotoxic stress is a life-threatening event for organisms as it alters 
the content and organization of the genetic material. The cellular responses to this 
danger are diverse and culminate in the activation of cell-cycle checkpoints and DNA 
repair pathways, or, in certain contexts, initiation of apoptotic programs (31, 33, 34). 
Regulation of these processes is accompanied by changes of the proteome, including 
altered protein expression levels or induced post-translational modifications.  
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1.2.1 Different types of DNA damage  induce distinct repair responses 	  
On the level of the DNA, damaging agents induce different types of DNA breaks and 
lesions, which require sophisticated repair machineries to prevent inheritance of 
lesions into the next generation (31) (Fig. 2).  
 
 
Figure 2. Cellular responses to DNA damage (35). 
 
In general, different types of DNA lesions may block transcription, which can only be 
resumed by transcription-coupled repair (TCR) via RNA Pol II displacement and 
subsequent recruitment of the repair machinery (36). Global genome nucleotide-
excision repair (ggNER) is another sub-pathway activated in response to bulky DNA 
lesions upon UV-damage, and follows a similar repair mechanism as in case of TCR. 
Interestingly, somatic mutations which occur in one of the repair machinery members 
of ggNER or TCR pathways strongly predispose individuals to sun-induced skin 
cancer (31). On the other hand, DNA damage may also block DNA replication. In that 
case, particular translesion synthesis (TLS) DNA polymerases (Rev1, Pol ζ, Pol κ, Pol 
η, and Pol ι) bypass the damage and thereby promote replication at the expense of 
introducing new mutations due to its flexible base-pairing properties (37).  
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In the case of oxidative DNA damage, formation of DNA strand adducts through 
oxygenation (8-Oxo-guanine), deamination (of all bases), hydroxylation (8-
hydroxylated guanine) or methylation (O-6-Methylguanine) as well as direct 
formation of DNA single-strand breaks (SSBs) make up the majority of lesions, 
which are potent inducers of the base-excision repair pathway (BER) (38, 39). As in 
the case of NER, mutations in SSB repair pathways are linked to different diseases, 
such as cancer and neurodegenerative diseases (40).  
The most cytotoxic but also mutagenic DNA lesions are DNA double strand breaks 
(DSBs). DSBs are typically induced upon high energy IR with X- and γ-rays (41) (see 
also 1.2.2). While naturally occurring radioisotopes or cosmic ray particles are 
responsible for γ-rays, X-ray photons can be generated artificially in a vacuum tube 
by electron acceleration against a metal anode. X-rays are used for many biological 
and medical applications, such as the determination of protein structure by X-ray 
crystallography or in diagnostic radiography and external-beam radiotherapy in 
medical care (42-44). Finally, DSBs are also formed during replication of SSBs in 
response to DNA replication fork collapses (45). Independent of the source, once 
DSBs are formed, the cell tries to restore genomic integrity in many ways, including 
checkpoint / transcriptional activation as well as induction of cell death (apoptosis) in 
cases of severe DNA damage. All of the previously mentioned DNA repair responses, 
also termed the DNA damage response (DDR), are however activated with the central 
goal to repair the damaged DNA and to facilitate DNA replication (46). DSBs can be 
either sealed by non-homologous end joining (NHEJ), which is on the one hand error 
prone but active in all phases of the cell cycle (47, 48). Alternatively, if the damage is 
encountered in the S/G2/M phase, DSBs can be repaired by homologous 
recombination (HR), which relies on the presence of sister chromatids and is thus less 
error-prone than NHEJ (35, 47, 49).  
 
1.2.2 DNA double strand break-induced ATM signaling  	  
Besides the induction of repair, DSBs also activate a signal transduction cascade, 
which is orchestrated by the ATM kinase as well as its close homologues ATR and 
DNA-PKcs with partly redundant functions (46, 50, 51). ATM belongs to a family of 
PI3K like kinases (PIKKs) together with ataxia-telangiectasia and Rad3-related 
(ATR), the catalytic subunit of DNA-PK (DNA-PKcs) as well as other PIKKs 
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(hSMG-1, mTOR and TRRAP), which either have a minor or no role in the DDR (52). 
While DNA-PKcs is a repair factor of the NHEJ pathway, the ATR kinase plays a 
role in the surveillance of replication stress and critically regulates maintenance of 
DNA replication. ATR knockout mice show embryonic lethality and patients with 
mutations in this gene develop syndromes which are characterized by growth 
retardation, dwarfism, microcephaly and mental retardation, as well as defects in the 
DDR (53, 54). These studies indicate ATR’s crucial role in developmental processes, 
while a recent study could also show ATR’s involvement in the classical DSB-
induced DDR (55). Even though the precise mechanism of ATM activation upon 
DSBs is under debate, the DSB-sensing MRN-complex seems to be at the forefront, at 
least when it comes to complete activation of the kinase (56-59). However, a recent 
study could also show a direct mechanism of ATM activation in the presence of H2O2 
but independent of double strand DNA damages (60). Oxidation of a critical Cys 
residue leads to homo-dimerization via disulfide bond formation and activation in the 
absence of MRN and DNA (61). Independent of the precise mechanism, once 
activated ATM initiates a classical phosphorylation cascade leading to cell cycle 
arrest, transcriptional changes, repair and in some cases apoptosis (50). Several 
proteomic studies recently described the complex network of ATM-regulated 
downstream targets in response to DSB-inducing agents (62, 63).  
One of the early-induced targets is H2A.X, which is phosphorylated by ATM (but 
also by other PIKKs of the DDR) at Ser197 in the SQ motif (γ-H2A.X) and serves as 
a well-accepted marker of DSB-induced DNA damage sites (41, 64-66). Despite a 
clear mechanism of its activation, the role of H2A.X in the DDR is still obscure. One 
recent study showed the necessity of phosphorylated H2A.X in the recruitment of 
MDC1 (67). MDC1 on the other hand is crucial for the juxtaposition of ATM in close 
proximity to non-phosphorylated H2A.X as shown by a study using MDC KO mice 
(68). Close proximity lead to ATM-dependent spreading of γ-H2A.X around the 
break sites. This implicates a positive feedback loop, which completes the recognition 
of DSBs and thus indicates γ-H2A.X’s role in facilitating the recognition of DSBs. 
Moreover, indirectly one can argue that γ-H2A.X must serve as a platform for the 
recruitment of DDR factors, since the knockdown of MDC1 prevents recruitment of 
important DDR sensors and repair factors to sites of DNA damage (69). Besides 
phosphorylation, ubiquitylation has also been shown to be a crucial early modification 
of H2A.X, facilitating the recruitment of BRCA1 and 53BP1 which are important 
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repair factors involved in the repair of DSBs by the HR pathway (70). To describe a 
general picture of epigenetic changes induced upon DNA damage, Steve Jackson’s 
lab performed a small-scale screen using PTM-specific histone antibodies (71). 
Interestingly, most of the well-known histone marks involved in epigenetic silencing 
or activation of gene expression remained unchanged upon treatment with a DNA 
intercalating DSB-inducing agent. However, the two new acetylation sites H3K9ac 
and H3K56ac could be added to the DDR-dependent histone code and were decreased 
upon DSB-induction. Interestingly, previously believed DDR-dependent changes like 
H3S10p, H3S28p and H3.3S31p were shown to be a consequence of DDR-dependent 
cell cycle changes rather than a direct DDR-dependent signaling mediated event. The 
absence of DDR induced histone mark changes could be also shown by yet another 
study on DSB-induced H3K79me changes (72). Even though crucial for the 
recruitment of the HR repair factor 53BP1 to DNA damage sites, methylation of H3 at 
Lys79 was not induced directly by DSBs. One explanation could be the induction of 
higher-order chromatin structure changes upon DNA breaks, which indirectly lead to 
H3K79 methylation and recruitment of 53BP1 to methylated histones residing at 
DNA breaks. Acetylation and methylation of non-histone substrates have also been 
described to be under control of the DDR (73-76).  
Until recently, DDR-induced signaling events have been traditionally placed 
downstream of the induction of DNA breaks and the research focus has been majorly 
set on signaling-dependent regulation of processes in the nucleus. New sophisticated 
proteomics and bioinformatics studies, however, expanded the DDR signaling 
network to the cytoplasm (62, 63, 77-80). Indeed, targeted approaches have identified 
many canonical cytoplasmic signaling pathways that are regulated by the DDR (e.g., 
NF-κB pathway (81-83), MEK-ERK pathway (84, 85), AKT/PKB pathway (86), p38-
MAPKAP2 pathway (87, 88) and many more (89)). Comparison between different 
types of post-translational modifications, induced by the ATM-mediated DDR, could 
show that phosphorylation events are predominant over acetylation of proteins, 
arguably pointing to kinase-dependent signal transduction as the crucial outcome of 
the DDR (78).  
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1.2.3 ATM-induced cell cycle arrest 	  
The major outcome of ATM activation, besides γ-H2A.X formation, is the activation 
of checkpoints for cell cycle arrest upon DNA damage (35). Cell cycle transition into 
S-phase is a two-waved G1 checkpoint response (90). However, a very early response 
regulated by DDR can also affect the phosphorylation status of the retinoblastoma 
protein (Rb), which controls transition through the restriction point in G1 via E2F. Rb 
is usually kept phosphorylated by the CDK4/6-Cyclin D complex, which releases E2F 
and drives cell cycle transition through the restriction point (91). However, upon 
starvation as well as under stress conditions, such as genotoxic stress, Cyclin D is 
phosphorylated on Thr286. Consequently, Cyclin D is degraded and Rb becomes 
hypo-phosphorylated, which keeps E2F in an inhibitory grip and blocks transition 
through the restriction point (91, 92). The first wave of the DDR-dependent G1/S 
arrest relies on Chk1/2 dependent phosphorylation of Cdc25A, leading to its 
ubiquitinylation-dependent proteasomal degradation (93). Cdc25A is a phosphatase 
which targets CDK2 for dephosphorylation on Tyr15. Tyr15 phosphorylation on the 
other hand, is an inhibitory modification, which prevents activation of the Cyclin E-
CDK2 complex. Consequently, degradation of Cdc25A keeps CDK2 modified in an 
inhibited state, thus blocking early G1/S transition in a fast and highly regulated 
manner without the need for time consuming transcriptional changes (90). In parallel, 
the DDR induces a second signaling cascade, which relies on the stabilization of p53 
by phosphorylation and thus leads to transcription of the general CDK inhibitor p21 
(94). In response to severe DNA damage, a permanent cell cycle arrest in G1 can be 
established by p16Ink4a, which is a CDK4/6 inhibitor (95, 96). The state of permanent 
cell cycle arrest is called senescence and is believed to be a crucial mechanism for 
cancer prevention (97). Besides a G1/S cell cycle arrest, the DDR can also induce an 
intra-S-phase or G2/M checkpoint. Like for the G1/S arrest, the G2/M checkpoint 
relies on the action of Cdc25 phosphatases, but Cdc25B and C are functionally 
inactivated in order to preserve an inhibitory phosphorylation on CDK1 (98). CDK1 
can also be directly phosphorylated on the inhibitory site Ser15 (like CDK2), which 
prevents complex formation between CDK1 and Cyclin B and thus arrests the cell 
cycle in G2/M (99). 
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1.2.4 DNA damage and cancer 	  
DNA damage and subsequent mutation of the information is the first step in tumor 
formation because it enables the evolution of the six hallmarks of cancer (97). Cancer 
development or malignant transformation of benign tissue relies on a set of hallmark 
capabilities, which initiate tumor growth and drive metastatic dissemination (97). 
Sustained proliferation through reprogramming of cellular signaling is one of the 
hallmarks of cancer.  
Two classes of cancer genes are affected by mutations: the so-called “gatekeepers” 
and “caretakers” (100). Gatekeepers combine oncogenes and tumor suppressor genes, 
which in case of gain-of-function (oncogenes) or loss-of-function (suppressors) 
mutations all increase tumor cell growth and proliferation. Caretakers, on the other 
hand, code for repair proteins of DNA repair pathways (Chapter 1.2.1) and, as the 
name implicates, try to maintain or take care of the genome integrity, which is 
constantly endangered from endogenous and exogenous DNA damaging sources. In 
contrast to caretakers, only mutations in gatekeepers affect net cell growth and 
therefore are the main drivers for the establishment of the hallmarks (101). On the 
other hand, only the presence of mutated caretakers predisposes cells to become 
cancer cells. Indeed, all of the known caretaker gene mutations have been shown to 
occur in the germ line and, based on the multiple-hit theory, are usually the first hit in 
cancer progression (102).  
 
1.3 Oxidative stress  
 
Oxidative stress is caused by environmental factors (pollutants such as cigarette 
smoke, high doses of radiation), as well as due to endogenous oxygen metabolism 
(aerobic respiration in mitochondria, different oxidases, cytochrome P450 family or 
NO synthases) (103). The production of superoxide anions (O2-) during aerobic 
respiration in mitochondria is the major source of endogenous ROS, and the 
mitochondrial superoxide dismutase (SOD) converts O2- into hydrogen peroxide 
(H2O2). H2O2 is membrane permeable and further ionized to highly reactive hydroxyl 
(HO) radicals in the presence of iron (Fenton reaction). Cytoplasmic accumulation of 
ROS induces oxidative stress conditions which, as described in chapter 1.3.1, can 
cause ER-stress induced unfolded protein response (UPR), lipid peroxidation in 
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presence of trace metals, as well as harm genomic integrity due to the introduction of 
oxidative DNA base lesions as well as the direct induction of SSBs.	  
 
1.3.1 Reactive oxygen species (ROS) and their role in cellular signaling 	  
Even though discussed so far controversial, there is a growing body of evidence 
which indicates the potential role of ROS in regulating cellular signaling events (104, 
105). The basis for the skepticism stems from the fact that ROS is highly reactive and 
thus leads to oxidation of organic macromolecules (proteins, lipids, DNA) and 
induces cytotoxicity in an uncontrollable manner. Even though true for free radical 
oxidants, for instance superoxide (O2-), nitric oxide (NO) or hydroxyl (HO) radicals, 
hydrogen peroxide (H2O2) as well as superoxide anions (O2-) exhibit lower reactivity 
with macromolecules. In fact, free radical chain reactions in cellular systems are kept 
at a very low level, and in the presence of detoxifying enzymes (e.g., SOD) the 
balance is shifted to less reactive, non-radical O2-, H2O2 or peroxynitrite (NO3-) (106-
108). Interestingly, signaling mediated by O2- or H2O2 can directly involve oxidation 
of regulatory Cys residues in a protein, as has been shown for the bacterial 
transcription factor SoxR, the molecular H2O2 sensor OxyR and the molecular 
chaperone Hsp33 (109-112). In the case of SoxR, oxidation of 2Fe-2S clusters leads 
to a conformational change and binding to a DNA-operator, which results in gene 
expression. The presence of heat and H2O2 activate Hsp33, which is a redox-regulated 
chaperone expressed in E. coli (112). Hsp33 contains a tetrahedral Zn2+ which is 
coordinated by a four-Cys zinc-binding motif. Under reducing conditions, Cys-bound 
Zn2+ keeps Hsp33 in an inactive conformation. In the presence of H2O2, Cys oxidation 
leads to disulfide bond formation and repulsion of the Zn2+, which results in an active 
chaperone (113). Redox-regulated signal transduction proteins were also found in 
higher eukaryotes (105, 106). Reversible oxidation-reduction of Cys and potentially 
also Met residues can, for example, regulate the enzymatic activity as an “on-off” 
switch, enhance or reduce the enzymatic activity (allosteric regulation), or change 
macromolecular interactions. In all cases, the protein function can be modulated by 
direct oxidation of Cys to form disulfide bond formation, S-Glutathionylation (GS-
lyation) and S-Nitrosylation (114). Examples for on-off switches include direct 
oxidation of protein tyrosine phosphatase-1B, GS-lyation of GAPDH, NF-κB and 
caspase 3 (115-118). Moreover, Cys residues have been found in detoxifying enzymes 
such as glutathione transferase (GST), cytochrom P450, thioredoxin (Trx), as well as 
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peroxiredoxin (Prx). Allosteric regulation of enzymes by redox-dependent 
mechanisms has been shown for different signal transduction factors, such as RAS or 
NMDA-receptor (119, 120). Thanks to modern proteomics analysis by mass 
spectrometry, many more redox-regulated proteins have been identified and the 
already huge list of redox-regulated proteins has been significantly extended (121, 
122).  
 
1.3.2 Cellular redox-system and antioxidant response 	  
To counteract oxidative stress conditions, cells have evolved antioxidant defense 
mechanisms comprised of scavenging enzymes such as superoxide dismutase (SOD), 
glutathione peroxidase (GPX), catalase and thioredoxin reductase (TrxR) (106) In 
addition, radical-scavenging chemicals such as Vitamin E and C can provide another 
protection against ROS (123). Several redox systems (e.g., NAD+/NADH, 
NADP+/NADPH, and oxidized glutathione/reduced glutathione (GSSG/GSH)) keep 
the cytosol in a reduced state and ensure redox homeostasis despite the presence of 
ROS (124). Reducing conditions in the cytosol are very important to maintain 
cysteine residues in their reduced state, which conserves many proteins in their three-
dimensional confirmation.  By contrast, the ER has an oxidizing milieu which is 
required for disulfide bond formation of nascent polypeptide chains during protein 
biosynthesis (125). One way to keep the ER in an oxidized state is to maintain a 
smaller GSH/GSSG ratio. Indeed the ratio of GSH/GSSG in the ER is between 1:1 
and 1:3 and thus about 30 times smaller than in the cytosol (30:1 to 100:1) (126). 
Even though the mechanism of increased GSSG maintenance in the ER is still under 
debate, one proposal is based on the function of ER oxidoreductin 1 (Ero1) (125). 
Ero1 assists protein disulfide isomerase (PDI) in disulfide bond formation of nascent 
polypeptides and generates ROS as a byproduct by transferring electrons from PDI to 
molecular oxygen (127). Detoxification of ROS in presence of GSH would eventually 
accumulate GSSG and maintain an oxidizing milieu. 
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1.3.3 Involvement of the Endoplasmic reticulum (ER) during oxidative stress 	  
The endoplasmic reticulum (ER) is a cellular organelle that is organized in a tubular 
and sac-shaped structure and is responsible for the biosynthesis, folding, assembly 
and post-translational modifications of cellular proteins (128). In addition, it also 
serves as a major intracellular Ca2+ store, which makes it an important signaling 
regulator through the dynamic release of this second messenger (17) (see chapter 1.4). 
Stress conditions such as oxidative stress lead to increased protein miss-folding and 
result in ER-stress and an unfolded protein response (UPR) when the folding capacity 
of the ER is exceeded (129). UPR regulates a signaling cascade, majorly aiming to 
reverse these stress conditions. This cascade is based on ER stress protein-sensors 
(e.g., IRE1α, PERK and ATF6), which are kept inactive by interacting with the 
abundant ER chaperone BiP (immunoglobulin-heavy-chain-binding protein, also 
called GRP78). Upon ER-stress, however, BiP is rapidly sequestered from the sensors 
through the interaction with misfolded polypeptides, thus leading to the activation of 
the ER-stress sensors (130). Major physiological outcomes of these activation events 
include ATF4 mediated transcriptional expression of UPR-target genes, involved in 
amino-acid biosynthesis and antioxidant response, as well as ATF6 and XBP1 
mediated transcriptional expression of genes encoding ER chaperones and enzymes 
that promote protein folding, maturation, secretion and ER-associated protein 
degradation (ERAD) (131, 132). However, if the cell fails to resolve the ER stress 
condition, extended activation of the ER-stress sensors ATF6 and PERK induce the 
transcription of CCAAT/enhancer-binding protein (CHOP), which is the main 
apoptosis mediator of the UPR (124). Other pro-apoptotic pathways in response to 
UPR include Bak/Bax-regulated Ca2+ release from the ER, IRE1α induction of the 
pro-apoptotic ASK1/JNK pathway, and cleavage-dependent activation of pro-caspase 
12 (inflammatory pro-caspase). Reduction of the ER-stress by reversing incorrect 
protein folding and recycling misfolded proteins by proteasomal degradation is 
crucial for cell survival and growth (133). Moreover, if the balance is shifted towards 
irreparable conditions, the ER is also able to generate ROS production. Mechanisms 
of ROS production include refolding under oxidizing conditions by PDI and Ero1, 
increased aerobic respiration, and Ca2+ leakage from the ER (124, 134, 135). In all 
cases, either ER-based or generated by the Mitochondria, ROS production is a threat 
to genomic integrity and for the sake of genome stability programmed cell death is a 
typical consequence as a last resort (136).  
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1.4 Calcium (Ca2+) signaling 
 
Ca2+ as a second messenger is an important player in intra- and extracellular signaling 
events (17, 137). In a resting cell, Ca2+ is maintained at low cytosolic concentrations 
of about 100 nM, while in response to stimuli its levels can reach up to 1000 nM (10 
fold increase) (137). Furthermore, its concentration in the extracellular matrix is in the 
mM range and the cell invests a lot of energy in extruding Ca2+ from the cytosol. 
Keeping cytosolic Ca2+ levels at a very minimum is important, since Ca2+ levels 
above a particular threshold are potent inducers of apoptosis (138) (see chapter 1.4.2). 
Even though the induction of apoptosis is a major function of Ca2+ signaling, it also 
regulates many cellular and physiological functions that are important for living cells, 
such as fertilization of mammalian eggs as well as during embryonic development of 
zebrafish, Xenopus and Drosophila embryos (139-142). Mammalian physiological 
processes include Ca2+ dependent regulation of cardiac muscle contraction (143) and 
neuronal function (144). On the cellular level Ca2+ regulates cell differentiation (145), 
the cell cycle and proliferation (146), and transcriptional activation (147-149). Its 
deregulation has also been reported to cause cancer (150, 151). 
 
1.4.1 Regulation of intracellular Ca2+ levels 	  
Depending on the stimulus, Ca2+ can be either released from external (extra-cellular 
medium) or internal stores of which ER is the major source. The Ca2+ concentrations 
in the ER are around 100 µM and the two major ion channels regulating its release are 
inositol-1,4,5-trisphosphate receptor (IP3R) and ryanodine receptor (RYR) (152). 
Depending on the stimulus, these channels are activated by different secondary 
messengers in which Ca2+ itself is an important regulator. The so-called Ca2+ induced 
Ca2+ release (CICR) is a mechanism through which changes of ER-luminal or 
cytosolic Ca2+ can sensitize IP3Rs or RYRs and either act inhibitory or stimulatory, 
depending on the concentration of the secondary messenger. For IP3R concentrations 
below 300 nM are stimulatory, while concentrations above 300 - 500 nM are 
inhibitory (153). However, for complete activation, IP3R has to be stimulated by the 
IP3 secondary messenger (138). In response to extracellular stimuli, for instance 
growth factors, G protein-coupled receptors (GPCRs) or RTKs activate PLC (β in 
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case of GPCR or γ in case of RTK), which in turn performs cleavage of PIP2 and thus 
generates the previously mentioned IP3 as well as diacylglycerol (DAG) secondary 
messengers (154) (Fig. 3). Activation of other PLC isoforms can be achieved by 
elevated cytosolic Ca2+ levels (PLCδ pumped in from the ECM or mitochondria) or 
through activation by RAS (PLCε) (17, 155). Interestingly, IP3R changes its 
sensitivity to Ca2+ upon binding of IP3 and becomes insensitive to inhibition by Ca2+ 
(138). Hence, activation of IP3R by IP3 causes complete store depletion, which can 
only be prevented by a decline of the external stimulus.  
 
Figure 3. Calcium-mobilizing messengers and modulators. Ca2+ release is regulated by various 
second messengers or modulators from internal stores by the inositol-1,4,5-trisphosphate receptor 
(Ins(1,4,5)P3R) or the ryanodine receptor (RYR). Activation of these channels is sensitive to factors 
from the cytosol and from the endoplasmic/sarcoplasmic reticulum (ER/SR). The Ins(1,4,5)P3R is 
regulated by inositol-1,4,5-trisphosphate (Ins(1,4,5)P3 and phospholipase C (PLC; β, δ, ε, γ and ζ).  
The nucleotides cyclic ADP ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate 
(NAADP) are produced by the synthase and hydrolase activity of ADP ribosyl cyclase, which is 
sensitive to the cellular metabolism. cADPR is described to regulate the sarco(endo)plasmic reticulum 
Ca2+-ATPase (SERCA) pump, which regulates the uptake of Ca2+ into the lumen of the ER, resulting 
in sensitization of the RYR. NAADP has an impact on a channel, located on a lysosomal-like organelle 
to release Ca2+ that can either stimulate the Ins(1,4,5)P3R or the RYR directly, or indirectly by 
increasing Ca2+ levels in the lumen of the ER (17). 
 
In contrast, RYRs are sensitized to elevated Ca2+ levels by cyclic-ADP-ribose 
(cADPR). CD38 (ADP-ribosyl cyclase) uses NAD+ as a substrate to generate cADPR, 
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but is also able to hydrolyze cADPR to ADP-ribose (ADPR) (156) (Fig. 3). ADPR in 
turn has been previously shown to activate the melastatin-related transient receptor 
potential channel 2 (TRPM2) channel and to induce Ca2+ influx into the cytosol (157). 
Interestingly, low concentrations of cADPR (around 10 µM) only sensitize TRPM2, 
and ADPR is required for full activation. On the other hand, cADPR concentrations 
above 100 µM are sufficient to fully activate TRPM2 in the absence of ADPR (158). 
Altogether, these data indicate a fine-tuning mechanism for Ca2+ influx, which 
involves CD38-induced potentiation of TRPM2 via cADPR and ADPR and 
consecutive stimulation of ER-based Ca2+ channels (RYR or IP3R). Even though 
crucial for RYRs potentiation, additional Ca2+ signaling modulators besides cADPR, 
for example CaM/CaMKII, FK-506-binding proteins, mAKAP/PKA, 
P130/calcineurin and many more, were shown to regulate the channel (159). Other 
channels, which regulate Ca2+ entry into the cytosol, include voltage-operated 
channels (VOCs), receptor-operated channels (ROCs), store-operated channels 
(SOCs) and, as already mentioned above, transient receptor potential (TRP) channels, 
most of which are involved in regulating Ca2+ entry from the ECM (17, 160). Once 
Ca2+ has reached a cytosolic threshold concentration, different signaling events and 
outcomes (mentioned above and in chapter 1.4.2 and 1.4.3) are initiated.  
 
1.4.2 Ca2+ release and mitochondria 	  
In response to stress conditions such as ER- and oxidative stress (chapter 1.3), Ca2+ 
fluxes from the ECM and intracellular stores (ER) can rise cytosolic Ca2+ in the µM 
range. A major outcome of increased cytosolic Ca2+ levels is permeabilization of the 
mitochondrial membrane leading to membrane swelling, rupture and opening of the 
mitochondrial permeability transition pore (PTP), which subsequently leads to 
apoptosis (161). In fact cross talk between mitochondrial and ER Ca2+ flux exists, 
which can induce a vicious circle if initiated by stress stimuli such as ER-stress or 
oxidative stress (124). As previously mentioned in chapter 1.3, oxidative stress can 
overload the ER with unfolded proteins, leading to increased ROS production as a 
byproduct of the refolding machinery. A positive feedback loop enhances the UPR, 
thus leading to Ca2+ leakage from the ER. The close proximity of ER to mitochondrial 
outer membrane leads to Ca2+ uptake by the mitochondria, while a major role is 
attributed to the voltage-dependent anion channels (VDACs) in regulating this uptake 
process (162). Furthermore, the anti-apoptotic protein Bcl-2 has been shown to 
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regulate Ca2+ release from the ER, thus preventing mitochondrial Ca2+ overload and 
apoptosis (163). By contrast, Bax, a pro-apoptotic member of the BH3-only family, 
was shown to regulate the opposite effect by increasing Ca2+ availability and inducing 
PTP (164, 165). Nevertheless, increased amount of Ca2+ in the mitochondria 
stimulates the TCA (Krebs cycle) and thereby increases oxygen consumption and 
subsequently ROS generation as a byproduct of oxidative phosphorylation (see 
chapter 1.3). Release of ROS into the cytosol enhances ER stress, thus closing the 
vicious circle, which eventually leads to the opening of the mitochondrial PTP and 
release of apoptosis inducing factors such as cytochrome c, AIF or SMAC/DIABLO, 
which in most cases induce apoptosis in a Caspase-dependent manner (138).  
 
 
1.4.3 Ca2+ signaling through calcium/calmodulin-dependent kinase II (CaMKII) 
 
Ca2+ initiates signaling events also through so-called Ca2+ binding proteins (166). EF-
hand proteins are the major Ca2+ binding proteins (167) and consist of a helix-turn-
helix motif, which stabilizes one Ca2+ atom by 7 negatively charged oxygen atoms 
usually originating from aspartic or glutamic acids. One important EF-hand 
containing Ca2+ binding protein is calmodulin (CaM), which is a ubiquitous adaptor 
protein present in the cytosol with the only purpose to propagate signaling initiated by 
Ca2+ influx (168). Upon the binding of Ca2+, CaM undergoes major conformational 
changes, which expose its hydrophobic surface and allow interaction with other 
proteins. Bound to CaM, these proteins become more active, dimerize or form 
complexes with other proteins. A recent proteome screen increased the quickly 
growing list of CaM-binding proteins (169). Maybe one of the best-characterized 
CaM target proteins is CaMKII, which belongs to the family of calmodulin-dependent 
kinases (CaMKI-IV) (170) (Fig. 4). All CaMKs are Ser/Thr kinases, preferentially 
phosphorylating their target proteins on Ser or Thr of the Arg-X-X-Ser/Thr consensus 
motif (171). Structurally, CaMKs are composed of a N-terminal bi-lobed catalytic 
domain followed by a regulatory domain, which includes an autoinhibitory and CaM 
binding domain. Apart from other CaMK members, CaMKII possess a C-terminal 
association domain, which allows it to form homo-dodecamers leading to the 
assembly of a twelve-subunit holoenzyme (172-174) (Fig. 4A). Once bound to CaM, 
CaMK’s catalytic domain is relieved from its autoinhibition. In case of CaMKII, 
autophosphorylation on Thr286 (alpha) or Thr287 (in beta, gamma or delta) increases 
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the affinity for CaM by more than 1000-fold and generates Ca2+-independent or 
autonomous activity (175, 176) (Fig. 4B). 
 
Figure 4. Structure and function of calcium/calmodulin-dependent kinase II (CaMKII) (177). 
(See text for explanations) 
 
CaMKII alpha and beta are predominantly found in the brain, while gamma and delta 
are expressed throughout the body (178). Due to its high presence in the brain 
(CaMKII alpha and beta) which can reach up to 2% of the whole brain mass, 
CaMKII’s major role is the regulation of synaptic and behavioral plasticity and a 
recently discussed crucial function in memory regulation (179, 180). On the 
molecular level, CaMKII and especially its closely-related cousin CaMKIV, have 
been shown to regulate proliferation by targeting cytoplasmic and nuclear 
transcription factors such as CREB, CREB-binding protein (CBP) ATF, CEBPβ and 
SRF (137, 148, 181). CaMKII was shown to interact and phosphorylate the signal 
transducers and activators of transcription 1 (Stat1) in response to increased cytosolic 
Ca2+ flux induced by IFN-γ (182). Complexation of Ca2+ by BAPTA (specific 
intracellular Ca2+ chelator) prevented Stat1 phosphorylation and target gene 
expression of interferon regulatory factor 1 (IRF-1).  
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1.5 Nuclear ADP-ribosylation in higher organisms 
 
1.5.1 ADP-ribosyltransferases 	  
Poly-ADP-ribose (PAR) is a sugar-based polymer, consisting of covalently linked 
ADP-ribose units and an important nuclear post-translational protein modification, 
which is majorly involved in chromatin-associated processes (183-187). PAR is 
synthesized by a few members of the ARTD family (ADP-ribosyltransferase 
diphtheria toxin-like, originally PARP), consisting of 18 mammalian ARTDs which 
all share the catalytic ART domain, required for ADP-ribosylation (188). While the 
majority of the ARTD family members are only able to catalyze protein mono-ADP-
riboslyation, some ARTDs have been reported to synthesize PAR through 
automodification or transmodificion (i.e. modification of target proteins). The first 6 
ARTD family members (ARTD1-6) are further subdivided into 3 subgroups 
according to their sequences of the catalytic domain, type of their catalytic activity, 
localization and function (187). Members of subgroup 1, including ARTD1-3 
(originally PARP1-3), are characterized by their WGR domain and their ability to 
synthesize large branched PAR polymer in response to various types of stress 
conditions (184, 187, 189). Based on in vitro studies by Altmeyer et al, ARTD3 was 
not able to synthesize PAR, in strong contrast to ARTD1 and 2, which showed clear 
PAR-modification ability in vitro (190). Other groups have reported a catalytically 
active mono-ADP-ribosylating ARTD3, being readily induced by DNA-breaks in 
vitro (191, 192). It remains to be clarified, whether ARTD3 is active as a PAR-
forming enzyme in vivo. Subgroup 2 consists of the single member ARTD4 
(originally vault-PARP), which is localized in the cytoplasm as a component of the 
vault particle, as well as the nucleus associating with the mitotic spindle (193). 
ARTD4 possesses poly-ADP-ribosylation activity and its only function, so far 
reported, has been linked to increased carcinogen-induced tumorigenesis based on 
studies with ARTD4 KO mice (194). Subgroup 3 consists of the two members 
ARTD5 (tankyrase-1) and ARTD6 (tankyrase-2a). These two members possess oligo-
ADP-ribosyltransferase activity and were identified as components of the telomeric 
complex (195), suggesting their crucial role in the cell cycle, especially during mitosis 
by regulating the spindle structure (196). 
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1.5.2 ARTD1- structural aspects 	  
The best-characterized ARTD family member of the “bona-fide” poly-ADP-
ribosyltransferase subfamily is ARTD1 (184, 187). ARTD1 is a 116-kDa nuclear 
enzyme consisting of an N-terminal DNA-binding domain (DBD), followed by a 
central automodification domain (AMD) and a C-terminal catalytic domain (CD or 
CAT) (Fig. 5).  
 
 
Figure 5. Modular domain architecture of human ARTD1. (Adapted from (197)) 
 
The DBD is composed out of two zinc fingers and one zinc binding domain (ZF1/2, 
ZBD or ZF3), a bipartite nuclear localizing sequence (NLS) and a Caspase-3 cleavage 
site lying between the two ZFs and the ZBD. Based on structural studies, all three 
zinc binding domains are involved in recognizing DNA breaks or altered chromatin 
structure, leading to enhanced catalytic activity of ARTD1 (see below) (197, 198). 
The ZBD is believed to regulate chromatin compaction, besides its major role in 
triggering ARTD1’s catalytic activity (199). The AMD contains a BRCT (BRCA1 C-
terminus) fold, which is believed to mediate phosphorylation-dependent protein-
protein interactions involved in cell cycle and DNA repair processes (200). Finally, 
the CD domain is composed of the NAD+ binding motif, also termed as PARP 
signature motif as well as the WGR domain. Based on a recently revealed structure of 
the ZF1/2/ZBD-WGR-CAT bound to a DSB, WGR was shown to be involved in 
DNA break-induced remodeling of an inhibitory helical domain (HD) near the active 
site, eventually triggering ARTD1 activity (197). 
 
1.5.3 Poly-ADP-ribosylation cycle, PAR substrates and PAR hydrolases 	  
In response to genotoxic stress, including oxidative and alkylation stress, ARTD1 
catalyzes the formation of PAR using NAD+ as a substrate (186). PAR is a 
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heterogeneous linear or branched polymer of ADP-ribose (ADPr) units, linked by a 
α(1à2) O-glycosidic bond, reaching a size of 200 - 400 ADPr units. Branching 
occurs every 20-50 elongation reactions (201). The PAR cycle is dived into five 
major steps, with i) Initiation; covalent auto-mono-ADP-ribosylation of the catalytic 
domain, ii) Trans-ADP-ribosylation; the instable initiation adduct is immediately 
trans-ADP-ribosylated to a more stable amino acid residue in the automodification 
domain of ARTD1 or on acceptor proteins by trans-ADP-ribosylation, iii) Elongation; 
polymer elongation involves the catalysis of a 2'–1'' glycosidic bond, whereby the 
postulated covalently bound mono-ADP-ribose serves as a starting unit, iv) Branching 
of the polymer, v) Release of the enzyme-bound branched poly-ADP-ribose, either 
through poly-ADP-ribose-glycohydrolase activities (PARG)) or a putative intrinsic 
poly-ADP-ribosyl-protein-hydrolase activity. Glutamic acid (Glu) residues were early 
shown to serve as acceptor sites for ADPr, however, recent studies by the Hottiger 
and Poirier lab were able to pin-point lysines (Lys) as well as arginines (Arg) as novel 
acceptor sites for automodified ADPr by mass-spectrometry (190, 202-205). The 
major cellular substrate for PAR-modification is ARTD1 itself (190). Other well-
described ARTD1 target proteins are histones, transcription factors and DNA-repair 
proteins (185, 206, 207). As already mentioned above, once formed, PAR is very 
quickly degraded with a predicted half-life of about 5 min in cells. Major PAR 
degrading enzymes belong to the family of endo- and exo- poly(ADP-ribose) 
glycohydrolases (PARG) family, including two cytoplasmic (PARG99 and PARG102) 
and one nuclear (PARG110) localized members (208). Recently another member of 
PAR catabolizing enzymes, ADP-ribosyl hydrolase 3 (ARH3), joined the family of 
PAR degrading catabolizing enzymes (209). 
 
1.5.4 DNA dependent activation of ARTD1 	  
ARTD1 has been recently coined as “cellular rheostat”, integrating different types and 
levels of stress conditions and initiating different cellular responses (184). In response 
to mild or moderate stress it regulates transcription and DNA repair, while upon 
severe and sustained stress conditions, hyper-activation of ARTD1 leads to apoptosis 
or necrosis (210, 211). Independent of the cellular outcome, its activation strongly 
depends on genotoxic stress (187).  In vitro, ARTD1 activity is readily induced in 
presence of naked double and to a lesser extent single-stranded DNA (190, 212). A 
series of studies could also show ARTD1 automodification in presence of double-
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stranded DNA hairpins, cruciforms and loops, indicating activation of ARTD1 by 
high-order DNA structure in a DNA damage independent manner (213, 214). Based 
on early studies both N-terminal zinc fingers (ZF1 and ZF2) were shown to be 
required for its enzymatic activity in presence of broken DNA, however with opposite 
results regarding the DNA specificity of each ZF (215, 216). In response to DSBs, 
ZF1/ZBD and WGR-CAT were shown by the Hottiger and Pascal lab to be essential 
and sufficient for ARTD1 activity in vitro (190, 199). In contrast to that, both N-
terminal zinc fingers (ZF1 and ZF2) were required and sufficient for the activation of 
ARTD1 in presence of DSBs and SSBs as confirmed by the Oliver lab (198).  
Many studies in the past were able to link ARTD1 activity to genotoxic stress in cells 
(45). Upon laser irradiation-induced DNA damage, ARTD1 is quickly recruited to 
sites of damage in a DBD-dependent manner and is required for the recruitment of 
ARTD2 and XRCC1, as shown by live cell microscopy using ARTD1 KO and 
enzymatically inactive mutants (217). Interestingly, recruitment was followed by 
dissociation, which was dependent on the enzymatic activity of ARTD1. These 
findings are in agreement with two recent studies, providing experimental evidences 
for the entrapment of ARTD1 and ARTD2 at DNA break sites in presence of PARP 
inhibitors, thus speaking for a role of PAR in regulating the chromatin compaction 
(218, 219). Altogether, these data contributed to the present model, which places 
ARTD1 activation downstream of DNA break recognition. Its activation leads 
subsequently to automodification, relaxation of the chromatin and a possible 
recruitment of the repair machinery to a DNA break. However, its role in break 
sensing was challenged by a recent study, showing ARTD1-independent recruitment 
of the BER machinery (XRCC1, Pol β) to the chromatin in response to H2O2 doses, 
that would not exceed the repair capacity of the cells, as confirmed by alkaline Comet 
assay and γH2AX staining (220). It still remains to be clarified which precise role 
ARTD1 is playing in DNA repair or genome instability upon genotoxic stress. Its role 
in genome stability is supported by studies based on ARTD1 -/- mice, which are 
viable, but sensitive to genotoxic stress (221-223).  
 
1.5.5 DNA-independent activation of ARTD1 	  
So far, DNA-dependent activation of ARTD1 could only be confirmed in vitro (190, 
197, 198, 212), or indirectly upon genotoxic stress (184).  Nucleosomes (intact DNA 
wrapped around core histones) were however also sufficient to induce ARTD1 
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activity and in fact led even to a stronger activation in comparison to activation by 
DNA fragments (224). Indeed, there is a growing body of evidences, indicating 
involvement of intracellular signaling in the activation of ARTD1 in a DNA break-
independent manner, but dependent on either protein complex formation or post-
translational modifications (225). Among the early observations, Ca2+ signaling has 
been placed upstream of ARTD1 activity in response to peroxynitrite (ONOO) 
treatment (226). Sequestration of ONOO-induced Ca2+ mobilization by Ca2+ chelators 
not only reduced PAR formation, but also decreased the induction of SSBs, indicating 
Ca2+-dependent regulation of ARTD1 activity as well as DNA SSB formation. 
Paradoxically, Ca2+ sequestration lead to increased internucleosomal DNA cleavage 
upon ONOO exposure, while at the same time protecting cells from cytotoxicity 
(226).  
Ca2+-dependent stimulation of ARTD1 activity was also reported in response to β-
lapachone, which is an NQO1-dependent ROS producer (227). Interestingly, studies 
from the Althaus lab could provide evidences for ARTD1-dependent Ca2+ regulation 
in response to lethal hydrogen peroxide doses, thus placing Ca2+ downstream of 
hydrogen peroxide induced ARTD1 activity (228, 229). Independent of the 
discrepancies regarding the physiological outcome in response to Ca2+ mobilization 
upon oxidative stress, the exact mechanism of Ca2+ dependent regulation of ARTD1 
activity is missing. One proposal came from the Cohen-Armon lab, showing ARTD1 
activation by PLC-IP3-dependent Ca2+ mobilization in a DNA-independent manner 
(230), however not providing the direct link from Ca2+ mobilization to ARTD1 
activity. One potential link could be shown by two recent studies, identifying 
calcium/calmodulin-dependent kinase II (CaMKII) as a positive regulator of ARTD1 
activity in neurons (231, 232). In both studies, CamKII directly modified ARTD1 by 
phosphorylation consequently leading to its activation. Positive regulation of ARTD1 
activity was also described for the extracellular signal-regulated kinase (ERK) (233-
235) as well as for c-Jun N-terminal kinase (JNK) (236), while negative regulation of 
ARTD1 by kinase-dependent phosphorylation was described to be under control of 
protein kinase C (PKC) (237-239). 
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2. Aim of the thesis 	  
Cells are constantly harmed by DNA damaging agents from external and endogenous 
sources and must protect its genetic information in order to assure faithful 
reproduction and genomic stability, which otherwise would lead to malignancies such 
as cancer. The response of cells to genotoxic stress is regulated by a sophisticated 
network of signal cascades. The aim of this thesis was to elucidate the components 
regulating cellular response to two different genotoxic stress conditions.  
 Primary human fibroblasts are able to withstand high doses of ionizing 
radiation and prevent radiation-induced apoptosis. However the underlying 
mechanism of radio-resistance remained unclear until now. The first goal of this 
thesis was to describe a kinetic signaling network and functionally identify signaling 
components which are important for survival of primary human fibroblasts in 
response to high doses or ionizing radiation.  
 ARTD1 is a nuclear chromatin associated protein and its enzymatic activity is 
strongly induced upon DNA in vitro. ARTD1 is also strongly activated upon 
oxidative stress in fibroblast. Whether theses two observations are functionally 
interconnected remains to be defined. The second goal of this thesis was to describe 
the H2O2-induced signaling network and to functionally characterize regulatory 
mechanisms of nuclear poly-ADP-ribosylation formation in response to H2O2.   	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3. Results 
3.1 Overview of the published results 
 
3.1.1 PKC signaling prevents irradiation-induced apoptosis of primary human           
         fibroblasts 
 
Authors: Andrej Bluwstein, Nitin Kumar, Karolin Léger, Jens Traenkle, Jan 
van Oostrum, Hubert Rehrauer, Michael Baudis, Michael O. Hottiger 
Journal: Cell Death and Disease 
Contribution: Planning, performing and evaluating the experiments. Preparation of 
the figures and revision of the manuscript. NK and HR analysed 
protein microarray data. KL generated and analysed quantitative PCR 
data. JT, JvO, HR, MB and MOH supervised the study. 
 
3.1.2 Opposite regulation of ADP-ribosylation by PKC signaling: ARTD1 is activated  
         by PKCα and inactivated by PKCδ 
 
Authors: Andrej Bluwstein, Nitin Kumar, Nicole Grosse, Jens Traenkle, 
Barbara van Loon, Michael Baudis, Michael O. Hottiger 
Journal: Manuscript submitted 
Contribution: Planning, performing and evaluating the experiments. Preparation of 
the figures and revision of the manuscript. NK analysed protein 
microarray data. NG performed and analysed comet assay. JT, BvL, 
MB and MOH supervised the study. 
 
3.1.3 Oxidative stress induced poly-ADP-ribose formation is initiated by a calcium- 
         dependent nuclease 
 
Authors: Andrej Bluwstein, Nicole Grosse, Karolin Léger, Barbara van Loon, 
Michael O. Hottiger 
Journal: Manuscript in preparation 
Contribution: Planning, performing and evaluating the experiments. Preparation of 
the figures and revision of the manuscript. NG performed and analysed 
comet assay. KL generated and analysed quantitative PCR data. BvL 
and MOH supervised the study. 
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3.1.1 PKC signaling prevents irradiation-induced apoptosis of primary human 
fibroblasts 	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3.1.2    Opposite regulation of ADP-ribosylation by PKC signaling: ARTD1 is 
activated by PKCα and inactivated by PKCδ 	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Abstract  
ADP-ribosylation is a post-translational protein modification that consists of 
mono- and poly-ADP-ribose (PAR) molecules and which plays important functions in 
epigenetics, transcription and stress responses.  Here, we aimed at identifying 
signaling pathways that are induced early upon the stimulation by oxidative stress 
(e.g., H2O2) and which regulate PAR formation.  We performed a reverse phase 
protein array (RPPA) approach and in-depth kinetic analyses of key signaling 
components of the oxidative stress response.  Even though H2O2 induces strong PAR 
formation within a few minutes, we identified positive and negative regulators of 
PAR formation.  Functional analysis revealed that PKCδ acted as a negative 
modulator of ARTD1 activity, while calcium signaling and PKCα were required for 
H2O2-induced PAR formation.  PKCα caused calcium-dependent DNA breaks, which 
are known to strongly activate PAR formation.  These results implicate for the first 
time calcium- and PKCα-dependent induction of DNA lesions in PAR formation 
during the oxidative stress response.  
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Introduction 
ADP-ribosylation is a post-translational protein modification that consists of 
mono- and poly-ADP-ribose (PAR) molecules that are covalently linked to specific 
residues of target proteins 1.  The linear or branched PAR polymer consists of 200-
400 ADP-ribose moieties that are linked by O-glycosidic ribose-ribose 1’-2’ bonds.  
These modifications are synthesized by a subfamily of ADP-ribosyltransferases 
(ARTs), which use NAD+ as a substrate and belong to the ARTD (ADP-
ribosyltransferase diphtheria toxin-like, originally PARP) family.  In mammalians, the 
ARTD family is comprised of 18 proteins, which contain a catalytic ART domain 
conferring enzymatic activity 2.  The best-characterized ARTD family member is 
ARTD1 (originally PARP1), a 116 kDa nuclear enzyme consisting of an N-terminal 
DNA-binding domain (DBD), a central automodification domain (AMD), and a C-
terminal catalytic domain (CAT) 3.  ARTD1 modifies itself in cis at the 
automodification domain 4 and other target proteins including histones, transcription 
factors and DNA-repair proteins, which points at an important function of ADP-
ribosylation in epigenetics, transcriptional regulation and repair 5.  Indeed, ADP-
ribosylation is implicated in the regulation of a plethora of cellular processes, 
biological phenomena and medical conditions 3,5,6.  
ADP-ribosylation, in particular ARTD1, is strongly activated by oxidative 
stress 1.  The most frequent form of oxidative stress is exerted by reactive oxygen 
species (ROS), which originate from environmental sources (pollutants such as 
cigarette smoke, high doses of irradiation) as well as from endogenous oxygen 
metabolism (aerobic respiration in mitochondria, oxidases, cytochrome P450, NO 
synthases) 7.  ROS lead to the oxidation of organic macromolecules (e.g., proteins, 
lipids, DNA) and consecutively induce cytotoxicity in an uncontrollable manner.  In 
the nucleus, ROS are thus believed to induce DNA damage and to expose DNA strand 
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breaks, which strongly stimulates the enzymatic activity of ARTD1.  However, until 
now it is not clear whether ARTD1 is activated by DNA damage in vivo or if the 
stimulation of ADP-ribosylation in response to oxidative stress is the result of 
signaling events that are not directly linked to DNA damage. 
ARTD1 has recently been termed a “cellular rheostat”, because it integrates 
different types and levels of stress signals 3.  In response to mild or moderate stresses, 
it regulates transcription and DNA repair, while upon severe and sustained stress 
conditions, hyper-activation of ARTD1 leads to apoptosis or necrosis 8,9.  
Interestingly, a series of studies showed ARTD1 automodification in the presence of 
specific DNA structures such as cruciform hairpins, indicating ARTD1 activation by 
higher-order DNA structures in a DNA damage-independent manner 10,11.  In line 
with these data, nucleosomes (intact DNA wrapped around core histones) were 
sufficient to induce ARTD1 activity and even to a stronger activation in comparison 
to activation by damaged DNA 12.  Moreover, ARTD1 activity could also be 
stimulated by cations (Mg2+, Ca2+), polyamines (spermine) and core histones (H1 and 
H3) alone or in combination, indicating DNA-independent mechanisms of ARTD1 
activity in vitro 13.  Indeed, there is a growing body of evidence that indicates the 
involvement of intracellular signaling in the activation of ARTD1 in a DNA damage-
independent manner 14.   
Calcium signaling has been placed upstream of ARTD1 activity, but the exact 
mechanism of calcium-dependent regulation of ARTD1 activity is still unknown.  
ARTD1 activation was also observed as a consequence of PLC-IP3-dependent 
calcium mobilization in a DNA-independent manner 15, and the calcium/calmodulin-
dependent kinase II (CaMKII) was identified as a positive regulator of ARTD1 
activity in neurons 16,17.  Calcium-dependent stimulation of ARTD1 activity was also 
reported as a response to treatment with β-lapachone, which is an NQO1-dependent 
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ROS producer 18.  In contrast, other studies provide evidence for ARTD1-dependent 
calcium regulation in response to lethal hydrogen peroxide doses, thus placing 
calcium downstream of hydrogen peroxide induced ARTD1 activation 19,20.   
Positive and direct regulation of ARTD1 activity was also described for the 
extracellular signal-regulated kinase (ERK) 21-23 as well as for c-Jun N-terminal 
kinase (JNK) 24, while opposing results for the involvement of protein kinase C 
(PKC) signaling in the regulation of ARTD1 have been obtained 25-28. The PKC 
family of protein kinases is particularly interesting, because it comprises conventional, 
calcium-dependent enzymes, as well as novel and atypical kinases that act 
independent of calcium 29. In mammalians, the PKC protein family is comprised of 
four conventional (PKCα, -βI/II and -γ), four novel (PKCδ, -ε, -η and -θ) and two 
atypical (PKCζ and -ι) isozymes 29.  Cellular signaling pathways thus have the 
potential to directly regulate ARTD1 activity by post-translational modification 
independent of DNA damage, even though the molecular mechanisms are still 
unknown.  This is in contrast to the traditional view that considers ARTD1 as part of 
the DNA damage response, which is induced upon genotoxic or oxidative stress.  
To resolve the conflicting information concerning PAR stimulating, the 
overall goal of this work was to identify cellular signaling pathways that are induced 
early upon the stimulation by oxidative stress (e.g., H2O2) and which regulate PAR 
formation.  In order to address this question, we pursued a systemic reverse phase 
protein array (RPPA) approach and the in-depth molecular analysis of the key 
signaling components.  Even though H2O2 induces strong PAR formation within a 
few minutes, our analysis identified both positive and negative regulators of PAR 
formation.  Oxidative stress-induced PKCδ attenuated PAR levels, while calcium-
dependent signaling mediated by CaMKIIδ and PKCα were required to stimulate 
PAR formation.  Interestingly, our results suggest the calcium-dependent activation of 
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PKCα and the consecutive induction of DNA lesions as the mechanism, which 
stimulates PAR formation in response to oxidative stress.  In addition to revealing an 
intricate and well-balanced interplay of counter-acting signaling pathways that fine-
tune ARTD1 activity and PAR synthesis, these results for the first time directly 
implicate calcium- and PKCα-dependent DNA lesions in PAR formation and the 
response to oxidative stress.	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Results 
H2O2 treatment induces cytoplasmic kinases 
To identify early H2O2-induced signaling events in protein extracts of MRC-5 
primary human fibroblasts, which might regulate PAR formation, a proteomics screen 
using reverse phase protein arrays (RPPA) was performed at the 10 and 60 min time 
points after H2O2 treatment (0.5 and 2 mM) (Fig. 1a).  These time-points were chosen 
because strong PAR formation is observed at the 10 min time-point, while no PAR is 
detectable at the 60 min time-point after H2O2 stimulation (Fig. 1b).  Based on 
viability assays (24 h treatment), non-lethal (0.5 mM) and sub-lethal (2 mM) H2O2 
doses were selected for further RPPA analysis (Fig. S1a).  H2O2-induced PAR 
formation was completely inhibited by the PARP inhibitors ABT-888, Olaparib or PJ-
34 as shown by immunofluorescence (IF) and western blotting (Fig. S1b and c).  
Significant protein changes were determined by statistical analysis using ANOVA 
(p<0.05, n=2) and untreated samples were used as a control group (Fig. 1c, S2 and 
S3a).  The significantly changed proteins were clustered based on their temporal 
changes upon 0.5 or 2 mM H2O2 treatment using k-means clustering algorithm (Fig. 
1d, S3b).  Overall, the majority of significant protein reductions concerned total 
protein levels, while increases in response to H2O2 treatment were often observed for 
phosphorylation events (Fig. 1c, S3a).  This could be explained by the H2O2-induced 
inhibition of translation 30, which causes a general reduction of the protein half-life.  
Interestingly, early activation clusters comprised kinases exclusively found in the 
cytoplasm that are known to be activated either directly by stress stimuli (p-p38, p-
JNK) or by growth factor signals (ErbB-2, p-Akt).  In addition, calcium signal 
transducers were found among the early-induced proteome changes (p-PKC, p-PLCγ, 
p-CaMKII, p-CREB, p-PLA2) (Fig. 1c-e, S3a-b).  The majority of late activated 
signaling events included DNA damage response and cell cycle players such as p-
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Aurora A, p-Chk1, p-Cyclin D, p-p53, p-p27 and gammaH2AX (Fig. 1e).  However, 
the main hubs (Akt, p38, ERK2) in the protein-protein interaction network were 
rather cytoplasmic signaling components (except of p53) and that were mostly 
induced at the early time point, indicating cytoplasmic signaling events as the initial 
signaling events upon oxidative stress  (Fig. 1f, S3c). 
In summary, this systemic RPPA analysis of H2O2-induced proteome changes 
identified cytoplasmic kinases and signaling components as candidates that may 
regulate ARTD1 and early poly-ADP-ribosylation in the cell independent of the 
classical DNA damage response.  
 
Oxidative stress induces positive and negative regulators of PAR formation 
H2O2 treatment caused a short-lived induction of PAR in primary fibroblasts 
(Fig. 1b).  In order to identify, which of the H2O2-induced early signaling pathways is 
responsible for the consecutive activation of ARTD1, a screen with small molecule 
inhibitors for a sub-set of the identified early-activated kinases was performed.   
Primary IMR-90 fibroblasts or NIH/3T3 cells were treated with inhibitors 
against ARTDs (Olaparib), CAMKK (STO-609), CaMKII (KN-93), cyclophilin D 
(Cyclosporin A), IKK (IKK VII), AMPK (Dorsomorphin), MEK (PD985059), PKC 
(GF109203X), JNK (SP600125), p38 (SB203580), as well as with the calcium 
chelator (BABTA), to determine the overall contribution of calcium signaling, and 
PAR formation was assessed by IF analysis with the 10H anti-PAR antibody or 
western blotting (Fig. 2 and S4a-b).  Even though the activation kinetics of p38 and 
Iκ-Bα (IKK) upon H2O2 treatment correlated with the enhanced PAR formation, their 
inhibition did not affect PAR levels (Fig. 2a-d and S4a).  In agreement with 
observations by Zhang et al, inhibition of JNK reduced PAR formation 24 (Fig. 2c-d, 
S4a).  However, we could not confirm this observation with JNK1/2 KO MEFs, 
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indicating an off-target effect of the JNK inhibitor SP600125 (Fig. S4c).  In contrast, 
PAR formation was strongly reduced in H2O2 treated IMR-90 cells that were treated 
with a calcium chelator (BAPTA) or the CaMKII inhibitor KN-93.  The identification 
of both, BAPTA and KN-93, as inhibitors of H2O2 induced PAR formation suggested 
that calcium signaling is a positive regulator of PAR formation upon oxidative stress 
that may directly activate ARTD1.  This finding is in agreement with studies that 
implicated calcium signaling and CaMKII in the activation of ARTD1 16-18.  In order 
to validate these results, the positive effect of CaMKIIδ on PAR formation was 
confirmed in more detail, since CaMKIIα and β were expressed at relatively low 
levels in NIH/3T3 cells (Fig. S5a).  Down-regulation of CaMKIIδ by siRNA 
treatment of NIH/3T3 cells was efficient, did not affect ARTD1 protein levels (Fig. 
S5b), but led to slightly reduced PAR levels, less PAR foci and ARTD1 auto-
modification (Fig. 2e and S5c-d). Unexpectedly, H2O2 treatment not only induced 
activators of PAR formation, but also negative regulators.  The PKC inhibitor 
GF109203X induced a strong and significant hyperaccumulation of PAR in H2O2 
treated human IMR-90 and NIH/3T3 cells (Fig. 2a-d), indicating that the entire PKC 
family or members thereof are negatively regulating PAR formation.   
 This inhibitor analysis thus demonstrated that H2O2 stimulation induced 
positive and negative regulators of PAR formation in human primary and mouse 
fibroblasts.  CaMKIIδ positively regulated PAR formation under oxidative stress 
conditions, while PKC signaling seemed to interfere with PAR formation.  
 
ARTD1 activity is attenuated by PKCδ-dependent phosphorylation  
 As indicated by our RPPA analysis and inhibitor screen, PKC negatively 
regulates PAR formation in response to treatment with H2O2.  This recapitulates the 
results of earlier studies on PKC and ARTD1 25-27.  In mammalians, the PKC protein 
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family is comprised of 10 proteins, which are classified into conventional (PKCα, -
βI/II and -γ), novel (PKCδ, -ε, -η and -θ) and atypical isozymes (PKCζ and -ι) 29. The 
four conventional PKCs are activated by calcium.  To elucidate the molecular 
mechanism, by which PKC attenuates PAR formation in response to oxidative stress, 
the overall effect of the PKC signaling pathway on PAR formation was analyzed.   
As shown before for IMR-90 cells (Fig. 2a-b), treatment of MRC-5 cells with the 
PKC inhibitor GF109203X led to enhanced PAR formation upon H2O2 treatment, 
thus confirming the negative regulation of PAR formation by PKC (Fig. 3a-b).  
Interestingly, in the presence of BAPTA, this effect was abolished; confirming that 
calcium signaling positively regulates PAR formation as shown by the inhibitor 
screen.  In order to test if PKC family members generally attenuate PAR formation 
upon oxidative stress, individual members were specifically studied. First, we 
analyzed the involvement of the novel PKCδ in regulating H2O2-dependent PAR 
formation.  PKCδ was selected because calcium signaling positively regulated PAR 
upon H2O2 stress, thus excluding a calcium-dependent PKC family member as a 
candidate for the negative regulation observed here (Fig. 2a-d).  Among the two 
calcium-independent, DAG-dependent PKC family members, PKCδ showed the 
strongest expression in NIH/3T3 cells (Fig. S6a). Full-length ARTD1 was incubated 
with the catalytic domain of PKCδ and radioactive ATP.  A strong signal 
corresponding to phosphorylated, full-length ARTD1 was only observed in the 
reactions containing PKCδ and in the absence of GF109203X (Fig. 3c).  
Phosphorylation of ARTD1 was evident for the N-terminal fragment comprising the 
first 214 amino acids, while all other fragments comprising amino acids 215 – 1014 
did not reveal any significant phosphorylation by PKCδ (Fig. 3d). This result 
indicates selective motifs in the first two zinc fingers of ARTD1, comprising direct 
phosphorylation sites for PKCδ. Indeed, in silico analysis by the Motif Scan 
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prediction tool (ScanSite) identified Ser20 (NetPhos2.0 score = 0.99), Ser27 
(NetPhos2.0 score = 0.61), Thr109 (NetPhos2.0 score = 0.87) and Thr127 
(NetPhos2.0 score = 0.82), all located in first two zinc fingers of the ARTD1 DNA 
binding domain, as putative PKCδ phosphorylation sites in the ARTD1 full-length 
sequence. To further understand, whether phosphorylation of ARTD1 by PKCδ has a 
direct influence on ARTD1’s enzymatic activity, phosphorylated ARTD1 was in vitro 
modified in presence or absence of DNA and radioactive labeled NAD. As expected, 
phosphorylation by PKCδ was able to attenuate the DNA-induced activation of 
ARTD1 (Fig. 3e), establishing ARTD1 phosphorylation in the N-terminal DNA 
binding domain by PKCδ as an important and powerful negative regulatory 
mechanism for ARTD1 activity and PAR formation.   
To confirm PKC-dependent regulation of PAR formation as a response to 
oxidative stress, MRC-5 were transfected with siPKC pan with the goal to reduce the 
general protein expression of PKC family members. Unexpectedly, knockdown of all 
PKC family members led to a strong reduction in the number of PAR foci in the 
response to H2O2 stress (Fig. 3f-g). These results indicated a positive regulation of 
PAR formation by certain PKC family members, which is opposite to the effect 
observed for PKCδ, and thus imply attenuating and stimulating functions of PKC 
family members.   
 
PKCα is required for poly-ADP-ribose formation during oxidative stress 
In order to disentangle these unexpected, positive effects on PAR formation, 
individual PKC family members were specifically studied.  The siPKC pan 
experiments have revealed that the calcium-dependent PKCα was predominantly 
down-regulated (Fig. 3g), while a significant reduction in PKCβ and PKCγ could not 
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be detected under these conditions (not shown).  These analyses therefore focused 
mainly on PKCα. 
Knockdown of the highly expressed, calcium-dependent PKCα (Fig. S6a), 
alone or in combination with PKCδ, led to a significant reduction in the number of 
PAR foci compared to the control (Fig. 4a-b), suggesting that PKCα is required for 
H2O2-induced PAR formation.  In order to assess a possible direct regulation of 
ARTD1 activity by PKCα, full-length ARTD1 was incubated with PKCα and 
radioactive labeled ATP. A signal corresponding to phosphorylated, full-length 
ARTD1 was observed in the reactions containing PKCα (Fig. 4c), indicating that 
PKCα is able to directly phosphorylate ARTD1 in vitro.  Incubation of different 
ARTD1 fragments with PKCα indicated that ARTD was phosphorylated 
unspecifically at various sites across the whole protein (Fig. 4d). In contrast to PKCδ, 
ARTD1 phosphorylation by PKCα did not significantly affect ARTD1’s enzymatic 
activity (Fig. 4e). These results thus excluded direct PKCα-dependent 
phosphorylation of ARTD1 as the mechanism by which PAR formation is stimulated 
in a calcium-dependent manner upon H2O2 treatment and also suggested an indirect 
mechanism of ARTD1 activation mediated by PKCα. Since ARTD1 is strongly 
activated by DNA damage in vitro, it was hypothesized that calcium- and PKCα-
dependent formation of DNA lesions may activate ARTD1. In order to test this 
hypothesis, NIH/3T3 cells were treated with the calcium chelator BAPTA or siPKCα 
and DNA integrity was assessed by the alkaline comet assay. BAPTA and siPKCα 
treatment both caused a significant reduction of the DNA tails in the comet assay, 
indicating that DNA strand breaks were induced by an enzyme regulated by PKCα 
and directly by reactive oxygen species (Fig. 4f-g and Fig. S6b). These results thus 
suggest a calcium-dependent activation of PKCα and the consecutive induction of 
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DNA lesions as the mechanism, which stimulates PAR formation in response to 
oxidative stress in NIH/3T3 cells. 
 
Altogether, our results indicate an opposite regulation of ARTD1 activity by 
calcium-dependent PKCα and calcium-independent PKCδ in response to oxidative 
stress.  Based on the findings presented here, we propose a model of calcium-
dependent activation of PKCα and PKCα-dependent formation of DNA lesions for the 
regulation of ARTD1 activity in response to oxidative stress. In addition to PKCα, 
which is required for PAR formation under the tested conditions, other PKC isoforms 
such as PKCδ act as modulators of PAR formation in response to H2O2 treatment 
(Fig. S6b).   
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Discussion  
Oxidative stress is a potent activator of PAR formation in different cell types, 
but a coherent picture of the molecular events that lead to ARTD1 activation and PAR 
formation does not exist.  Although it is assumed that ARTD1 is indirectly activated 
by oxidative stress via the induction of DNA damage, a mechanism explaining such 
an activation has not been reported and ample evidence suggests the direct 
modification of ARTD1 enzymatic activity.  The work described here identified 
cellular signaling pathways that were induced in MRC-5 human fibroblasts early after 
the induction of oxidative stress and whose kinetics correlated with PAR formation.  
Consecutive validation and in-depth analyses revealed that PKCδ attenuates PAR 
formation upon the exposure to oxidative stress, while PKCα was required for PAR 
formation under the same conditions.  In addition, our results suggest the calcium-
dependent activation of PKCα and the consecutive induction of DNA lesions as a 
novel mechanism, which stimulates PAR formation in response to oxidative stress.  
This study thus identifies opposing, calcium-dependent and -independent regulatory 
mechanisms for PAR formation upon oxidative stress within the PKC family of 
proteins. 
These results are confirmatory of earlier findings that documented positive 
regulation of ARTD1 and PAR formation by calcium signaling and which implicated 
PKC and the MEK-ERK pathway in the regulation of ADP-ribosylation.  In contrast 
to these earlier findings, our results indicate that positively and negatively regulating 
pathways are activated at the same time during oxidative stress in human primary 
fibroblasts as well as in murine NIH/3T3 cells.  However, in contrast to reports on a 
positive regulation of ARTD1 by PKC and MEK-ERK, the results presented here also 
point at a negative regulation under the oxidative stress conditions of this study.  Our 
systemic study thus integrates and extends the previous results and implies a complex 
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signaling network of simultaneously present and counter-acting components that 
regulate and fine-tune the nuclear PAR levels. 
Inhibition of PKC signaling by a small molecule inhibitor (GF109203X, BIM 
1) led to a significant increase in PAR induction upon H2O2 treatment, identifying 
PKC signaling as a negative modulator upon H2O2 stress.  This result is in agreement 
with data obtained upon MNNG stress 26, indicating a general regulatory mechanism 
of ARTD1 activity by PKCs in response to genotoxic stress.  Our in vitro experiments 
showed that phosphorylation of ARTD1 by PKCδ directly attenuates ADP-
ribosyltransferase activity in the presence of DNA (Fig. 4e).  Indeed, PKC has been 
previously shown to phosphorylate ARTD1 in vitro 27 and its inhibition resulted in 
increased PAR induction upon alkylation stress 26.  In contrast, there are also studies, 
which reported a positive regulation of ARTD1 by the Ca2+-independent PKCδ 
isoform in response to histamine and we did not observe a stimulation of ARTD1 by 
PMA treatment alone (data not shown) 28,31.  However, our results document that the 
calcium-dependent isoform PKCα and the consecutive DNA strand break formation 
are required for PAR synthesis.  This study thus identified for the first time opposing, 
isoform-specific functions of PKC family proteins under the same conditions. 
Here, we describe stimulation and attenuation of ARTD1 activity upon in vitro 
phosphorylation by PKCα and PKCδ, respectively. We localized the phosphorylation 
by PKCδ to the N-terminal DBD of ARTD1, with a strong preference for the region 
encompassing the first two zinc fingers (Fig. 4d-e).  Based on in silico analysis, 
sequence-stretches around Ser20 in the N-terminal DBD of ARTD1 match the 
consensus-motif of the two Ca2+-independent PKC isoforms PKCδ and PKCε (Motif 
Scan, ScanSite) and also show a high probability score for phosphorylation.  Indeed, 
based on two recently published structures of ARTD1 zinc finger domains bound to 
DNA, Ser20 stabilizes the interaction with the DNA backbone by forming a hydrogen 
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bond with a phosphate of a phosphodiester bond 32,33. It can thus be speculated that 
phosphorylation of Ser20 by PKCδ destabilizes the interaction of the first ADRT1 
zinc finger with the DNA backbone due to the negative charge of the 
phosphorylation, eventually resulting in less activity in response to H2O2. Previous 
studies have already shown ARTD1 phosphorylation by PKCα and PKCβ, and 
identified Ser504, Ser519 and Thr656 as preferential phosphorylation targets of PKCβ 
in full length ARTD1 34.  In contrast, we only observed weak phosphorylation of 
PKCα that could not be localized to a specific domain and which did not alter ARTD1 
enzymatic activity in vitro.  It is currently unknown and almost impossible to assess if 
PKCα specifically phosphorylates ARTD1 in vivo.  The weak phosphorylation 
without effect on enzymatic activity makes an in vivo phosphorylation of ARTD1 by 
PKCα doubtful.  The results presented here rather suggest that a yet unidentified 
enzyme is activated by PKCα upon oxidative stress and consecutively induces DNA 
strand breaks.  Likely candidates for this activity are calcium- and PKCα-dependent 
endonucleases or topoisomerases.  Interestingly, activation of topoisomerases by PKC 
has been reported, although PKCα has not been studied specifically 35.  In contrast to 
the strongly reduced PAR formation upon siPKCα treatment, the DNA lesions, as 
determined by the alkaline comet assay, were only slightly, but significantly, reduced.  
BAPTA treatment, on the other hand, affected both, DNA lesions and the number of 
PAR foci. This indicates that not all observed DNA lesions might contribute to PAR 
formation and that the lesions that are formed following PKCα activation are those 
responsible for the activation of ARTD1. BAPTA treatment therefore not only 
abolishes PKCα activity, but also inhibits processes that cause additional types of 
DNA lesions that are distinct of those induced by the PKCα-dependent process.  
Interestingly, these results also indicate that cells respond to oxidative stress by the 
early, controlled induction of DNA lesions, which is thus likely a beneficial response.  
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For example, early activation of ARTD1 likely changes the metabolic state of the 
nucleus and provides a platform for the recruitment of proteins.  These effects may 
explain the benefit of the early, controlled induction of DNA lesions in response to 
oxidative stress and represent a priming step that prepares and shields the DNA from 
the forthcoming effect of radicals that are formed upon the continued emanation of 
oxidative stress.  It remains to be clarified where in the genome DNA lesions are 
induced. 
Opposite regulation and specific phosphorylation of ARTD1 by PKCα and 
PKCδ has important biological consequences and may explain functional differences 
among the PKC isoforms. For example, depending on the cell type and its sub-cellular 
localization, PKCα is implicated in a variety of biological phenomena such as 
proliferation, apoptosis, differentiation and inflammation 36. Interestingly, so far 
PKCα has not been linked to the regulation of PAR metabolism and ARTD1 activity 
and was only studied as a factor affected by PARP inhibition 37. Interestingly, in the 
absence of Ca2+, ARTD1 activity was reduced in response to nitrosative and oxidative 
stress 18,38.  Therefore, PKC-dependent regulation can either reduce ARTD1 activity 
through phosphorylation in the DBD independent of Ca2+ (e.g., by PKCδ) or lead to 
Ca2+-dependent DNA break formation and thereby activate ARTD1 (e.g., by PKCα).  
Whether the stimulation of ARTD1 activity due to PKCα-induced DNA damage in 
addition includes effects via other calcium-dependent processes or PKC family 
members in vivo remains to be determined. 
In summary, the here presented study identified the concurrent, H2O2-
dependent activation of stimulatory and attenuating regulators of nuclear PAR 
formation. These findings thus highlight the complexity of the signaling network 
regulating PAR levels in the nucleus and identify key players determining and fine-
tuning the nuclear PAR pool. Most importantly, the results presented here link 
  76	  
cytoplasmic signaling components and pathways to the formation of DNA strand 
breaks as a consequence of the calcium-dependent activation of PKCα.  These 
findings for the first time explain how ARTD1 activity can be activated in the nucleus 
under conditions that are not directly linked to DNA damage formation by reactive 
oxygen species or irradiation. These results thus revealed a new mechanism for the 
intricate regulation of ARTD1 and ADP-ribosylation and thereby hopefully stimulate 
a more comprehensive view and study of the cellular functions of ADP-ribosylation.   
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Methods 
Cell culture, IR treatment, siRNA transfection, lysis and proliferation assay 
The MRC-5 and IMR-90 human lung fibroblast cell strains 39,40 were obtained from 
the American Type Culture Collection (ATCC) and cultured in supplemented MEM 
(Invitrogen). NIH/3T3 were obtained from American Type Culture Collection 
(ATCC) and cultured in supplemented DMEM (Invitrogen). JNK1/2 WT and (-/-) 
MEFs were a kind gift of the Roger Davies lab and were cultured in cultured in 
supplemented DMEM (Invitrogen). Cells were preincubated with inhibitors or 
activators (stocks dissolved in DMSO) for 1 h prior to H2O2 treatment in FCS-free 
media, which was also used as a vehicle for H2O2.. All inhibitors were obtained from 
Enzo Life Sciences, except from Olaparib (AstraZeneca), PD98059 (Santa Cruz), 
IKK VII and KN-93 and PMA (Merck Millipore) and used at a final concentration as 
indicated in the figures or figure legends. To reduce isoform specific ARTD1, PARG, 
CaMKIIδ/γ and siPKCα/δ and siPKC pan expression, 2x105 NIH/3T3 or 1x105 MRC-
5 cells were transfected using mouse siARTD1 (QIAGEN, SI02731428), siPARG 
(QIAGEN, SI01369571), siCaMKIIδ (QIAGEN, SI00940415), siCaMKIIγ 
(QIAGEN, SI00940443), siPKCα (QIAGEN, SI01388583), siPKCδ (QIAGEN, 
SI01388744) or siPKC pan (Santa Cruz Biotechnology, sc-29449) or siCtl. 
(scrambled sequence, lacking significant homology to any known human or mouse 
gene sequence) with Lipofectamine RNAiMAX transfection reagent (Invitrogen) 
according to manual’s instructions over 3-4 days, prior to H2O2 treatment. Whole cell 
extracts were prepared with standard RIPA lysis buffer (50 mM Tris/pH8, 400mM 
NaCl, 0.5% NP-40, 1% DOC, 0.1% SDS supplemented with proteinase inhibitor 
cocktail (Roche), 10 mM β-glycerolphosphate, 1mM NaF and DTT) and total protein 
concentration determined using standard Lowry method. Cell viability was 
determined by the MTT assay (Sigma). 
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Reverse phase protein arrays (RPPA) 
RPPA were prepared as described 41.  In brief, whole cell extracts were spotted onto 
hydrophobically coated Zeptosens Chips (Bayer Technology Services GmbH).  
Serially diluted lysates (100, 75, 50 and 25%) were arrayed in duplicates onto 
hydrophobic Zeptosens Chips using the Nanoplotter NP2.0 (GeSiM), followed by 
blocking in an ultrasonic nebulizer (ZeptoFOG, Bayer Technology Services GmbH).  
Antibody incubation (Invitrogen), microarray data acquisition (ZeptoREADER, Bayer 
Technology Services GmbH) and data analysis (ZeptoVIEW version 3.1.0.2, Bayer 
Technology Services GmbH) was performed exactly as described 42.  The eight data 
points (100, 75, 50, 25% lysate amount in duplicates) were fitted using a weighted 
linear least squares fit 43 and the relative fluorescence intensity determined by 
interpolating at the median protein concentration or modification.  To correct for 
small variations in protein content, relative intensities were normalized to the signals 
of β-Catenin, which did not show any significant variation (ANOVA, p < 0.05) in 
response to H2O2 over 10-60 min.. 
 
Significance and clustering analysis 
To identify significant proteome changes in response to IR, relative fluorescence 
intensities were imported to MeV version 4.6 44.  Relative fluorescence intensities 
were log2 transformed and normalized, before performing statistical analysis using 
One-way ANOVA as described in 45.  The mean transformed fluorescence intensities 
for group 1 (biological duplicates of untreated_10 min), group 2 (biological duplicates 
of 0.5 mM or 2 mM_10 min), group 3 (biological duplicates of 0.5 mM or 2 mM_60 
min) were compared using F-statistics with p < 0.05. For fold-change analysis, 
transformed means of the biological replicates were normalized to the untreated 
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sample (set as 1) and proteome changes were filtered (cut off set at 1x SD equal to 
log2 > 0.77 / < -0.77 for 0.5 mM or log2 > 0.72 / < -0.72 for 2 mM).  Significant 
proteome changes in response to H2O2 were selected for clustering analysis (Fig. 1 b-
c) if significant by one-way ANOVA (p < 0.05). To correct for potential false 
negatives or positives, significance analysis was performed using fold change cut off 
with thresholds described above or performing a quality control analysis by 
visualization (V.C.) for clustering analysis as shown Fig. 1e. Similar profiles of the 
fold changes over time were identified by clustering analysis using the k-means 
clustering algorithm and default parameters of MeV version 4.6 44. K-means based 
clustering analysis in Fig. 1e comprises significant proteome changes, identified by 
ANOVA (n=2, p<0.05), Fold change cut off (1 S.D.) and/or visual control (V.C.) and 
thus might slightly differ from the results obtained by k-means clustering using only 
ANOVA (n=2, p<0.05) in Fig. 1d and Fig. S3b.  
 
Pathway and network analysis 
Gene pathway memberships corresponding to 200 pathways from protein interaction 
database (PID 46) and 211 from KEGG 47 was obtained. The background protein list 
consisted of all analyzed proteins in this study (unique IDs) and only, pathways with 
more than 5 proteins were considered in the statistical analysis. This selection resulted 
in 93 and 63 pathways from PID and KEGG respectively. Pathways significantly 
affected by irradiation (significant by ANOVA and fold-change) induced protein 
(modification) change were identified using Fisher's exact test, performed using R 
statistical framework 48.  A Benjamini-Hochberg corrected p value cut-off of 0.05 was 
used to identify significantly affected pathways. . 
Protein-protein interaction analysis on significant protein changes (ANOVA + log2 
fold change cut-off) was performed using STRING (v 9.0) 49.  Interactions with a 
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STRING score more than 0.7 were analyzed with the help of Cytoscape 
(http://www.cytoscape.org/) 50.   
 
Immunoblotting 
For Western Blot analysis, proteins were separated by SDS PAGE gel electrophoresis 
and bands were visualized by either using horseradish peroxidase-conjugated 
antibodies (1:5000, GE Healthcare) and ECL detection (GE Healthcare) or by using 
IR-Dye-conjugated antibodies (1:15000, LI-COR) and detection by the Odyssey 
infrared imaging system (LI-COR).  For quantification, bands were analyzed by 
ImageJ 1.46 (35) and the Odyssey imaging software (LI-COR).   
Antibodies used for Western blotting were anti-ARTD1 (Santa Cruz), anti-
CaMKIIdelta (Santa Cruz), anti-CREB Phospho (pS133)/ATF-1 Phospho (CST), anti-
JNK1/2 (CST), anti-JNK1/2 Phospho (CST), anti-PAR (10H, homemade), anti-PKCα 
(CST), antiPKC-δ (CST), anti-Tubulin (1:10’000, Sigma). If not else stated, antibody 
dilution was 1:1000.   
 
Immunofluorescence (IF) microscopy  
For PAR- IF analysis 1.5x105 NIH/3T3 and 2.5x104 MEF, MRC-5 and IMR-90 cells 
were grown on cover slips overnight prior to inhibitor/activator preincubation and 
H2O2 treatment. Afterwards cells were washed with PBS (1x), fixed with ice-cold 
methanol and acetic acid (3:1) for 10 min at 4°C, washed with PBS (3x), blocked in 
5% milk/0.05% Tween-20 in PBS for 30 min and stained immunohistochemically 
with primary mouse anti-poly(ADP-ribose) IgG, 1:250 (10H, homemade). Next, cells 
were washed with PBS (3x) before hybridization with a secondary antibody (1:250 
Cy3 conjugated anti-mouse IgG, Jackson ImmunoResearch or 1:250 Alexa Fluor 488 
ocnjugated anti-rabbit IgG, Invitrogen). Eventually, cells were mounted on glass 
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slides using DAPI-containing VECTASHIELD (Vector Labs) and images acquired 
using an inverted fluorescence microscope at 40x, oil immersion (Leica). 
Fluorescence intensity or foci number were quantified using ImageJ (v. 1.46r) or 
Imaris (v. 7.6.0, Bitplane) and equal set-up between the images and experiments.  
 
RNA extraction and real-time PCR analysis 
Total RNA was reverse transcribed using High-Capacity cDNA Reverse 
Transcription kit (Applied Biosystems).  Real-time PCR was performed using SYBR 
green premixed buffer and analysed by the Rotor-Gene Q cycler (QIAGEN).   
 
In vitro kinase and ARTD1 automodification assay 
For CaMKII kinase assay, experiment was performed according to the vendors 
recommendations (New England BioLabs, NEB, P6060) using 100 µM ATP (Sigma) 
spiked with 0.74 MBq gamma-labeled ATP (20 nM), 125 units CaMKII (NEB) and 1 
µg recombinant ARTD1 fl. or ARTD1 deletion fragments (ARTD1 fr.) per reaction 
incubating for the indicated time points. Prior to the kinase reaction in the CaMKII 
kinase buffer, CaMKII was activated by 1.2 µM calmodulin according to the manual 
instructions. For PKCδ kinase assay, experiment was performed using 0.2 µl 
recombinant PKC catalytic subunit of the PKCδ isoform from rat brain (Sigma, 
P1609) and 1 µg ARTD1 fl. or ARTD1 fr. in PKCδ kinase buffer (120 mM Tris/pH 
7.5, 40 mM MgCl2, 2 mM CaCl2, 2 mM DTT) and 20 nM ATP (Sigma) spiked with 
0.74 MBq gamma-labeled ATP (20 nM) and reaction time as indicated in the figure or 
figure legend. For PKCα kinase assay 100 ng recombinant PKCα (Enzo, BML-
SE494-0005) were incubated in PKCα kinase buffer (25 mM MOPS/pH 7.2, 12.5 mM 
β-glycerophosphate, 25 mM MgCl2, 5 mM EGTA, 2 mM EDTA and 0.25 mM DTT) 
with 100 µM ATP (Sigma) spiked with 0.74 MBq gamma-labeled ATP (20 nM) / 
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reaction and 1 µg recombinant ARTD1 fl. or ARTD1 deletion fragments (ARTD1 fr.) 
for 15 min. For ARTD1 automodification assay, the kinase assay reaction was 
supplemented with PARP reaction buffer (50 mM Tris-HCl/pH 8, 4 mM MgCl2, 250 
µM DTT, 1 µg pepstatin/bestatin/leupeptin), 100 µM NAD (Sigma) spiked with 100 
nM gamma-labeled NAD and in some cases 0.5 pmol of EcoRI dsDNA linker to 
induce ARTD1 activity in vitro. 
 
Alkaline comet assay 
5x105 NIH/3T3s were grown over night in 6-well-plates before inhibitor/activator 
preincubation for 1 h followed by H2O2 treatment. NIH/3T3 cells were collected by 
Trypsin/EDTA (Invitrogen) accordingly, span down and diluted to 3-4x105 for 
alkaline comet assay, which was performed according to the manufacture’s 
recommendations (Trevigen).  Picture acquisition was performed using an inverted 
fluorescence microscope at 20x (Leica). For tail DNA quantification the free software 
CASP, version 1.2.2, was used (casplab.com). 
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Figure Legends 
Figure 1.  H2O2 treatment induces cytoplasmic kinases.  a) Work flow for 
characterization of H2O2 induced proteome changes by reverse phase protein 
microarrays (RPPA). b) PAR immunofluorescence analysis of primary MRC-5 
treated with 0.5 mM H2O2 for 10-60 min or left untreated (U, 10min). c-d) Time 
profile clustering of 0.5 mM H2O2-dependent proteome changes (ANOVA, n=2, 
p<0.05) by k-means algorithm showing protein expression and modification (green) 
or repression and de-modification (red). Modifications are indicated in brackets, 
antibodies which have been applied more than once are indicated by a 1-digit number 
at the end of the analyte name, antibodies from different vendors are indicated by a 3-
digit number in brackets (e.g. 2-02). e) Identification of overlapping proteome 
changes induced by 0.5 or 2 mM H2O2 over time. Shown are overlapping changes of 
0.5 and 2 mM H2O2 significant proteome (ANOVA, n=2, p<0.05 (green), fold change 
cut off (1 S.D.) + visual control (V.C.) (yellow),  V.C. only (orange) or fold change 
cut off only (red)) assigned to cluster 1 & 2 & 3 (early activation), cluster 4 (late 
activation) or cluster 5 (repression). Numbers in the venn diagrams indicate unique 
and overlapping proteome changes induced by 0.5 and 2 mM.  f) In silico protein-
protein interaction analysis of significant proteome changes induced by 0.5 mM using 
STRING with a STRING score cut off > 0.7.  Colors indicate phosphorylation 
(purple), total protein changes and phosphorylation (violet). Hubs (more ≥ 20 
interactions) are enlarged.  
 
Figure 2.  Oxidative stress induces positive and negative regulators of PAR 
formation.  a) PAR-immunofluorescence (PAR-IF) analysis of IMR-90 cells 
preincubated with selected kinase inhibitors or DMSO (control) followed by 0.1 mM 
H2O2 treatment or left untreated. Cells were fixed and immunostained with anti-
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poly(ADP-ribose) (red) and counterstained with DAPI (blue) 10 min after H2O2 
treatment. b) Quantification of PAR intensity per nucleus from a). 10-20 nuclei 
analyzed per area (n=10). c) PAR-IF analysis of NIH/3T3 preincubated with 
inhibitors against targets indicated left of the images using 10-50 µM followed by 0.5 
mM H2O2 treatment for 10 min or untreated as control. d) Quantification of PAR 
intensity per nucleus from c). 50-100 nuclei analyzed per area (n = 3-5). e) PAR-
immunofluorescence analysis of NIH/3T3 transfected with siRNA targeting 
CaMKIIdelta (siCtl., used as control) followed by 0.1 mM H2O2 treatment. For 
quantification of PAR foci or intensity from b) 50 nuclei analyzed / area (n=10-15) 
from 5 independent experiments.  Inhibitors were used against ARTD1/2 (Olaparib, 1 
μM), calcium (BAPTA, 10 μM), CaMKK (STO-609, 10 μM), CaMKII (KN-93, 5 
μM), cyclophilin D (Cyclosporin A, 1 μM), IKK (IKK VII, 10 μM), AMPK 
(Dorsomorphin, 10 μM), MEK (PD985059, 20 μM), PKC (GF109203X, 10 μM), 
JNK (SP600125), p38 (SB203580). Data are mean +/- SD by t-test with *p<0.05, 
**p<0.01, ***p<0.001, n.s. not significant. Scale bars, 25 μm.  
  
Figure 3. Negative modulation of ARTD1 activity by PKCδ . a) PAR-IF analysis 
of MRC-5 preincubated with 5 µM GF109203X (PKC-specific inhibitor) or 10 µM 
BAPTA (calcium chelator) prior to 0.1 mM H2O2 for 10 min. siCtl. and siARTD1 
were used as control for not affecting or reducing ARTD1 protein levels, respectively.  
Scale: 25 μm.  b) Quantification of a). c) PKC kinase assay in presence or absence of 
PKC inhibitor (GF109203X, 5 µM) using full length ARTD1 (CIP treated) as 
substrate and radiolabeled ATP. d) PKCδ kinase assay using ARTD1 deletion 
fragments as substrate and radiolabeled ATP (32P) performed as in Fig. 2g. e) 
Experiment performed as in Fig. 2h in presence or absence of EcoRI linker (ds DNA) 
  91	  
and incubation for 10 min at 30°C.  f) PAR-immunofluorescence staining of primary 
MRC-5, transfected with siPKC (pan), followed by H2O2 treatment for 10 min. Scale 
bar, 10 μm. g) Quantification of f) (50-100 cells/condition, n=2).  KD confirmation 
by immunoblotting anti-ARTD1, anti-PKCalpha or anti-PKCdelta using anti-Tubulin 
as loading control, indicated in the right corner of the panel.  Data are mean +/- SD by 
t-test with *p<0.05.  
 
Figure 4. PKCα is required for poly-ADP-ribose formation during oxidative 
stress.  a) PAR-IF analysis of NIH/3T3, transfected with siPKCα and/or siPKCδ or 
siARTD1 (positive ctl) and siCtl (negative control), followed by H2O2 (0.1 mM) 
treatment for 10 min (500 cell/condition, n=2).  b) KD confirmation of a) by 
immunoblotting anti-ARTD1, anti-PKCalpha and/or anti-PKCdelta using anti-
Tubulin as loading control.  c) PKCα kinase assay using ARTD1 full length (CIP 
treated) and Pol beta (positive control) as substrates and radiolabeled ATP (32P). 
Loading controlled by Coomassie blue staining of the gel (lower panel, CB). d) PKCα 
kinase assay using ARTD1 deletion fragments or full length ARTD1 as substrate and 
radiolabeled ATP (32P) performed as in Fig. 2g. e) Experiment performed as in Fig. 
2h in presence or absence of EcoRI linker (ds DNA) and incubation for 10 min at 
30°C. f) Alkaline comet assay of NIH/3T3 preincubated with BAPTA (20 μM) 
followed by 100 μM H2O2 treatment for 3-20 min (50 nuclei analysed / independent 
experiment, n=2). g) Alkaline comet assay, performed as in f), using PKCα 
transfected NIH/3T3 or siCtl (negative control) followed by 100 μM H2O2 treatment. 
Data are mean +/- SD by t-test with *p<0.05, **p<0.01, ***p<0.001. 
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Supplementary Figure Legends 
 
Figure S1. Sample preparation and workflow for identification of PAR-
dependent proteome changes upon H2O2 by RPPA. a) MTT assay of MRC-5 
treated with different doses of H2O2 and recovery for 24 h (n=3). b) PAR IF of MRC-
5 preincubated with different PARP inhibitors using 1 μM for ABT-88 and Olaparib 
and 10 μM for PJ-34. c) Immunoblotting analysis of MRC-5 pretreated with 1 µM 
ABT-888 or DMSO (control) and H2O2 treatment for 10-60 min.  
  
Figure S2.  Significance analysis of H2O2-dependent proteome changes.  a-b) 
Relative fluorescence intensities (RFIs) (log2) for group 1 (biological duplicates for 
untreated (U)_10 min), group 2 (biological duplicates for 0.5 / 2 mM _10 min ), group 
3 (biological duplicates for 0.5 / 2 mM _60 min) were compared using F-statistics 
(ANOVA) with p < 0.05. c-d) Means of RFIs (replicates) were log2 transformed and 
fold changes (to U, group 1) were plotted individually for 0.5 mM (c) and 2 mM (d) 
to determine the standard deviation, resulting in 1 S.D. = 0.77  for 0.5 mM and  1 S.D. 
= 0.72 for 2 mM. e-f) Statistical, fold change and quality control analysis of 
significant proteome changes in response to 0.5 mM H2O2 (e) and 2 mM (f) using 
ANOVA (p < 0.05, n = 2) (green) and cut off (1 S.D.) (dashed line). Proteome 
changes which passed the cut off filter (1 S.D.) and satisfied visual quality control are 
highlighted in yellow, proteome changes which only passed the cut off filter (1 S.D.) 
are highlighted in red, proteome changes which only passed the visual quality control 
are highlighted in orange.  
 
Figure S3.  Clustering, protein-protein interaction and pathway analysis of 
H2O2-dependent proteome changes. a-b) Time profile clustering of 2 mM H2O2-
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dependent proteome changes (ANOVA, n=2, p < 0.05) by k-means algorithm 
showing protein expression and modification (green) or repression and de-
modification (red). Modifications are indicated in brackets, antibodies which have 
been applied more than once are indicated by a 1-digit number at the end of the 
analyte name, antibodies from different vendors are indicated by a 3-digit number in 
brackets (e.g., 2-83). c) In-silico protein-protein interaction analysis of significant 
proteome changes induced by 2 mM using STRING with a STRING score cut off > 
0.7.  Colors indicate phosphorylation (purple), total protein changes and 
phosphorylation (violet). Hubs (more >= 20 interactions) are enlarged. d-e) 
Enrichment of pathways from the pathway interaction database (PID) with significant 
proteome changes (ANOVA, p < 0.05) induced by 0.5 mM (d) and 2 mM (e) using 
Fisher’s exact test.  (FDR corrected p-value cut off = 0.05). 
 
Figure S4. Identification of signaling players upstream of PAR induction upon 
H2O2. a) PAR-immunoblotting analysis of NIH/3T3 preincubated with ARTD1/2 
inhibitor (Olaparib, 10 μM), increasing amount of JNK inhibitor (SP600125, 10-30 
μM and p38 inhibitor (SB203580, 10 μM) for 1h, followed by 0.5 mM H2O2 
treatment for 10 min. b) Experiment performed as in a, using Ca2+ chelator (BAPTA, 
10 μM) and increasing amount of AMPK inhibitor (Dorsomorphin, 10-50 μM). c) 
Immunoblotting analysis of JNK1/2 double KO or WT MEF pretreated with 30 µM 
SP600125 (JNK-specific inhibitor) followed by 0.5 mM H2O2 treatment. Anisomycin 
(10 μM) treatment used as control for inducing JNK signaling. ARTD1 used as 
loading control and JNK1/2 to control absence of JNK in JNK1/2 double KO MEF. 
PAR intensity normalized to Tubulin and reported as percent of H2O2 + DMSO. 
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Figure S5. Negative modulation of ARTD1 activity by PKCδ . a) Gene expression 
analysis of CamKII family members in NIH/3T3 (n=3). b) Knockdown confirmation 
of CaMKIIδ in NIH/3T3. siCtl, siARTD1, siRYR1, siIP31 and siIP3R2 were used as 
negative controls for not affecting CaMKIIδ levels. Tubulin was used as loading 
control. c) Immunoblotting analysis of NIH/3T3 transfected with increasing amount 
of siCaMKIIdelta (50 -100 nM) followed by  cell lysis and immunostaining. Tubulin 
used as loading control. d) Quantification of CamKIIδ, ARTD1 and PAR levels from 
c). e) PAR-immunofluorescence analysis of calmodulin1-3 (CaM1-3) transfected 
NIH/3T3 followed by 0.5 mM H2O2 treatment for 10 min. Data are mean +/- SD by t-
test with *p<0.05, **p<0.01, ***p<0.001.  
  
Figure S6. PKCα is required for poly-ADP-ribose formation during oxidative 
stress.  a) Gene expression analysis of PKCs with i) calcium-dependent, ii) DAG and 
calcium-dependent or iii) calcium and DAG-independent family members in 
NIH/3T3s (n=3).  b) Schematic presentation of signaling-dependent regulation of 
ARTD1 activity induced by H2O2. Calcium- and DNA-break dependent activation of 
ARTD1 by PKCα is negatively fine-tuned through direct phosphorylation (+P) by 
PKCδ upon H2O2 exposure.  Activation of ARTD1 activity can be perturbed by 
inhibition of calcium by BAPTA or knockdown by PKCα/siPKC pan dominantly over 
the inhibitory effect of GF109203X and knockdown of PKCδ. 	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3.1.3    Oxidative stress induced poly-ADP-ribose formation is initiated by a Calcium 
dependent nuclease 	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Abstract  
The human genome is continuously exposed to various DNA damaging 
agents, which induce many types of DNA lesions. A major portion of these lesions 
represents DNA damages induced by reactive oxygen species (ROS). DNA lesions, 
induced by oxidative DNA damage, are expected to be repaired by the base excision 
repair pathway which is accompanied by a strong but short wave of nuclear poly-
ADP-ribose (PAR) formation. The molecular details of the signalling processes that 
mediate this PAR formation are still largely under debate.   
The results presented here show that a sub-lethal dose of H2O2 induced 
temporal PAR accumulation that depended on PLC, IP3R and calcium release from 
the endoplasmatic reticulum.  ROS itself was not responsible for the observed PAR 
formation. Most importantly, our findings indicate that H2O2 treatment induced DNA 
lesions in a calcium- and calmodulin dependent manner. Furthermore, preliminary 
experiments towards the identification of the nuclease, revealed that inflammaosome-
induced nucleases or the recently described ER released and calcium-dependent 
DNAS1L3 are both not involved in H2O2-induced PAR formation. The work 
described here thus reveals an H2O2-induced, calcium-dependent endonuclease 
pathway that stimulates PAR formation in the nucleus. 
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Introduction  
Nuclear and mitochondrial DNA is continuously exposed to endogenous or 
exogenous DNA damaging agents, which induce many types of DNA lesions (1).  Per 
day, about 20’000 DNA lesions are endogenously formed in mammalian cells.  
Among the most important endogenous DNA damaging agents are reactive oxygen 
species (ROS), which can be produced as a result of exposure to toxic agents such as 
irradiation and environmental pollutants.  The cell itself also produces ROS as 
byproducts of oxygen consuming enzymatic reactions, such as the mitochondrial 
respiratory chain (2).  ROS are implicated in the cellular response to a variety of 
inflammatory stimuli and are also implicated in mediating apoptosis or programmed 
cell death and ischaemic injury, including stroke and heart attack (2).  ROS constantly 
attack DNA and depending on the type and the extent of exposure, ROS also modify 
other vital cellular macromolecules such as lipids, proteins and RNA.  One of the 
best-characterized oxidative DNA lesions is 7,8-dihydro-8-oxoguanine (8-oxo-G) (1). 
Cells have evolved a plethora of mechanisms to launch a specific response to different 
types of genotoxic stress in order to prevent the inheritance or repair of DNA damage 
(3,4).  Incorporation of incorrect bases and DNA strand breaks can be repaired by 
proteins that specifically recognize such mutations or lesions.   
ADP-ribosyltransferases (ARTs) synthesize mono- and poly-ADP-ribose 
(PAR) modifications on specific residues of target proteins by using nicotinamide 
adenine dinucleotide (NAD+) as a substrate (5).  The 18 human ART family members 
are divided into diphtheria toxin-like ARTs (ARTDs) and cholera toxin-like ARTs 
(ARTCs) (6) and have been implicated in a variety of biological functions (7,8).  
ARTD1 (PARP1) is the best-studied nuclear ART and has been linked to many 
chromatin-associated processes (9,10). The current scenario of oxidative stress-
induced PAR formation describes that ARTD1 is activated in response to oxidative 
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DNA damage. Beside the possibility that the oxidation of nucleotides (such as 8-
oxoG) can induce DNA strand breaks directly by a fenton-reaction (11), this DNA 
modification can also trigger a chain of events that starts with the activation of 
glycosylases (OGG1) and leads to the formation of an ARTD1-activating nick in the 
DNA as part of the base excision repair process.  The ADP-ribose polymers (PAR) 
formed by ARTD1 were suggested to serve as “flag” marking the site of DNA 
damage and to assist the recruitment of further DNA repair adaptor and effector 
proteins (12,13), defining ARTD1 as a integral component of the efficient DNA 
repair machinery.  Thus, inhibition of PAR formation by PARP inhibitors or deletion 
of ARTD1 sensitizes cells to the cytotoxic effects of DNA-damaging agents and 
impairs the viability of cells that suffered DNA damage.  On the other hand, excessive 
PAR formation might lead to cell death in a complex, cell-type- and stimulus-
dependent manner.  Strong or prolonged activation of PAR formation causes NAD+ 
and ATP depletion, severely impairs the energy-dependent functions of a cell, and 
changes the cell death program from apoptosis to necrosis (14).  Under these 
conditions, PARP inhibitors prevent the depletion of NAD+ and ATP and partially 
restored the cell’s ability to carry out metabolic processes. In the case of excessive 
and sustained PAR formation, the polymers might also leave the nucleus and trigger 
the release of apoptosis inducing factor (AIF) from the outer mitochondrial 
membrane, thus mediating caspase-independent cell death termed parthanatos (15-
18).   
Under physiological genotoxic stress conditions (approx. 20’000 oxidative 
lesions per day and cell), ARTD1 does however not appear to be required for the 
above described BER, since ARTD1 knockout mice are viable and healthy (19), while 
mice deficient in one components of the BER machinery are all lethal (20-22).  In 
accordance, re-analysing the BER impairment in ARTD1-/- cells indicated that 
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ARTD1 is not required for BER, but that ARTD1 rather reduces the BER kinetics 
(23,24).  These data support a model where BER of physiological DNA damage 
occurs in a single, coordinated step that is ARTD1 independent.  However, following 
DNA damage induction above normal endogenous levels and exceeding the level of 
the BER capacity, ARTD1 might play an important role in the stress response (25). 
Although this enzyme is strongly activated by double-stranded DNA in vitro, a direct 
induction of PAR formation in vivo through DNA damage has only been analysed in a 
correlative manner. 
 Signaling via calcium is a universal mechanism both in excitable and non-
excitable cells.  In a model of oxidative stress-induced cytotoxicity, several 
laboratories have demonstrated that a calcium (Ca2+) signal was required for the 
activation of ARTD1 (26,27). Cellular Ca2+ is mainly stored in the endoplasmatic 
reticulum (ER), an organelle additionally responsible for folding and assembly of 
membrane and secreted proteins, synthesis of lipids as well as sterols (28,29). Both, 
oxidative stress and ER stress through ROS generation may increase Ca2+ leakage 
from the ER lumen (30-32). Notably, the Ca2+ concentration in the ER is 1’000-times 
greater than in the cytosol.  The ER Ca2+ levels are modulated by the ER located Ca2+ 
release channels, inositol-1.4.5-trisphophate receptor (IP3R) and the ryanodine 
receptor (RyR) (33,34). Ca2+ uptake on the other hand is mediated through the 
Sarco/Endoplasmic Reticulum calcium ATPase (SERCA) and numerous ER-
associated enzymatic cascades (35). Mitochondria and the ER form a delicate network 
that is fundamental for the maintenance of cellular homeostasis and survival.  In 
addition to a structural connection (32), there is dynamic exchange of Ca2+ ions 
between these two organelles, which regulates processes such as ER chaperone-
assisted folding of newly synthesized proteins, regulation of mitochondria-localized 
de-hydrogenases involved in the Krebs cycle, and the activation of Ca2+-dependent 
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enzymes that execute cell death programs (36).  ER stress has been shown to trigger 
Ca2+ release from the ER and subsequent Ca2+ uptake by mitochondria (32).  The 
efficiency of this process depends on the proximity between ER and mitochondria 
(37).  
 
 Here, we characterize the oxidative stress induced signalling cascade 
important for the formation of PAR. Our data provide evidence that Ca2+ release from 
the ER, though the signalling of PLC-catalysed IP3 is essential for nuclear PAR 
formation by ARTD1. Moreover, we provide evidence that ROS, either exogenous or 
endogenous, as a consequence of the treatment of cells by H2O2 is not responsible for 
PAR formation. Furthermore, comet assays provide strong evidence, that the Ca2+ 
release is responsible for inducing DNA strand breaks. Finally, we exclude that an 
inflammasome induced caspase-dependent nuclease or the recently described 
DNAS1L3, which is Ca2+-dependent and released after ER stress are not involved in 
H2O2-induced PAR formation. The nuclease responsible for the induction of strand-
breaks leading to PAR formation remains thus to be identified.   
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Results 
A sub-lethal dose of H2O2 induces temporal PAR formation 
 Although oxidative, stress-induced PAR formation was reported by several 
laboratories using high doses of hydrogen peroxide (H2O2), the molecular mechanism 
leading to PAR formation under non-lethal doses was so far not studied in detail.  To 
investigate the molecular mechanism of PAR formation in response to sub-lethal 
oxidative stress, human primary fibroblasts (MRC-5) were pulse-treated with 0.1 or 
0.5 mM H2O2.  PAR formation was analyzed by immunofluorescence staining using 
the 10H anti-PAR antibody and data were collected by conventional fluorescence 
microscopy.  PAR staining was observed as soon as 5 min after treatment and was no 
longer detectable at the 30 min time-point, independent on the dose used (Fig. 1A).  
To elucidate whether the applied doses induce cell death, cell viability was measured 
24 hours after H2O2 treatment by the MTT assay and the proliferation ability after 10 
days with a colony-forming assay (CFA). H2O2 doses of 1 mM or higher reduced cell 
viability significantly after 24 hours and did not allow the formation of colonies after 
10 days (Fig. 1B,C).  In contrast, H2O2 doses below 1 mM did not affect cell viability, 
but only impaired cell proliferation, suggesting that oxidative stress induced by 
concentrations below 1 mM H2O2 only induced a cell cycle arrest and possibly 
senescence (Fig. 1B,C).  Repetition of these experiments with NIH/3T3 cells 
confirmed these observations, although these cells seemed to be more resistant to 
H2O2 (2 mM H2O2 was not lethal, Suppl. Fig. 1A,B).  This experiment suggested, that 
the extent of PAR formation would be co-regulated by the ability of the cell to 
detoxify applied H2O2 molecules.  Inhibition of catalase by 3-AT indeed extended 
PAR formation up to 40 min, indicating that the activity of this enzyme is strongly 
contributing to the kinetics of the induced PAR levels (Fig. 1D).  A second treatment 
with the same H2O2 dose after 30 min also prolonged PAR formation, indicating that 
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the cells were not refractory after the first oxidative stress response and that the first 
H2O2 treatment did not deplete the NAD+ pool to such an extent, that PAR formation 
was abrogated. To understand whether the half-life of H2O2 was also influencing cell 
viability, MRC-5 were treated with H2O2 in the presence of increasing amount of 
serum, which has been reported to scavenge H2O2 molecules (38). Indeed, cell 
viability improved from 0 – 1 % and almost completely abolished the cytotoxic effect 
of H2O2 even in response to 10 mM (Fig. 1E).  Interestingly, PAR formation was also 
inhibited by increasing amount of serum (data not shown), suggesting a direct 
correlation between the amount of H2O2 molecules, the PAR signal and cell viability 
in response to H2O2.  
 
H2O2-induced PAR formation depends on PLC, IP3 and calcium release from the 
endoplasmic reticulum. 
 Oxidative stress induces cytosolic calcium accumulation as a fast response.  
To test whether early induction of PAR is influenced by calcium, human fibroblast 
were treated with a sub-lethal dose of H2O2 in the presence of small molecule 
inhibitors of components that are involved in Ca2+ signaling. Subsequent treatment 
with a sub-lethal H2O2 dose revealed that pretreatment with the endogenous calcium 
chelator BAPTA diminished PAR formation to comparable extent as the PARP 
inhibitor Olaparib (Fig. 2A,B).  A direct effect of BAPTA on ARTD1 activity can be 
excluded, since ARTD1 automodification was not affected by the addition of BAPTA 
to the in vitro reaction (Suppl. Fig. S2A).  Moreover, the inhibition of the IP3 (IP3R) 
or the Ryanodine receptor (RyR), two receptors located in the ER and involved in 
Ca2+ signaling, reduced PAR formation (Fig. 2A,B), confirming that Ca2+ is released 
from the ER upon H2O2 treatment.  Assessing PAR formation by immunoblot analysis 
confirmed the above observations (Suppl. Fig. 2B).  To exclude that the observed 
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effects were not due to an off-target effect of the tested inhibitors, the levels of all 
above-mentioned proteins were reduced by siRNA treatment and PAR formation was 
analyzed.  Knocking-down ARTD1, IP3R or RyR indeed reduced PAR formation 
upon H2O2 treatment significantly, confirming these proteins as part of the oxidative 
stress-induced signaling cascade that induces PAR formation through the release of 
Ca2+ (Fig. 2C,D and Suppl. Fig. 2C).  To strengthen the conclusion, that IP3 
production by PLC at the cellular membrane is responsible for the observed PAR 
formation, PLC was inhibited and PAR formation subsequently induced by H2O2. 
Inhibition of phospholipase C (PLC) indeed reduced PAR formation substantially, 
indicating that oxidative events at the membrane may initiate a signaling cascade, 
which leads to the synthesis of IP3 and the subsequent release of Ca2+ from the ER 
(Fig. 2A). 
 
H2O2-induced calcium release is essential for PAR formation. 
Calmodulin (CaM) is an important Ca2+ binding protein and calcium signal transducer 
(39). Application of small molecule inhibitors of CaM reduced PAR levels to the 
same extent as BAPTA, thus indicating its crucial involvement in regulating PAR 
formation upon H2O2 stress (Suppl. Fig. 2A). Moreover, knockdown of CaM3 almost 
completely abolished PAR formation upon H2O2 treatment and thus confirmed the 
results with the specific CaM inhibitor (Suppl. Fig. 2C,D).   Inhibition of Cyclophilin 
D (CypD) and Complex I (NADH dehydrogenase), two mitochondrial proteins, did 
not affect H2O2-induced PAR formation, indicating that the mitochondrial 
permeability transition pore and electron transport chain are unlikely involved in these 
early signaling events (Fig. 2A,B and Suppl. Fig. 2B).  Interestingly, also the 
scavenging of endogenous ROS by the treatment with NAC did not reduced PAR 
formation within the first 30 min, revealing that a possible perturbation of 
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mitochondria by Ca2+ and the subsequent release of endogenous ROS do not 
contribute to the observed PAR formation within the first few minutes after H2O2 
treatment (Fig. 2E).  Together these results suggested, that the initiating signal leading 
to PAR formation is not originating from the mitochondrial, but more likely generated 
by events at the plasma membrane. Under physiological conditions, Ca2+ is constantly 
leaking from the ER and needs to be pumped back to avoid the induction of 
mitochondrial ROS production, the activation ER-stress, or caspase dependent cell 
death (40,41).  Inhibition of SERCA by thapsigargin (Tg) was reported to increase 
intracellular Ca2+ levels (42).  Indeed, pre-treatment of cells with Tg prolonged the 
observed PAR formation up to 60 minutes, while treatment with the inhibitor alone 
was not able to induce PAR formation (Fig. 2F and Suppl. Fig. 2E).  Together, these 
results provide strong evidence that the physiological fluctuation of Ca2+ is not 
sufficient to induce PAR formation, but that the enhanced release of Ca2+ by IP3 is 
required to reach an intra-cellular Ca2+ threshold, which is important for PAR 
formation.   
 
Sublethal doses of H2O2 induce the anti-oxidant response but not the unfolded 
protein response in ER. 
H2O2 is reported to induce ER-stress and to activate the anti-oxidant response (43).  
To test whether this is the case under the conditions tested here, NIH/3T3 were treated 
with H2O2 for 10 min and the expression of marker genes involved in ER-stress 
(Calreticulin, BIP, Grp94) and the anti-oxidant response (SOD, GSR) was analyzed 
(11,44).  As expected, ER-stress was affected by Tg treatment alone, but the response 
to H2O2 was not significant and combination of Tg and H2O2 did not affect the 
expression of the tested genes as compared to Tg treatment alone (Fig. 2G).  BAPTA 
treatment alone, or in combination with H2O2, did not cause significant changes in 
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gene expression neither (Suppl. Fig. 2F).  These results indicated, that ER-stress is not 
induced or enhanced by H2O2 treatment within the first 10 min, and therefore cannot 
contribute to calcium-dependent activity of ARTD1.  In contrast, H2O2 treatment led 
to a fast expression of genes involved in the anti-oxidant response, which was also 
inhibited by BAPTA, indicating calcium-dependent activation of oxidative stress (Fig. 
2H and Suppl. Fig. 2G).  In summary, our data provide evidence for an early-induced 
oxidative stress response that leads to the release of Ca2+ via the PLC-IP3R/RyR 
pathway and consecutive PAR formation. 
 
The base excision repair pathway is not involved in PAR formation. 
 ARTD1 was described to be only activated in BER in cases where the number 
of DNA lesions exceeds the endogenous BER capacity (4).  We thus analyzed the 
number of PAR foci induced upon H2O2 treatment in cells depleted of XRCC1 (which 
reduces the BER repair capacity).  Oxidative stress induced the same amount of PAR 
foci in siXRCC1 and siMock treated cells (Fig. 3A), indicating that the initial 
activation of ARTD1 after H2O2 treatment is not dependent on the BER capacity.  To 
analyze whether initiation of the BER pathway is required for initial PAR formation, 
WT and OGG1 MEFs were treated with H2O2 and PAR formation analyzed.  
Induction of PAR formation was comparable in both cell types.  Kinetic experiments 
however revealed that removal of PAR was delayed at the 60 min time point, 
indicating that the presence of OGG1 is positively affecting PAR formation, but only 
at a late time point after treatment and that the initial strong PAR formation is induced 
by a mechanism distinct from BER (Fig. 3B).  
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H2O2 induces DNA lesions in a calcium dependent manner. 
The current model of ARTD1 activation foresees that DNA is damaged by ROS either 
directly (e.g., induction of single strand breaks) or indirectly (e.g., induction of 
oxidative DNA lesions), which are subsequently repaired by BER (45).  To confirm 
that treatment of cells with H2O2 indeed induces DNA strand breaks, cells were 
treated with different doses of H2O2 for either 3 or 20 min.  Treatment with 50 µM 
H2O2 for 3 min already induced detectable DNA lesions as observed by the alkaline 
comet assay (Fig. 3C).  Increasing the H2O2 concentration lead to an increased 
number of DNA lesions. Interestingly, extending the treatment period to 20 min led to 
no dramatic increase in DNA damage, indicating that the detoxification system 
reacted comparably to a 3 or 20 min H2O2 exposure (Fig. 3C).  Moreover, there was 
no evidence for DNA breaks below 50 µM H2O2, which correlates with the minimal 
dose of H2O2 (50 µM) required to induce PAR (Suppl. Fig. 1A).  In conclusion, we 
observed a positive correlation between the formation of DNA lesions and PAR 
formation in response to H2O2.   
 Since the alkaline comet assay does not distinguish between single or double-
strand break formation, DNA damage was further analyzed by investigating markers 
of true DNA double strand breaks.  The observed H2O2-induced DNA damage was 
very unlikely the accumulation of DNA double-strand breaks (DSBs), as treatment of 
cells with 6 Gy IR, which arrested cells in a CFA experiment, and induced early 
γH2AX and 53BP1 foci formation (DSB markers), was not able to induce PAR 
formation at all (Suppl. Fig 3A, B).  In contrast, H2O2 treatment led to a delayed 
induction of γH2AX foci formation (peaking after 60 min), while showing no sign of 
53BP1 foci formation at all (Fig. 3D-E). Together, these experiments indicated that 
H2O2 might induce single-strand DNA lesions which are converted into double-strand 
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DNA lesions (after 60 min) and which are different from a classical DNA damage 
response (DDR) induced upon irradiation. 
 To confirm that the induced DNA breaks are dependent on the Ca2+ release 
from the ER, the alkaline comet assay was performed in the presence of BAPTA.  Co-
treatment of cells with BAPTA and H2O2 significantly reduced DNA damage at two 
different time points (3 and 20 min; Fig. 3F).  Interestingly, irradiation of cells with 5 
or 20 Gy induced detectable DNA damage, which was however not inhibited by 
BAPTA, again indicating that the mechanism responsible for the DNA damage upon 
H2O2 treatment is not activated upon irradiation (Fig. 3G). Interestingly, BAPTA 
treatment also reduced γH2AX foci formation after 60 min recovery from IR, 
providing strong evidence that these foci are indeed generated from the single-strand 
lesions observed already at 3-10 min (Fig. 3H). Moreover, inhibition of ROS by NAC 
did not lead to a reduction in DNA break formation, which is in line with slightly 
elevated PAR formation upon NAC pretreatment, thus excluding ROS as a direct 
inducer of PAR upon H2O2 treatment (Fig. 3I). Finally, addition of H2O2 to irradiated 
cells led to a strong DNA break induction, which was abrogated in presence of 
BAPTA to the level of IR-induced DNA breaks (Fig. 3I). These results confirm 
calcium dependent formation of H2O2 induced SSBs rather than IR-induced DSBs and 
strongly correlate with PAR formation. 
 
Inflammasome-induced nucleases or the ER released endonuclease, DNAS1L3, 
are not involved in H2O2-induced PAR formation.   
The above reported findings eliminated the possibility that ROS directly induce DNA 
damage and rather pointed at a nuclease, which is either Ca2+-dependent or which 
translocates to the nucleus in a Ca2+-dependent manner.  Several endonucleases have 
already been published to contribute to chromatin degradation during apoptosis in a 
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Ca2+-dependent manner (46,47).  Caspase-activated DNases (CAD) are the most 
favourable candidates (48).  A calcium sensor (CasR) was recently described to be an 
important component linking Ca2+release from the ER to the inflammasome and the 
activation caspase-1 (49).  To investigate whether a CasR is involved in the observed 
H2O2-induced DNA damage, CasR was depleted by siRNA and PAR formation 
induced by H2O2 treatment.  Knockdown of CasR did not reduce PAR formation, 
indicating that the inflammasome-induced nuclease is unlikely to induce PAR 
formation (data not shown). Furthermore, alkaline comet formation was analysed in 
cells treated with H2O2 in the presence of Z-VAD, a Pan Caspase inhibitor.  The 
addition of Z-VAD did not inhibit DNA damage upon H2O2 treatment, indicating that 
CADs are unlikely involved in this process (Fig. 4A).  Recently, an ER-released Ca2+-
dependent endonuclease was described to be important in internucleosomal DNA 
fragmentation including DNAS1L3 (50).  Preliminary results did however not show 
an effect on PAR formation upon deletion of DNAS1L3 by siRNA, indicating that 
DNAS1L3 was neither involved in this process (data not shown). 
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Discussion  
 The results presented here show that a sub-lethal dose of H2O2 induced 
temporal PAR accumulation with fast kinetics and independent of the redox system of 
the cell.  H2O2-induced PAR formation was dependent on PLC, IP3R and calcium 
release from the endoplasmatic reticulum.  Our findings indicate that H2O2 induces 
single-stranded DNA lesions in a calcium-dependent manner. Furthermore, we show 
that these DNA lesions were not generated by inflammasome-induced nucleases or 
the ER-released endonuclease DNAS1L3. The work described here thus reveals an 
H2O2-induced, Ca2+-dependent endonuclease pathway that stimulates PAR formation 
in the nucleus. 
 Although the H2O2 dose was chosen not to induce immediate cell death, the 
reduction of colony formation after treatment indicates that the induced DNA lesions 
indeed affected long-term cell proliferation.  This growth phenotype could be caused 
by defects in sister chromatid exchange or by the activation of cell cycle check points 
and the consecutive induction of senescence. Whether this phenotype was induced by 
the initial BER independent induction of DNA lesions, or by additional DNA lesions 
(e.g. OGG1-dependent DNA lesions, induced after 60 minutes), requires further 
experimental analysis. Moreover, Ca2+-induced DNA lesions might be single-stranded 
DNA strand breaks, that are during S-Phase converted into double stranded DNA 
lesions (after 60 minutes) as observed by the induction of  γH2AX foci. This 
hypothesis is strengthened by the observation, that  γH2AX foci formation could also 
be inhibited by BAPTA, indicate that the Ca2+-induced number of DNA lesions either 
exceeded the endogenous repair capacity for single-stranded DNA strand breaks or 
that the cellular repair system was not able to recognize or repair the induced single-
strand DNA lesion due to other constrains. The S-phase induced conversion of single-
strand to double-strand DNA breaks would thus provide an alternative way for 
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proliferating cells to repair the induced single strand breaks by double strand break 
repair pathways.  
 ARTD1 and its induced PAR formation have in general been traditionally 
implicated in the response to DNA damage.  An important cornerstone for this model 
is the activation of ARTD1 by DNA in vitro and the detection of PAR upon treatment 
of cells with genotoxic compounds.  A causative link between DNA lesions and the 
activation of ARTD1 in vivo, remained however on the correlative level. The first 
evidence for a fast activation of ARTD1 by signals evoked in the cell membrane, 
involving IP3 and Ca2+ mobilization, was observed in neurons (51). In contrast to the 
above-presented data, these studies with neurons did not observe DNA breaks. 
Comparable to our studies, treatment of thymocytes with low concentrations of 
peroxynitrite induced rapid Ca2+ mobilization (1 to 3 min), DNA single-strand 
breakage and activation of ARTD1 (27), suggesting signals that can induce PAR 
formation originate at the plasma membrane, traverse the cytoplasm and finally reach 
the nucleus, where DNA strand breaks are induced and PAR formation is stimulated. 
 Whether the described signal pathway is the only required pathway for the 
induction of nuclear PAR formation remains to be confirmed, as PLC not only 
generates IP3 , but also diacetylglycerol (DAG) which was described induce the PKC 
kinase family. Recent own observation indicated that the PKC family shows a dual 
role in the regulation of ARTD1 activity (manuscript submitted). While knockdown 
of the DAG-dependent PKCδ enhanced ARTD1 activity upon H2O2 treatment, 
knockdown of the calcium-dependent PKCα strongly reduced H2O2-induced PAR 
formation, indicating a calcium-dependent and DNA-independent regulation of 
ARTD1-induced PAR formation upon oxidative stress. Similarly, Ca2+- signaling was 
essential for PAR formation as confirmed by the elimination of its formation after 
knockdown of Calmodulin. Whether Calmodulin is directly involved in the induction 
  121	  
of the endonuclease or activating a so far unidentified pathway that is additionally 
required (e.g. phosphorylation of ARTD1) needs additional clarification. Based on 
our own studies (manuscript submitted) we identified the calmodulin-dependent 
kinase IIδ (CaMKIIδ) as a positive regulator of ARTD1 activity upon oxidative stress, 
which is in line with previous observations in neurons (52,53) and may explain an 
alternative mechanism of ARTD1 modulation by kinase signaling.  
 ARTD1 and PARG have both been described to control extracellular Ca2+ 
fluxes, although as upstream regulators, through melastatin-like transient receptor 
potential 2 channels (TRPM2) in a cell death-signalling pathway (54).  TRPM2 
activation accounted for essentially the entire Ca2+ influx into the cytosol, activating 
caspases and causing the translocation of apoptosis inducing factor (AIF) from the 
inner mitochondrial membrane to the nucleus followed by cell death.  ADP-ribose-
loading of cells induced Ca2+ fluxes in the absence of oxidative damage, suggesting 
that ADP-ribose is the key metabolite of the ARTD1/PARG system regulating 
TRPM2, controlling a cell death signal pathway including different cell 
compartments. 
  β-lapachone ( β-lap) was the first chemotherapeutic agent shown to elicit a 
Ca2+-mediated cell death by ARTD1 hyperactivation at clinically relevant doses in 
cancer cells expressing elevated NAD(P)H:quinone oxidoreductase 1 (NQO1) levels 
(26).  β-lap induced the NQO1-dependent generation of ROS and DNA breaks, and 
triggered Ca2+-dependent γ-H2AX formation and ARTD1 hyperactivation. Reduction 
of ARTD1 activity or Ca2+ chelation protected cells.  The same group reported that 
Ca2+ chelation abrogated H2O2, but not MNNG-induced ARTD1 hyperactivation and 
cell death suggesting hat the MNNG and H2O2-induced PAR formation might not be 
induced by a common mechanism (26). In contrast, own MNNG experiments 
revealed that also MNNG induced PAR formation can be strongly reduced by 
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BAPTA (data not shown), suggesting that MNNG, might induce also a Ca2+-induced 
nuclease comparable to H2O2. Interestingly, the required minimal doses of MNNG to 
induce PAR, also induced cell death, suggesting that PAR formation might be 
induced as a secondary effect after alkylating DNA mutation. Moreover, MNNG 
induced PAR formation appeared later the H2O2-induced PAR formation and also 
remained longer (data not shown).  
 These studies provide strong evidence that H2O2 treatment induced an 
endonuclease that cleaves DNA and thereby induces PAR formation.  Initial efforts to 
identify the responsible endonuclease revealed that the inflammasome-induced 
pathways and the ER-release DNAS1L3 are not involved in PAR formation. Several 
other possible nuclease candidates can however be foreseen, and should be 
experimentally analazed. 
 Together, these studies provide evidence that H2O2 treatment induces PAR 
formation not through oxidative damage of the DNA during the first 30 minutes, but 
rather induces through Ca2+ signaling an endonuclease, that induces single-strand 
lesions.  
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Experimental procedures 
 
Cell culture, IR treatment, siRNA transfection and lysis   
The MRC-5 and IMR-90 human lung fibroblast cell strains (20, 21) were obtained 
from the American Type Culture Collection (ATCC) and cultured in supplemented 
MEM (Invitrogen). NIH/3T3 from ATCC, shXRCC1 HeLa (kind gift of Dr. Roberta 
Minotti), OGG1 WT and KO MEFs (kind gift of Dr. Michaelo Razumenko) were 
cultured in supplemented DMEM (Invitrogen). Cells were preincubated with 
inhibitors (stocks dissolved in DMSO) for 1h prior to H2O2 treatment in FCS-free 
media, which was also used as a vehicle for H2O2. All inhibitors were obtained from 
Enzo Life Sciences, except from Olaparib (AstraZeneca), 3-AT (Sigma), and used at a 
final concentration as indicated in the figures or figure legends. To reduce isoform 
specific ARTD1, IP3R or CaM expression, 2x105 NIH/3T3 cells were transfected 
using mouse siARTD1 (AAGGGCAAGCACAGTGTCAAA, QIAGEN, 
SI02731428),  siIP3R1 (CAGGGAAATGATGACCAAAGA, QIAGEN, 
SI01079085), siIP3R2 (CAGCCTGGGATTACAGAAATA, QIAGEN, SI02694293), 
siIP3R3 (CACCATGGAGTTCGTAGAAGA QIAGEN, SI01079099), siCaM1 
(TAGAAGTGTGTTGCATTTAAA, QIAGEN, SI00940009), siCaM2 
(CACAACTTGCCTCAAATCCAT, QIAGEN, SI00940044), siCaM-like3 
(ATGGTGAATGAAATTGACAAA, QIAGEN, SI00940142) or siCtl. (scrambled 
sequence, lacking significant homology to any known mouse gene sequence) with 
Lipofectamine RNAiMAX transfection reagent (Invitrogen) according to manual’s 
instructions over 3-4 days, prior to H2O2 treatment. Whole cell extracts were prepared 
with standard RIPA lysis buffer (50 mM Tris/pH8, 400mM NaCl, 0.5% NP-40, 1% 
DOC, 0.1% SDS supplemented with proteinase inhibitor cocktail (Roche), 10 mM β-
glycerolphosphate, 1mM NaF and DTT) and total protein concentration determined 
using standard Lowry method.   
 
Immunoblotting 
For immunoblot analysis, proteins were separated by SDS PAGE gel electrophoresis 
and bands were visualized by either using horseradish peroxidase-conjugated 
antibodies (1:5000, GE Healthcare) and ECL detection (GE Healthcare) or by using 
IR-Dye-conjugated antibodies (1:15000, LI-COR) and detection by the Odyssey 
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infrared imaging system (LI-COR).  For quantification, bands were analyzed by 
ImageJ 1.46 (35) and the Odyssey imaging software (LI-COR).   
Antibodies used for immuneblotting were anti-PARP1/2 (Santa Cruz), anti-PAR 
(10H, homemade), anti-Tubulin (1:10’000, Sigma), anti-β-Actin (CST). If not else 
stated, antibody dilution was 1:1000.   
 
Immunofluorescence (IF) microscopy  
For PAR- IF analysis 1.5x105 NIH/3T3 and Raw 264.1 or 2.5x104 MEF, MRC-5 and 
IMR-90 cells were grown on cover slips overnight prior to inhibitor/activator 
preincubation and H2O2 treatment. Afterwards cells were washed with PBS (1x), 
fixed with ice-cold methanol and acetic acid (3:1) for 10 min at 4°C, washed with 
PBS (3x), blocked in 5% milk/0.05% Tween-20 in PBS for 30 min and stained 
immunohistochemically with primary mouse anti-poly(ADP-ribose) IgG, 1:250 (10H, 
homemade) or anti-PARP1/2 rabbit IgG, 1:250 (Santa Cruz). Next, cells were washed 
with PBS (3x) before hybridization with a secondary antibody (1:250 Cy3 conjugated 
anti-mouse IgG, Jackson ImmunoResearch or 1:250 Alexa Fluor 488 ocnjugated anti-
rabbit IgG, Invitrogen). Eventually, cells were mounted on glass slides using DAPI-
containing VECTASHIELD (Vector Labs) and images acquired using an inverted 
fluorescence microscope at 40x, oil immersion (Leica). Fluorescence intensity or foci 
number were quantified using ImageJ (v. 1.46r) or Imaris (v. 7.6.0, Bitplane) and 
equal set-up between the images and experiments. For  γH2A.X or 8-OxoG- IF 
analysis, experiment performed as described above using ice cold methanol for 
fixation, blocking with 10% FCS in PBS and immunostaining with primary mouse 
anti-Histone H2A.X Phospho (Ser139) IgG1, 1:500 (Millipore) or mouse anti-8-
oxoguanine IgM, 1:250 (Millipore) and secondary FITC conjugated anti-mouse 
IgG,1:250 or TexasRed AffiniPure F(ab’)2 fragment donkey anti-mouse IgM µ chain, 
1:250 (Jackson ImmunoResearch). For 53BP1- IF analysis, experiment performed as 
described above fixing cells with 4% paraformaldehyde (PFA), washing with PBS 
(2x) and permeabilization by 0.25% Triton X100 in PBS for 5 min followed by brief 
washing (2x) before applying blocking solution (5% milk/0.05% Tween-20 in PBS) 
and immunostaining with primary rabbit anti-53BP1 IgG, 1:300 (Santa Cruz) and 
secondary Cy3 conjugated anti-rabbit IgG, 1:250 (Jackson ImmunoResearch). 
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RNA extraction and real-time PCR analysis 
Cells were harvested either by trypsin or directly lysed on the plate in lysis buffer.  
RNA extraction was performed with the NucleoSpin® RNA II kit (Macherey-Nagel, 
Düren, Germany).  RNA was quantified with a NanoDrop (ThermoFisherScintific, 
Waltham, MS, USA) and reverse transcribed according to the supplier’s protocol 
(High Capacity cDNA Reverse Transcription Kit, Applied Biosystems, Foster City, 
CA, United States).   
Quantitative-real-time polymerase chain reactions (qPCR) were performed with 
SYBR® green SensiMix SYBR Hi-ROX Kit (Bioline Reagents Ltd, London, UK) 
and a Rotor-Gene Q 2plex HRM System (Qiagen, Hilden, Germany). 
 
Alkaline Comet assay 
5x105 Raw 264.1 or NIH/3T3s were grown over night in 6-well-plates before 
inhibitor/activator preincubation for 1 h followed by H2O2 treatment. Raw and 
NIH/3T3 cells were collected by scrapping and Trypsin/EDTA (Invitrogen) 
accordingly, span down and diluted to 3-4x105 for Comet Assay, which was 
performed according to the manufacture’s recommendations (Trevigen).   
 
Cell proliferation and viability assay 
Cell proliferation was determined by the clonogenic assay as described elsewhere 
(55). AlamarBlue® assay (Invitrogen, Carlsbad, CA, USA) or MTT assay (Sigma) 
were used to measure cell viability. 
 
  
  126	  
References 
1. Markkanen, E., Hubscher, U. and van Loon, B. (2012) Regulation of oxidative 
DNA damage repair: the adenine:8-oxo-guanine problem. Cell Cycle, 11, 1070-
1075. 
2. Cai, H. and Harrison, D.G. (2000) Endothelial dysfunction in cardiovascular 
diseases: the role of oxidant stress. Circ Res, 87, 840-844. 
3. Zhou, B.B. and Elledge, S.J. (2000) The DNA damage response: putting 
checkpoints in perspective. Nature, 408, 433-439. 
4. Dianov, G.L. and Hubscher, U. (2013) Mammalian base excision repair: the 
forgotten archangel. Nucleic Acids Res. 
5. Hassa, P.O., Haenni, S., Elser, M. and Hottiger, M.O. (2006) Nuclear ADP-
ribosylation reactions in mammalian cells: where are we today and where are we 
going? Microbiol Mol Biol Rev, 70, 789-829. 
6. Hottiger, M.O., Hassa, P.O., Lüscher, B., Schüler, H. and Koch-Nolte, F. (2010) 
Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends 
Biochem Sci, 35, 208-219. 
7. Luo, X. and Kraus, W.L. (2012) On PAR with PARP: cellular stress signaling 
through poly(ADP-ribose) and PARP-1. Genes Dev, 26, 417-432. 
8. Schreiber, V., Dantzer, F., Ame, J.-C. and De Murcia, G. (2006) Poly(ADP-
ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol, 7, 517-528. 
9. Kraus, W.L. and Hottiger, M.O. (2013) PARP-1 and gene regulation: Progress 
and puzzles. Mol Aspects Med. 
10. Hassa, P.O. and Hottiger, M.O. (2008) The diverse biological roles of mammalian 
PARPs, a small but powerful family of poly-ADP-ribose polymerases. Front 
Biosci, 13, 3046-3082. 
  127	  
11. Jones, D.P. (2008) Radical-free biology of oxidative stress. Am J Physiol Cell 
Physiol, 295, C849-C868. 
12. De Vos, M., Schreiber, V. and Dantzer, F. (2012) The diverse roles and clinical 
relevance of PARPs in DNA damage repair: Current state of the art. Biochem 
Pharmacol, 84, 137-146. 
13. Trucco, C., Oliver, F., de Murcia, G. and Ménissier-de Murcia, J. (1998) DNA 
repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids 
Res, 26, 2644-2649. 
14. Berger, N.A., Sims, J.L., Catino, D.M. and Berger, S.J. (1983) Poly(ADP-ribose) 
polymerase mediates the suicide response to massive DNA damage: studies in 
normal and DNA-repair defective cells. Princess Takamatsu Symp, 13, 219-226. 
15. Andrabi, S.A., Kim, N.S., Yu, S.W., Wang, H., Koh, D.W., Sasaki, M., Klaus, 
J.A., Otsuka, T., Zhang, Z., Koehler, R.C. et al. (2006) Poly(ADP-ribose) (PAR) 
polymer is a death signal. Proc Natl Acad Sci USA, 103, 18308-18313. 
16. Wang, Y., Kim, N.S., Haince, J.F., Kang, H.C., David, K.K., Andrabi, S.A., 
Poirier, G.G., Dawson, V.L. and Dawson, T.M. (2011) Poly(ADP-ribose) (PAR) 
binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent 
cell death (Parthanatos). Sci Signal, 4, ra20. 
17. Yu, S.-W., Andrabi, S., Wang, H., Kim, N., Poirier, G., Dawson, T. and Dawson, 
V. (2006) Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-
induced cell death. Proc Natl Acad Sci USA, 103, 18314-18319. 
18. Yu, S.-W., Wang, H., Poitras, M., Coombs, C., Bowers, W., Federoff, H., Poirier, 
G., Dawson, T. and Dawson, V. (2002) Mediation of poly(ADP-ribose) 
polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 297, 
259-263. 
  128	  
19. Wang, Z., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M. 
and Wagner, E. (1995) Mice lacking ADPRT and poly(ADP-ribosyl)ation develop 
normally but are susceptible to skin disease. Genes Dev, 9, 509-520. 
20. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H. and Rajewsky, K. (1994) 
Deletion of a DNA polymerase beta gene segment in T cells using cell type-
specific gene targeting. Science, 265, 103-106. 
21. Tebbs, R.S., Flannery, M.L., Meneses, J.J., Hartmann, A., Tucker, J.D., 
Thompson, L.H., Cleaver, J.E. and Pedersen, R.A. (1999) Requirement for the 
Xrcc1 DNA base excision repair gene during early mouse development. Dev Biol, 
208, 513-529. 
22. Xanthoudakis, S., Smeyne, R.J., Wallace, J.D. and Curran, T. (1996) The 
redox/DNA repair protein, Ref-1, is essential for early embryonic development in 
mice. Proc Natl Acad Sci USA, 93, 8919-8923. 
23. Strom, C.E., Johansson, F., Uhlen, M., Szigyarto, C.A., Erixon, K. and Helleday, 
T. (2011) Poly (ADP-ribose) polymerase (PARP) is not involved in base excision 
repair but PARP inhibition traps a single-strand intermediate. Nucleic Acids Res, 
39, 3166-3175. 
24. Allinson, S.L., Dianova, II and Dianov, G.L. (2003) Poly(ADP-ribose) 
polymerase in base excision repair: always engaged, but not essential for DNA 
damage processing. Acta Biochim Pol, 50, 169-179. 
25. Woodhouse, B. and Dianov, G. (2008) Poly ADP-ribose polymerase-1: an 
international molecule of mystery. DNA Repair (Amst), 7, 1077-1086. 
26. Bentle, M., Reinicke, K., Bey, E., Spitz, D. and Boothman, D. (2006) Calcium-
dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular 
metabolism and DNA repair. J Biol Chem, 281, 33684-33696. 
  129	  
27. Virag, L., Scott, G.S., Antal-Szalmas, P., O'Connor, M., Ohshima, H. and Szabo, 
C. (1999) Requirement of intracellular calcium mobilization for peroxynitrite-
induced poly(ADP-ribose) synthetase activation and cytotoxicity. Mol Pharmacol, 
56, 824-833. 
28. Gething, M.J. and Sambrook, J. (1992) Protein folding in the cell. Nature, 355, 
33-45. 
29. Kaufman, R.J. (1999) Stress signaling from the lumen of the endoplasmic 
reticulum: coordination of gene transcriptional and translational controls. Genes 
Dev, 13, 1211-1233. 
30. Berridge, M.J., Bootman, M.D. and Roderick, H.L. (2003) Calcium signalling: 
dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol, 4, 517-529. 
31. Gorlach, A., Klappa, P. and Kietzmann, T. (2006) The endoplasmic reticulum: 
folding, calcium homeostasis, signaling, and redox control. Antioxid Redox 
Signal, 8, 1391-1418. 
32. Giorgi, C., De Stefani, D., Bononi, A., Rizzuto, R. and Pinton, P. (2009) 
Structural and functional link between the mitochondrial network and the 
endoplasmic reticulum. Int J Biochem Cell Biol, 41, 1817-1827. 
33. Hajnoczky, G., Csordas, G., Madesh, M. and Pacher, P. (2000) Control of 
apoptosis by IP(3) and ryanodine receptor driven calcium signals. Cell Calcium, 
28, 349-363. 
34. Hanson, C.J., Bootman, M.D. and Roderick, H.L. (2004) Cell signalling: IP3 
receptors channel calcium into cell death. Curr Biol, 14, R933-R935. 
35. Csordas, G. and Hajnoczky, G. (2009) SR/ER-mitochondrial local 
communication: calcium and ROS. Biochim Biophys Acta, 1787, 1352-1362. 
36. Franzini-Armstrong, C. (2007) ER-mitochondria communication. How 
privileged? Physiology, 22, 261-268. 
  130	  
37. de Brito, O.M. and Scorrano, L. (2008) Mitofusin 2 tethers endoplasmic reticulum 
to mitochondria. Nature, 456, 605-610. 
38. Oowada, S., Endo, N., Kameya, H., Shimmei, M. and Kotake, Y. (2012) Multiple 
free-radical scavenging capacity in serum. J Clin Biochem Nutr, 51, 117-121. 
39. Hoeflich, K.P. and Ikura, M. (2002) Calmodulin in action: diversity in target 
recognition and activation mechanisms. Cell, 108, 739-742. 
40. Berridge, M.J. (2002) The endoplasmic reticulum: a multifunctional signaling 
organelle. Cell Calcium, 32, 235-249. 
41. Janssen, K., Horn, S., Niemann, M.T., Daniel, P.T., Schulze-Osthoff, K. and 
Fischer, U. (2009) Inhibition of the ER Ca2+ pump forces multidrug-resistant 
cells deficient in Bak and Bax into necrosis. J Cell Sci, 122, 4481-4491. 
42. Jones, K.T. and Sharpe, G.R. (1994) Thapsigargin raises intracellular free calcium 
levels in human keratinocytes and inhibits the coordinated expression of 
differentiation markers. Exp Cell Res, 210, 71-76. 
43. Malhotra, J.D. and Kaufman, R.J. (2007) Endoplasmic reticulum stress and 
oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal, 
9, 2277-2293. 
44. Zhang, K. and Kaufman, R.J. (2008) From endoplasmic-reticulum stress to the 
inflammatory response. Nature, 454, 455-462. 
45. Caldecott, K.W. (2008) Single-strand break repair and genetic disease. Nat Rev 
Genet, 9, 619-631. 
46. Lee, M.J., Kee, K.H., Suh, C.H., Lim, S.C. and Oh, S.H. (2009) Capsaicin-
induced apoptosis is regulated by endoplasmic reticulum stress- and calpain-
mediated mitochondrial cell death pathways. Toxicology, 264, 205-214. 
  131	  
47. Norberg, E., Gogvadze, V., Vakifahmetoglu, H., Orrenius, S. and Zhivotovsky, B. 
(2010) Oxidative modification sensitizes mitochondrial apoptosis-inducing factor 
to calpain-mediated processing. Free Radic Biol Med, 48, 791-797. 
48. Nagata, S. (2000) Apoptotic DNA fragmentation. Exp Cell Res, 256, 12-18. 
49. Lee, G.S., Subramanian, N., Kim, A.I., Aksentijevich, I., Goldbach-Mansky, R., 
Sacks, D.B., Germain, R.N., Kastner, D.L. and Chae, J.J. (2012) The calcium-
sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. 
Nature, 492, 123-127. 
50. Errami, Y., Naura, A.S., Kim, H., Ju, J., Suzuki, Y., El-Bahrawy, A.H., Ghonim, 
M.A., Hemeida, R.A., Mansy, M.S., Zhang, J. et al. (2013) Apoptotic DNA 
fragmentation may be a cooperative activity between caspase-activated 
deoxyribonuclease and the poly(ADP-ribose) polymerase-regulated DNAS1L3, an 
endoplasmic reticulum-localized endonuclease that translocates to the nucleus 
during apoptosis. J Biol Chem, 288, 3460-3468. 
51. Homburg, S., Visochek, L., Moran, N., Dantzer, F., Priel, E., Asculai, E., 
Schwartz, D., Rotter, V., Dekel, N. and Cohen-Armon, M. (2000) A fast signal-
induced activation of Poly(ADP-ribose) polymerase: a novel downstream target of 
phospholipase c. J Cell Biol, 150, 293-307. 
52. Ju, B.-G., Solum, D., Song, E., Lee, K.-J., Rose, D., Glass, C. and Rosenfeld, M. 
(2004) Activating the PARP-1 sensor component of the groucho/ TLE1 
corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene 
activation pathway. Cell, 119, 815-829. 
53. Midorikawa, R., Takei, Y. and Hirokawa, N. (2006) KIF4 motor regulates 
activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. 
Cell, 125, 371-383. 
  132	  
54. Blenn, C., Wyrsch, P., Bader, J., Bollhalder, M. and Althaus, F.R. (2011) 
Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca2+ fluxes in 
oxidative cell death. Cell Mol Life Sci, 68, 1455-1466. 
55. Franken, N.A., Rodermond, H.M., Stap, J., Haveman, J. and van Bree, C. (2006) 
Clonogenic assay of cells in vitro. Nature Protoc, 1, 2315-2319.  
  133	  
Author Contributions 
A.B. designed and performed experiments; N.G. performed and analysed the comet 
assays; K.L. performed gene expression analysis; B.vL. and M.O.H.  supervised the 
work and M.O.H.  wrote the manuscript. 
 
The authors declare that they have no conflict of interest. 
  
Acknowledgements 
Roberta Minotti (Former member of the IVBMB, University of Zurich, Switzerland) 
is acknowledged for providing the shXRCC1 HeLa cells. Mykhailo Razumenko 
(University Hospital Zurich, Switzerland) is acknowledged for providing the OGG1 
WT and KO MEFs. Florian Freimoser (University of Zurich, Switzerland) provided 
editorial assistance and critical input during the writing.  This work was supported in 
part by the Swiss National Science Foundation Grants 31-122421, Mäxi-Foundation 
and the Kanton of Zurich (to M.O.H.).   
 
  
  134	  
Figure Legends 
Fig. 1. Induction of early PAR in response to low, non-lethal H2O2 doses depends 
on the cellular redox system. a) PAR-IF kinetic analysis of MRC-5 upon increasing 
dosage of H2O2. b) Viability assay (MTT) of primary MRC-5, pulse-treated with 
increasing dosage of H2O2 for 15 min and recovery for 24 h. c) Colony forming assay 
(CFA) of MRC-5 pulse-treated with increasing dosage of H2O2 for 15 min and 
recovery for 10 days. d) PAR-IF analysis of MRC-5 either directly treated with 0.5 
mM H2O2 for 10-40 min or pretreated with 30 mM 3-AT (catalase inhibitor) prior to 
H2O2 treatment for 10-40 min. In another case, H2O2 treated cells (30 min) were 
boosted with 0.5 mM H2O2 (final) and fixed either 3 min (“30 min”) or 10 min (“40 
min”) after stimulation with freshly added H2O2. e) Viability assay (MTT) of primary 
MRC-5, pulse-treated with increasing dosage of H2O2 (supplemented with increasing 
amount FCS) for 15 min and recovery for 24 h. Data are mean +/- SD by t-test with 
*p<0.05, **p<0.01, ***p<0.001, n.s. not significant. Significant only in case of 
reduction to control (U). Fold induction to U (untreated = 0 mM H2O2).   
  
Fig. 2. H2O2-induced PAR formation is dependent on PLC, IP3 and calcium 
release from the endoplasmic reticulum. a) PAR-IF analysis of IMR-90 
preincubated with selected inhibitors or DMSO (control) followed by 0.1 mM H2O2 
treatment or left untreated. b) Quantification of PAR intensity per nucleus from a). 
10-20 nuclei analyzed per area (n=10). c) PAR-IF analysis of NIH/3T3 transfected 
with siRNA against IP3R1-3 (siCtl. or siARTD1 used as control) followed by 0.5 mM 
H2O2 treatment. For quantification of PAR foci or intensity 50 nuclei analyzed / area 
(n=5). d) PAR-IF analysis of NIH/3T3 transfected with siRNA against RyR1 (siCtl. 
or siARTD1 used as control) followed by 0.5 mM H2O2 treatment. e) PAR-
immunoblotting analysis of NIH/3T3, preincubated for 1 h with selected inhibitors or 
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DMSO (control) followed by 0.5 mM H2O2 treatment or left untreated. Tubulin was 
used as loading control. f) PAR-IF analysis of thapsigargin (Tg) treated NIH/3T3 for 
1 h, before H2O2 treatment for 10-60 min. Quantification of PAR foci number over 
time determined by analyzing 100-200 nuclei per independent experiment (n=3). g-h) 
Gene expression analysis of ER-stress genes (Calreticulin, BIP, Grp94) and anti-
oxidant response genes (SOD2, GSR) in NIH/3T3 treated with 0.5 mM H2O2 for 10 
min, before RNA extraction. In some cases, cells were perincubated with 10 µM 
BAPTA or 1 µM thapsigargin for 1 h before addition of H2O2. DMSO was used as 
control. Data are mean +/- SD by t-test with *p<0.05, **p<0.01, ***p<0.001, n.s. not 
significant. Scale bars, 25 µm. Concentrations of inhibitors (µM, if not else stated) are 
indicated behind the compound name. Ola = Olaparib (ARTD1/2 inghibitor), BAPTA 
(Ca2+ chelator), 2-APB (IP3R inhibitor), Dn = Dantrolen (RyR inhibitor), D609 
(PLC inhibitor), U73 = U73221 (PLC inhibitor), CsA = Cyclosporine A (Cyclophilin 
D inhibitor), FK506 (Calcineurin inhibitor), NAC (ROS inhibitor).   
  
 
Fig. 3 H2O2 induces single-stranded DNA lesions in a calcium dependent 
manner. a) PAR-IF analysis of stably transduced HeLa with shXRCC1, treated with 
0.5 mM H2O2 and recovery for 10 min. For quantification 50 nuclei per area were 
analyzed (n=3). b) PAR-IF analysis of OGG1 KO MEF treated with 0.5 mM H2O2 for 
the indicated time points. For quantification 50 nuclei per area were analyzed (n=3). 
c) Alkaline comet assay of NIH/3T3, treated with increasing concentration of H2O2 
for the indicated time points (50 nuclei analyzed / independent experiment, n=2). d) 
IF analysis of MRC-5 treated with 0.5 mM H2O2 for 10-60 min followed by fixation 
and immunostaining with anti-PAR (red), anti-γH2A.X (green) or anti-53BP1 (red) 
and counterstaining with DAPI (blue). e) Quantification of PAR and γH2A.X foci 
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number from d) (10-20 nulcei analyzed / area, n=5). f) Alkaline comet assay of 
NIH/3T3 preincubated with BAPTA (10 µM) followed by 25 and 50 µM H2O2 
treatment for 3-20 min (50 nuclei analyzed / independent experiment, n=2). g) 
Alkaline comet assay of NIH/3T3 preincubated with BAPTA (20 µM), PMA (0.2 
µM), Olaparib (1 µM) or DMSO (control) followed by H2O2 treatment with 100 µM 
and incubation for 3 min before lysis (50 nuclei analyzed / independent experiment, 
n=2). In some cases cells were treated with KBrO3 (3 min) or 5-20 Gy X-rays (15 
min recovery). h) γH2A.X-IF staining of NIH/3T3 preincubated with BAPTA (10 
µM) or DMSO (control) followed by 0.1 mM H2O2 treatment for 10-60 min. i) 
Alkaline comet assay of NIH/3T3 preincubated with BAPTA (20 µM) or NAC (30 
mM) followed by H2O2 treatment with 100 µM and incubation for 3 min before lysis 
(50 nuclei analyzed / independent experiment, n=2). In some cases cells were treated 
with KBrO3 (30 mM, 1 h) or MNNG (50 µM, 1 h) or 20 Gy X-rays (15 min 
recovery). For quantification 50 nuclei analyzed / area (n=6). Data are mean +/- SD 
by t-test with *p<0.05, **p<0.01, ***p<0.001, n.s. not significant.   
  
Figure 4.  Nuclease X is activated/released in a Calcium-dependent manner.  a) 
Alkaline comet assay of NIH/3T3 preincubated with BAPTA (20 µM), Z-VAD (50 
µM) or DMSO (control) followed by H2O2 treatment with 100 µM and incubation for 
3 - 20 min before lysis and electrophoresis (50 nuclei analyzed / independent 
experiment, n=2). Data are mean +/- SD by t-test with *p<0.05, **p<0.01, 
***p<0.001, n.s. not significant.  
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Supplementary Figure Legends 
Supplementary Figure 1.  Induction of early PAR in response to low, non-lethal 
H2O2 doses depends on the cellular redox system.  a) PAR-IF kinetic analysis 
NIH/3T3 upon increasing dosage of of H2O2 treated for the indicated time points. b) 
Viability assay (AlamarBlue) of NIH/3T3, treated with increasing dosage of H2O2 for 
24 h. Data are mean +/- SD by t-test with ***p<0.001. Scale bar = 25 µm.  
  
Supplementary Figure 2. H2O2 induced calcium release from the ER positively 
regulates PAR induction and the cellular antioxidant response. 
a) ARTD1 auto-modification assay in presence of increasing amount of BAPTA 1-10 
µM using radioactive-labeled NAD. PJ-34 (1-10 µM) and DMSO (1-10 µl) were used 
as positive and negative control, respectively. Coomassie blue staining of the gel was 
used as loading control. b) PAR-immunoblotting analysis of NIH/3T3, preincubated 
for 1 h with selected inhibitors (indicated below the quantification bars) or DMSO 
(control) followed by 0.5 mM H2O2 treatment or left untreated. Tubulin was used as 
loading control. c) KD efficiency from transfections in Fig. 2c and from Suppl. Fig. 
2d determined by quantitative PCR. For each siRNA ARTD1 expression levels were 
determined to rule out off-target effects due to reduced ARTD1 levels. d) PAR-
immunofluorescence analysis of NIH/3T3 transfected with siRNA against CaM1-3 
(siCtl. or siARTD1 used as control) followed by 0.5 mM H2O2 treatment. For 
quantification of PAR foci or intensity 50 nuclei analyzed / area (n=5). e) PAR-IF 
analysis of thapsigargin (Tg) treated NIH/3T3 for 1 h, before H2O2 treatment for 10-
60 min. Quantification of PAR foci number over time determined by analyzing 100-
200 nuclei per independent experiment (n=3). f-g) Gene expression analysis of ER-
stress genes (Calreticulin, BIP, Grp94) and anti-oxidant response genes (SOD2, GSR) 
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in NIH/3T3 treated with 0.5 mM H2O2 for 10 min, before RNA extraction. In some 
cases, cells were perincubated with 10 µM BAPTA or 1 µM thapsigargin for 1 h 
before addition of H2O2. DMSO was used as control. Data are mean +/- SD by t-test 
with *p<0.05, **p<0.01, ***p<0.001, n.s. not significant. Scale bars, 25 µm. 
Concentrations of inhibitors (µM, if not else stated) are indicated behind the 
compound name.  
  
Supplementary Figure 3. Early induction of DNA double-strand breaks upon IR. 
a) IF analysis of MRC-5 treated with 6 Gy X-rays for 10-60 min followed by fixation 
and immunostaining with anti-PAR (red), anti-γH2A.X (green) or anti-53BP1 (red) 
and counterstaining with DAPI (blue). b) Colony forming assay (CFA) of primary 
MRC-5 irradiated with an increasing dose of X-rays or untreated (control) and 
recovery for 10 days (n=8-16). Data are mean +/- SD by t-test with *p<0.05, 
**p<0.01, ***p<0.001, n.s. not significant.   
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3.2 Unpublished Results 
 
Primary MRC-5 fibroblasts are more sensitive towards high doses of IR compared to 
immortalized counterparts 
Human fibroblasts are extremely resistant towards stress induced by treatment with 
different types of DNA damaging agents and resist particularly high doses of double 
strand break-inducing ionizing irradiation (IR) (240). The aim of the first study “PKC 
signaling prevents irradiation-induced apoptosis in human fibroblasts” was to describe 
general proteome changes induced by high doses of IR in order to identify the 
mechanisms, which are employed by human fibroblasts to overcome severe DNA 
damages.  
To assess the repair capacity of human fibroblasts upon IR-induced DNA damage, 
primary human MRC-5 cells were treated with increasing concentrations of X-rays. 
Proliferation and survival was monitored using colony forming assays (CFA) to test 
for clonogenicity (ability of cells to form colonies from a single cell) over a time 
period of 10 days (Fig. 1a-b). Irradiation induced a dose-dependent decrease in 
proliferation, with an LD50 (dose at which 50% of the population are impaired in 
proliferation) of 2 Gy (Fig. 1a-b). In strong contrast to that, immortalized MRC-5 
showed a LD50 of 6 Gy, thus being more resistant to IR compared to primary MRC-5. 
These findings indicate that presence of loss- or gain-of-function mutations in 
immortalized MRC-5 might have increased resistance towards ionizing radiation. 
Indeed, immortalized MRC-5 showed a faster reproduction rate and reduced cell size 
in comparison to primary cells (data not shown), indicating the presence of mutations, 
which might affect growth, doubling rate or alter the metabolism of these cells. 
Interestingly, the induction of the DDR as measured by γH2A.X foci formation, was 
comparable in both cell strains (Fig 1c and Fig. 1 of first manuscript for data for 
primary MRC-5). However, it remains to be clarified, whether primary MRC-5 have a 
reduced repair capacity compared to immortalized MRC-5 cells, which would explain 
their sensitivity towards irradiation. DSBs have been described as a potent inducer of 
ARTD1 activity in vitro and in cells induced upon laser damage (190, 217). To check, 
whether IR is also able to induce PAR formation, immortalized MRC-5 were 
irradiated with increasing dosage of X-rays. PAR formation was significantly induced 
in response to IR doses between 10-40 Gy (Fig. 1d). Interestingly, doses above 10-40 
Gy lead to a marked decrease in proliferation and cells above 20 Gy showed no sign 
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of proliferation at all (Fig. 1b). Altogether, these results indicate that PAR formation 
was only induced by lethal doses of IR., 
 
Fig. 1. PAR formation in response to lethal IR doses. a-b) Colony forming assay (CFA) of primary 
a) or immortalized b) MRC-5 irradiated with an increasing dose of X-rays or untreated (U) and 
recovery for 10 days (n=8-16 for (a) or n=2-6 for (b)). c) γH2A.X-IF of immortalized MRC5 irradiated 
with increasing dosage of X-rays and recovery for 15 min – 6 h. Lower panel is a 63x acquisition of 
γH2A.X and DAPI positive stained and merged nuclei. d) PAR-IF of immortalized MRC-5, irradiated 
with increasing dosage of X-rays and recovery for 3 min. Data are mean +/- SD by t-test with *p<0.05, 
**p<0.01, ***p<0.001, n.s. not significant. Significant only in case of reduction to control (U).  
 	  
Doxorubicin and IR treatment of immortalized MRC-5 cells induce a DDR but nor 
PAR formation  
It was the aim of the second and third manuscripts (in preparation) to understand the 
network signaling and the regulatory mechanisms of ARTD1 activation by oxidative 
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linked to oxidative stress-induced DNA damage repair (190, 217). To identify a 
potent inducer of ARTD1 activity, primary as well as immortalized MRC-5 cells were 
treated with DNA intercalating agents (doxorubicin) and DNA alkylating compounds 
(MNNG). Cell proliferation and cytotoxicity were measured as in Fig. 1 by 
clonogenic assay, as well as with the MTT assay, which measures the metabolic 
activity of living cells and thus indicates reduced viability.  
 
Fig. 2. Doxorubicin treatment reduces survival of immortalized MRC-5 in a dose- and time-
dependent manner and leads to the induction of a DDR. a) CFA of immortalized MRC-5 pulse-
treated with increasing concentration of doxorubicin or DMSO (control) for 15-120 min and recovery 
for 10 days (n=3). b) MTT assay of immortalized MRC-5 pulse-treated with increasing concentration 
of doxorubicin or DMSO (control) for 60 min - 24 h and recovery for 24 h (n=4). c) Immunoblot 
analysis of IR (40 Gy), staurosporine (STS, 1µM), doxorubicin (Doxo, 0.5 µg/ml) or hydroxyurea (HU, 
2 mM) treated primary MCR-5 for 20 h, before cell lysis. In some cases, cells were preincubated for 1 
h with PKC inhibitor (GF109203X, 10 µM). Data are mean +/- SD by t-test with *p<0.05, **p<0.01, 
***p<0.001, n.s. not significant. Significant only in case of reduction to control (DMSO).   
 
Pulse-treatment of doxorubicin from 15-120 min abolished proliferation above 0.5 
µg/ml following 10 days recovery. (Fig. 2a). Interestingly, short-term recovery (24 h 
instead of 10 days) from pulsed and constitutive doxorubicin treatment (60min - 24h) 
revealed a much higher tolerance of immortalized MRC-5 towards Doxorubicin as 
confirmed by the MTT assay (Fig. 2b). These results indicate that treated cells 
survived a short-term period (24 h), while leading to deficiency in colony formation 
over a long period of repair recovery (10 d). These observations also suggest a 
delayed induction of cell cycle arrest or apoptosis, which is not seen within the first 
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24 h. Doxorubicin treatment (0.5 µg/ml) was able to induce a strong DNA damage 
response shown by the induction of ATM phosphorylation and p53 stabilization (Fig. 
2c), but failed to induce early PAR formation, even in response to doses above 0.5 
µg/ml (data not shown).  
 
MNNG treatment induces a proliferation stop and is sufficient for the induction of 
calcium-dependent PAR formation  
To check for survival and PAR formation upon alkylating stress, primary MRC-5 
were treated with increasing amount of MNNG and clonogenicity as well as PAR 
formation determined as described above. In response to an increasing dose of 
MNNG, clonogenicity was reduced in a dose-dependent manner. Primary MRC-5 
were resistant to MNNG doses of 15 µM and showed a significant, but rather mild 
proliferation stop upon 25 µM following 10 days recovery (Fig. 3a). However, doses 
above 50 µM led to a strong reduction in proliferation, reducing clonogenicity to 10 
% compared to non-treated cells. Strikingly, the induction of PAR upon MNNG 
exposure was only obvious upon doses, which led to a strong reduction of 
clonogenicity (Fig. 3b). Similar findings were also made in immortalized MRC-5, 
showing a correlation between PAR induction and reduced proliferation upon MNNG 
treatment (Fig. 3c-d). Hence our results suggest, that the induction of PAR requires 
MNNG doses, which either induce a permanent cell cycle arrest or lead to apoptosis. 
Interestingly, these data are in strong contrast to H2O2-induced PAR formation, which 
could be readily induced upon doses, which did not show any sign of proliferation 
stop or significant reduction in viability (Fig. 1b, third manuscript). Moreover, 
MNNG-induced PAR revealed a long half-life, showing comparable signal intensity 
between 3 – 20 min of MNNG treatment. In contrast, H2O2 induced PAR formation 
was transient, showing already 10 min after adding peroxide a gradual decrease in the 
PAR signal (Fig. 1a, third manuscript). Altogether, these data indicate a distinct 
nature of PAR in response to MNNG compared to H2O2. Most likely the difference in 
the response is due to differences in the triggered cellular stress and introduction of 
DNA lesions between MNNG and H2O2. Calcium sequestration by BAPTA (Ca2+ 
chelator) led to a strong reduction in MNNG-induced PAR formation, indicating a 
similar mechanism of calcium-dependent activation of ARTD1/2 (Fig. 3f, third 
manuscript) as observed for oxidative stress.   
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Fig. 3 Direct correlation between reduction in proliferation and induced PAR formation upon 
MNNG treatment. a) CFA of primary MRC-5 pulse-treated with increasing concentration of MNNG 
for 15 min or DMSO (control) (n=4-8) b) PAR IF of primary MRC-5 pulse-treated with increasing 
concentration of MNNG for 30 min and recovery in drug-free media for additional 10 min before 
fixation and immunostaining with anti-PAR (green) and counterstaining with DAPI (blue) to detect the 
nucleus. c) CFA of immortalized MRC-5 pulse-treated with increasing concentration of MNNG for 15 
min or DMSO (control) (n=3). d) Experiment performed as in b) using immortalized MRC-5 pulse 
treated fwith increasing dose of MNNG and recovery for 15 min. e) PAR IF of H2O2 (0.5 mM, 10 min 
w/o recovery) or MNNG (50 μM, 30 min w/o recovery) treated MEF in presence of BAPTA or 
DMSO (control) preincubation for 1 h. Data are mean +/- SD by t-test with *p<0.05, **p<0.01, 
***p<0.001, n.s. not significant. Significant only in case of reduction to control (DMSO).    
  
 
Knockdown of CDK2 reduces ARTD1 protein levels and leads to reduced PAR 
formation in response to H2O2  
For the inhibitor screen described in the second manuscript, we observed a reduced 
PAR formation in presence of the JNK inhibitor SP600125. However, this could not 
be confirmed by treating WT and JNK1/2 KO MEFs with H2O2 (as shown by PAR 
WB and IF, second manuscript). This is in contrast to earlier studies which 
documented the regulation of PAR induction by JNK upon H2O2 treatment (236), 
although a direct involvement of JNK in the regulation of ARTD1 activity has so far 
not been shown. Others and we observed a rather delayed induction of JNK in 
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response to H2O2, peaking 30-60 min upon treatment (second manuscript, (241)). In 
contrast to this observation, PAR formation is induced very early (first 5 minutes) and 
reaches again basal levels after 30 min, Fig. 1a, third manuscript). Hence, our results 
based on the JNK inhibitor SP600125 as well as reported by Zhang et al., would 
rather point to an off target effect of this inhibitor, that reduces PAR formation upon 
H2O2 treatment. Indeed, SP600125 has been described to target other kinases as 
potently as JNK itself (242). Based on the JNK off-targets identified by Bain et al., 
we performed a small-scale siRNA screen for JNK-off targets and assessed PAR 
formation by IF and WB using NIH/3T3.  
 
Fig. 5. KD of CDK2 reduces ARTD1 protein levels and leads to reduced PAR formation in 
response to H2O2. a) Immunofluorescence analysis of siCDK2 transfected NIH/3T3 (4 days) or siCtl 
and siARTD1 for not affecting or reducing ARTD1 protein levels as control and immunostaining with 
anti-PAR or anti-ARTD1 (control). b) Immunoblotting analysis of siCDK2 transfected NIH/3T3 as in 
a) and immunostaining with anti-PAR. anti-ARTD1 was used as control to confirm ARTD1 protein 
level reduction upon siARTD1. anti-Tubulin was used as loading control. Quantification is shown on 
the right-hand site of the blots.  
 
Knockdown (KD) of CDK2 by siRNA in NIH/3T3 cells, reduced ARTD1 protein and 
H2O2-induced PAR formation by IF (Fig. 5a and b). These data indicate that CDK2 
acts upstream of PAR formation by regulating ARTD1 protein levels or transcription. 
To clarify whether the residual activity is due to the incomplete reduction of ARTD1 
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Since other ARTD members, such as TNKS1 (ARTD5) or TNKS2 (ARTD6) have 
been described to posses poly-ADP-ribosylation activity (187), we also combined KD 
of CDK2 with KD of either TNKS1, TNKS2 or in combination with both (Fig. 6). 
Interestingly, siTNKS-1, but not siARTD1 or siTNKS-2, led to a complete reduction 
of PAR formation in the siCDK-2 background, indicating that CDK2 might regulate 
PAR formation in response to H2O2 through ARTD1 and that TNKS-1 might also 
contribute to PAR formation upon H2O2 treatment. 
 
Fig. 6. KD of TNKS-1 in combination with CDK2 leads to a complete reduction of PAR 
fromation upon H2O2 treatment. Confocal immunofluorescence analysis of siCDK2 combined with 
siTNKS-1 and siTNKS-2 transfected NIH/3T3 and immunostaining with anti-PAR. siCtl and siARTD1 
transfection were used as control for not affecting or reducing ARTD1 protein levels, respectively.   
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Another candidate, who has been shown to be a potent off-target of SP600125, is 
Chk1 (242).  
 
Fig. 7. Knockdown of Chk1 does not reduce PAR formation induced by H2O2. a) Immunoblotting 
analysis of siChk1 transfected NIH/3T3 using two different siRNA oligos targeting siChk1 (_1 and _2) 
and immunostaining with anti-PAR and anti-ARTD1. anti-Tubulin was used as loading control and for 
quantification PAR was normalized to Tubulin protein levels. Quantification is shown below the blots. 
b) Immunofluorescence analysis of siChk1 transfected NIH/3T3 using two different siRNA oligos (_1 
and _2) or siCtl and siARTD1 for not affecting or reducing ARTD1 protein levels as control and 
immunostaining with anti-PAR or anti-ARTD1 (control) c) KD confirmation of siChk1 transfected 
NIH/3T3 by immunoblotting from b). siCtl, siARTD1 and siCDK2 were used as control for not 
affecting Chk1 protein levels. d) Chk1 kinase assay using GST-tagged Chk1 and two purified ARTD1 
constructs (full length and CIP treated for His-ARTD1) as substrates and gamma-labeled ATP. e) 
Experiment performed as in d) using instead ARTD1 deletion fragments either in presence (1-1014, 
lane 5-9) or in absence of GST-Chk1 (373-1014, lane 1-3). GST-Chk1 alone (lane 4) was used as 
negative control.     
 
siChk1 transfected NIH/3T3 cells exhibited reduced PAR formation after H2O2 
treatment. However, these reduced PAR levels	   correlated with reduced ARTD1 
protein levels, which might explain this effect (Fig. 7a). 
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To confirm the reduction of PAR upon Chk1 KD, the experiment was performed 
exactly as in Fig. 7a, however, using PAR-IF as a readout. However, reduction of 
Chk1 did not show any significant difference in PAR levels between siControl and 
siChk1 transfected cells (Fig. 7b). The experiment was well controlled, since 
siARTD1 treatment led to a complete reduction of PAR levels comparable to 
untreated cells (Fig. 7b). It could be argued that a difference was not observed due to 
a weak KD as confirmed by WB (Fig. 7c). However, we have also noticed strong 
induction of cell death upon siChk1 treatment, indicating that the observed phenotype 
in a) might be an artifact of cell death. Independent of the discrepancies regarding 
Chk1’s role in regulating ARTD1 activity, ARTD1 was phosphorylated by Chk1 in 
vitro and we could pin-point the phosphorylation site to the N-terminal zinc-finger 
DNA binding domain (Fig. 6d-e). It remains to be clarified, whether Chk1 might also 
play a role in the regulation of ARTD1 activity in vivo.  	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4. Discussion and Perspectives 
 
4.1 Summary of results 
 
To elucidate the molecular mechanism regulating the resistance of primary human 
fibroblasts to high doses of ionizing irradiation of up to 80 Gy (240, 243), we 
performed a proteome-wide analysis using RPPAs. Based on the kinetics of 
cytoplasmic and nuclear phosphorylation events affected by IR, we discovered a 
significant activation of protein kinase C (PKC) family members, including PKCβII, 
PKCδ and PKCζ in MRC5 fibroblasts. Inhibition of PKC signaling by a broad-range 
PKC inhibitor (GF109203X) or down-regulation of PKC protein levels sensitized 
primary fibroblasts to IR, led to the activation of pro-apoptotic signaling (ARTD1 
cleavage, stabilization of p53, upregulation of Bad), as well as to inhibition of pro-
survival signaling (CREB and Bad dephosphorylation). This analysis thus identified a 
molecular switch, which is responsible for the radio-resistance of primary human 
fibroblasts. 
 To identify possible regulatory mechanisms of ARTD1 activation in response 
to oxidative stress, we again used RPPA analysis. The results of this broad analysis 
were validated and followed up using a small molecule inhibitor screen and IF with 
PAR formation as a readout. This analysis identified calcium (Ca2+) and CaMKII as 
positive and PKC as negative regulators of ARTD1 activity. Moreover, knockdown of 
CaMKIIδ led to reduced PAR levels upon H2O2 exposure and we confirmed the direct 
phosphorylation and activation of ARTD1 by CaMKIIδ in in vitro kinase assays. In 
contrast, PKCδ-dependent phosphorylation of ARTD1 in vitro led to a decrease of its 
automodification in the presence of DNA. More importantly, knockdown of the Ca2+-
dependent PKCα isoform and a general depletion of PKC protein expression strongly 
reduced the number of PAR foci induced by H2O2.  
 Our results also indicated an early induction of Ca2+ signaling upon H2O2 
exposure, which pointed at a possible important upstream regulation of ARTD1 
activity by Ca2+. Indeed, inhibition of Ca2+ signaling by BAPTA completely abolished 
H2O2 induced PAR formation. Using small molecule inhibitors and siRNA, we further 
identified PLC-dependent production of IP3 and subsequent activation of ER-based 
IP3R and RyR receptors to be responsible for the Ca2+ release from the ER. Moreover, 
H2O2-induced DNA breaks, as observed by an alkaline Comet assay, could be 
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prevented by BAPTA, which on the other hand, had no influence on IR or KBrO3 
induced DNA break induction, indicating a link between Ca2+-dependent induction of 
DNA lesions and PAR formation upon H2O2 treatment.  
 
4.2 PKC signaling prevents irradiation-induced apoptosis of primary human 
fibroblasts 
 
Dependent on the severity of DNA damage, the DDR either leads to survival of the 
cell or to cell death by apoptosis (34, 96). In contrast to epithelial or cancerous cells, 
human fibroblasts are highly resistant towards IR and thus a perfect model to study 
the molecular signaling events regulating the decision in response to severe DNA 
damage (240). We were able to describe an early signaling network, encompassing 
cytoplasmic pro-survival and pro-proliferation pathways including phosphorylation of 
MEK-ERK, LKB-AMPK, PKC-CREB as well as phosphorylation of the Akt-
substrate Bad (Fig. 2b/c, Supp. Fig. S7-S9). Interestingly, mounting evidence 
indicates the involvement of cytoplasmic signaling events in the regulation of survival 
and DNA break repair upon IR (244). Using human tumor cells, a series of studies 
identified the importance of EGFR-Akt signaling-dependent activation of DNA-PKcs 
upon IR for protecting tumor cells from irradiation induced cell death (245-247). 
Similarly, the direct translocation of Akt into the nucleus leads to the activation of the 
DDR via DNA-PKcs (86). Interestingly, compared to early signaling events 
mentioned above, we observed a delayed activation of the γH2A.X-p53-p21 pathway, 
as well as the non-canonical MKK3/6-p38-MAPKAP2-Hsp27 DDR kinase signaling 
pathway (Fig. 2b/c, Supp. Fig. S7-S9). It thus remains to be clarified whether 
cytoplasmic signaling directly affects the DDR upon IR.  
The MEK-ERK signaling pathway, also identified as an early-induced event in our 
screen, was confirmed by others as a positive regulator of ATM activation and 
homologues recombination (HR) efficiency in response to UV-C irradiation (248). 
Compared to cytoplasmic signaling-dependent regulation of the DDR, a recent 
proteomics study identified over 700 proteins, including cytoplasmic kinases, carrying 
the ATM/ATR recognition motif (SQ/TQ motif), which indicates regulation of a 
broad phospho-proteome by the DDR (62). One interesting example from this screen 
is the enrichment of members of the AKT/PKB signaling network. This signaling 
cascade is typically activated by cell membrane-bound PDK1 or Pi3K, which trigger 
AKT signaling upon extracellular stimuli such as insulin (6). Although not tested for 
  157	  
AKT, we could show ATM-dependent activation of two MAPK pathways, including 
the p38-Hsp27 (Suppl. Fig. S10d) and the MEK-ERK pathway (data not show). For a 
direct activation of these kinases, ATM would have to translocate to the cytoplasm. 
Indeed, such a translocation event of the ATM kinase has been described for the 
activation of the NF-κB pathway upon IR (82).  
Systemic analyses of DSB-induced proteome changes have been performed 
previously (63, 77, 78). In strong contrast to our study, however, nuclear 
phosphorylation events dominated the identified proteome changes, indicating the 
nucleus as the dominant organelle for the DDR. Major findings included 
phosphorylation of RNA processing and splicing, as well as epigenetic phospho-
proteome changes. Besides the confirmation of the already described activation of the 
p38-MAPK and NF-κB pathways, cytoplasmic kinase signaling was identified in 
none of these studies as a significant component of the DDR (78, 82, 249). One 
important explanation for the failure to detect cytoplasmic kinase signaling as an 
element of the DDR could be the experimental set-up of the studies cited above. 
While Bennetzen et al. excluded the cytoplasm from the proteomics analysis, Beli et 
al. did not analyze earlier time points than 1 h after treatment (250). In contrast, we 
investigated phospho-proteome changes upon early recovery from IR, including a 30 
min time point. Moreover, our studies were based on whole cell extracts and a strong 
bias to canonical cytoplasmic signaling pathways, which might explain the 
enrichment for cytoplasmic signaling events identified here.     
 The key observation of our study was the early induction of protein kinase C 
family members (PKCζ, PKCδ and PKCβII) and their role in preventing IR-induced 
apoptosis upon high doses of IR exposure (Fig. 4 and 5). Indeed, PKCδ activation was 
previously linked to the DDR, being targeted by the c-Abl kinase for phosphorylation 
and nuclear translocation upon IR (251). Our study using two broad PKC inhibitors 
(GF109203X, RO-318220), which target the PKC family members PKCα-γ, PKCδ-ε 
and PKCζ (29, 252, 253), revealed a protective role of PKC signaling in the DDR 
upon IR (Fig. 4 and 5). Prevention of apoptosis upon IR could be also confirmed by 
the down-regulation of PKCδ (novel) and PKCζ/λ (atypical) protein levels (Fig. 5d 
and h). PKCδ is described to be a double edged sword regarding its involvement in 
survival and apoptosis upon genotoxic stress (254). PKCδ null mice are resistant to 
apoptosis and p53 phosphorylation by PKCδ has been shown to be important for 
apoptosis (255, 256). Regulation of apoptosis by PKCδ also requires its direct 
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activation by phosphorylation, proteolytic cleavage by Caspase 3 and nuclear as well 
as mitochondrial shuttling (257-261). Besides a pro-apoptotic function, PKCδ as well 
as members from the canonical and atypical PKCζ pathway, have also been shown to 
promote survival (254). Interestingly, many tumors overexpress PKCδ and 
sensitization of chemotherapy treated tumors with PKC inhibitors as well as antisense 
oligonucleotides, enhances chemotherapy induced apoptosis (262, 263). While there 
is a vast amount of information on the involvement of PKCδ in survival and 
apoptosis, only little information is present about the regulation of these mechanisms 
for the Ca2+-dependent members of the PKC family. Nevertheless, a recent study 
linked integrin αv dependent up-regulation of PKCα and PKCα-dependent re-
localization of p53 from the nucleus to survival in melanoma (264). Other studies 
identified PKCα protein expression as a prerequisite for survival and proliferation of 
malignant glioma and PKCβ expression in tumor microenvironment to support 
growth of adjacent malignant B cells (265, 266).  
 In our study, we treated primary fibroblasts with IR, hence not directly 
addressing the question whether acquired radioresistance in cancer cells might be 
dependent on similar survival cues. On the other hand, fibroblasts are part of the 
tumor microenvironment and recent studies indicate a link between senescence and 
tumor progression (267-270). Even though senescence is a well-accepted barrier for 
tumor formation due to permanent cell cycle arrest in vivo, co-culture and conditioned 
medium studies could show the secretion of pro-survival and pro-angiogenic 
chemokines by senescent fibroblasts, leading to tumor progression of nearby 
premalignant cells (267-270). Moreover, a recent study could show the importance of 
cancer-associated fibroblasts in promoting resistance of tumors to chemotherapy. 
Irradiation of prostate fibroblasts led to the release of WNT16B, which supported 
survival and invasion of adjacent cancer cells by paracrine NF-κB/Wnt pathway 
activation (271). Reducing the expression of WNT16B in tumor-associated fibroblasts 
led to tumor volume shrinkage and attenuated chemoresistance. Prospectively, our 
results open up an avenue for new treatment strategies by sensitizing the tumor-
associated microenvironment for apoptosis by combined radiotherapy and PKC 
inhibition. 
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4.3 Opposite regulation of ADP-ribosylation by PKC signaling: ARTD1 is 
activated by PKCα and inactivated by PKCδ 
 
The enzymatic activity of ARTD1 has been previously shown to be regulated by 
phosphorylation events in vitro (225). So far only two phosphorylation sites have 
been confirmed to be functionally relevant in vivo (233). Here, we reported the 
identification of different positive and negative modulators of ARTD1 enzymatic 
activity in response to oxidative stress in human and mouse fibroblasts. Inhibition of 
PKC by a small molecule inhibitor (GF109203X, BIM 1) led to a significant increase 
in PAR induction upon H2O2 treatment, identifying PKC as a negative modulator 
upon H2O2 stress. This observation could also be strengthened by in vitro experiments 
showing a reduced enzymatic activity of ARTD1 upon phosphorylation by PKCδ in 
the presence of DNA. Indeed, PKC has been previously shown to phosphorylate 
ARTD1 in vitro (237) and its inhibition resulted in increased PAR induction upon 
alkylation stress (239). In contrast, there are also studies, which reported a positive 
regulation of ARTD1 by the Ca2+-independent PKCδ isoform in response to 
histamine (272, 273). Indeed, our results identified Ca2+-dependent PKCα as a 
positive regulator of PAR formation in response to H2O2 treatment. Independent of 
the precise mechanism of ARTD1 activation in vivo, we could confirm the negative 
regulation of ARTD1 activity upon phosphorylation by PKCδ by in vitro experiments 
and were able to localize the phosphorylation site of ARTD1 by PKCδ to the region 
encompassing the first two zinc fingers of N-terminal DBD (Fig. 4). Based on in 
silico analysis, sequence-stretches around Ser20 and Thr109 in the N-terminal DBD 
of ARTD1 match the consensus-motif of two Ca2+-independent PKC isoforms 
including PKCδ and PKCε, respectively (Motif Scan, ScanSite). Interestingly, both 
sites also show a high probability score for phosphorylation using another prediction 
tool (NetPhos 2.0, with 0.993 for Ser20 and 0.872 for Thr109). Indeed, based on two 
recently published structures of ARTD1 zinc finger domains bound to DNA, Ser20 
stabilizes the interaction with the DNA backbone by forming a hydrogen bond with a 
phosphate of a phosphodiester bond (197, 198). It can thus be speculated that 
phosphorylation of Ser20 by PKC destabilizes the interaction of the ADRT1 first zinc 
finger with the DNA backbone due to a highly negative charge of the added 
phosphate group, eventually resulting in less activity in response to H2O2 exposure. In 
contrast, other laboratories identified Ser504, Ser519 and Trh656 as preferential 
phospho-targets of PKC in full length ARTD1 (274). Indeed, based on in silico 
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prediction Ser504 can be modified by Ca2+-dependent PKCs (Motif Scan, ScanSite). 
One explanation for the difference of the modified region could be the use of different 
PKC isoforms for the in vitro kinase assay. While Gagne et al. relied on a Ca2+-
dependent PKCβ, we performed the assay using PKCδ, which is not Ca2+-dependent 
(274). Indeed, chelation of Ca2+ was reported to reduce ARTD1 activity in response to 
nitrosative and oxidative stress (226, 227). Therefore, PKC could either reduce 
ARTD1 activity through phosphorylation in the DBD by a Ca2+-independent member 
(e.g., PKCδ) or lead to stimulation through modification in the AMD by a Ca2+-
dependent PKC member (e.g., PKCβ). It remains to be clarified which PKC isoform 
is responsible for enhancing or inhibiting ARTD1 enzymatic activity in response to 
different stimuli in vivo. Based on our data, knockdown of the Ca2+-dependent PKCα 
alone, in combination with the calcium-independent PKCδ in murine NIH/3T3, as 
well as a general depletion of PKC protein expression in human MRC-5, strongly 
reduced the number of PAR foci. Interestingly, single knockdown of PKCδ enhanced 
PAR formation upon H2O2 treatment, thus confirming the in vitro kinase data 
mentioned above. Altogether, these results indicate a dual role of PKC family 
members in the regulation of PAR formation upon oxidative stress. While PKCδ is a 
direct negative modulator of ARTD1 activity, the Ca2+ -dependent PKCα seems to be 
an essential kinase for the activity of ARTD1 upon oxidative stress-induced Ca2+ 
accumulation in the cytoplasm.  
 Besides PKCδ, activation of three additional kinases led to enhanced PAR 
formation upon their inhibition including AMPK, GSK3 and MEK. Interestingly, all 
three kinases were induced as early as 10 min after stimulation with H2O2 (Fig. 1e). 
Based on in silico prediction analysis, AMPK and GSK3 are predicted to 
phosphorylate Ser257 and Thr368, respectively (Motif Scan, ScanSite). Interestingly, 
Ser257, comparable to Ser20, is crucial for the interaction of ARTD1 with the DNA 
by stabilizing an interaction of ZnF3 with the backbone of the DNA (197). Strikingly, 
phosphorylation of ARTD1 by AMPK could be shown in vitro, specifically in the 
third zinc finger, indicating a realistic possibility of a direct regulation of ARTD1 by 
AMPK in vivo (Kassner et al, 2012; doctoral thesis). GSK3 inhibition by GSK3 
kinase inhibitors (SB-415286) enhanced PAR formation after H2O2 treatment, 
indicating GSK3 as a negative upstream regulator of PAR formation upon H2O2 
treatment (data not shown). Moreover, knockdown of GSK3α and GSK3β enhanced 
ARTD1 activity, while combinatorial knockdown of both isoforms showed no 
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additive effect of this phenotype (data not shown). However, based on preliminary in 
vitro kinase analysis, ARTD1 was not phosphorylated by GSK3β, thus indicating an 
indirect mechanism of ARTD1 activity modulation by GSK3 (data not shown). 
Interestingly, two studies recently provided evidence for negative regulation of the 
GSK3β kinase activity by ARTD10-dependent mono-ADP ribosylation (275, 276). 
Whether there is a biologically relevant link between ARTD10 and GSK3β-dependent 
regulation of ARTD1 still remains to be solved. 
Based on reports by others (231, 232), PAR formation was shown to be positively 
regulated by CaMKII, which is a Ca2+-dependent kinase and therefore a potential 
candidate for a DNA-independent mechanism of ARTD1 activation. Indeed, we could 
show direct phosphorylation of ARTD1 by CaMKII, which led to automodification of 
ARTD1 in the absence of DNA in vitro (data not shown). However, based on a 
CaMKII-specific inhibitor or CaMKIIδ siRNA, we could not detect a complete 
inhibition of ARTD1 activity, indicating an alternative or additional mechanism of 
ARTD1 activation upon non-lethal doses of H2O2. 
 Most of the identified negative and positive regulators of ARTD1 activity are 
able (i) to translocate into the nucleus (PKC, AMPK, MEK-ERK, CaMKII) (232, 
277-279), (ii) to act in the same pathway (PKC-GSK3 / PKC-MEK) (280, 281) and 
are (iii) readily activated upon oxidative stress (second manuscript). To get a better 
insight into the direct modulation of ARTD1 activity by kinase signaling, one could 
try to identify possible phosphorylation sites for the above-mentioned kinases using 
mass spectrometry. Based on ARTD1 phospho-dead or –mimicking mutants, one 
could look at transcriptional, epigenetic or cell survival changes to understand their 
biological relevance in response to oxidative stress, but also other stimuli, such as 
inflammation, using models suited for the corresponding question. Since there is a 
group of negative regulators, some of which are described to act in a pathway (PKC-
GSK3 or PKC-MEK), it would be also interesting to understand whether they act 
dependent on each other upon oxidative stress. Most importantly, the identification of 
the most prominent terminal kinase, which directly modifies ARTD1 and influences 
its activity, would be very interesting. Our proteomics and inhibitor screen analyses 
were biased towards signaling- and phosphorylation-dependent candidates. Thus, the 
activity of ARTD1 is also likely regulated by other posttranslational modifications, as 
has been shown for acetylation, ubiquitinylation or SUMOylation, even though 
without a direct effect on its enzymatic activity (184). 
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4.4 Oxidative stress induced poly-ADP-ribose formation is initiated by a 
Calcium dependent nuclease 	  
 
Oxidative stress, for example reactive oxygen species (ROS), is an important stimulus 
for Ca2+ release from the ER, upon which the divalent ion can unleash its signaling 
potential (137). ARTD1 activity is strongly stimulated upon oxidative stress, which is 
so far believed to be exclusively due to the introduction of DNA breaks by direct 
oxidation of the DNA (45). Here, we report a Ca2+-dependent activation mechanism 
of ARTD1 in a DNA break-dependent, but oxidation damage-independent manner. 
Inhibition of endogenous Ca2+ by a cell permeable Ca2+ chelator (BAPTA) reduced 
PAR formation to nearly basal levels. Moreover, inhibition or knockdown of IP3- or 
ryanodine receptors, as well as the IP3 producing enzyme PLC, all led to a significant 
reduction in PAR formation upon H2O2 treatment, indicating that the induction of 
PAR in response to H2O2 is dependent on the Ca2+ release from the ER. Indeed, Ca2+ 
signaling has been linked to ARTD1 activity in response to various stimuli ranging 
from growth factors to membrane depolarization, interestingly in all cases in a DNA 
break-independent manner (230-232). In contrast, we observed early break formation 
(after 3 min) in response to H2O2, which could be prevented by the addition of 
BAPTA. Interestingly, introduction of DNA breaks in response to ionizing radiation 
as well as oxidation of the DNA by KBrO3 was Ca2+-independent, indicating an 
H2O2-specific type of DNA breaks. Others have already reported the induction of 
DNA SSBs after H2O2 treatment as an upstream regulatory event of ARTD1, which 
was prevented in presence of BAPTA (226). In contrast to others, we were, however, 
able to identify the source of Ca2+ and excluded ROS formation as an upstream 
inducer of PAR formation using NAC (226). Altogether, our data point to a Ca2+-
dependent regulation of ARTD1 activity by a DNA nuclease induced upon oxidative 
stress. Even though BAPTA was described to be highly selective (>105) for Ca2+ over 
Mg2+ (282), two early studies challenged BAPTA’s selectivity and could even show 
its preference for metal ions such as ferric iron (Fe3+) (283, 284). Removal of 
extracellular Ca2+ by EGTA reduced H2O2-induced cytosolic and nuclear Ca2+, but 
could not prevent DNA break induction (283). Interestingly, both BAPTA as well as 
selective membrane permeable metal ion chelators such as TPEN and PHEN 
prevented DNA breakage, while only BAPTA reduced intracellular Ca2+ levels, 
indicating metal ions as crucial mediators of H2O2-induced DNA break formation 
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(283). Whether metal ions are directly involved in DNA break formation has to be 
further investigated, however, it is well accepted that in the presence of ferrous (Fe2+) 
or ferric (Fe3+) iron, H2O2 is transformed into highly reactive hydroxyl free radicals 
(HO) via the Fenton reaction (106). Free hydroxyl radicals, on the other hand, could 
react with macromolecules such as the DNA and induce DNA breakage. Iron-
dependent formation of free radicals, leading to DNA breaks and PAR formation, 
would insofar make sense, since direct DNA breakage by KBrO3 or IR was BAPTA-
independent. On the other hand, inhibition or knockdown of Ca2+ signaling 
modulators (such as PLC or IP3R) strongly reduced PAR levels, indicating that the 
release of intracellular Ca2+ is an important regulatory component of PAR formation. 
Moreover, another laboratory recently observed a reduction in SSB formation upon 
nitrosative stress by using two additional Ca2+ chelators (cell permeable ester of 
EGTA and Quin-2), indicating the crucial role of Ca2+ in DNA break formation (226). 
Interestingly, increasing the cytosolic Ca2+ concentration by inhibiting the Ca2+ pump 
SERCA with the inhibitor thapsigargin prolonged PAR formation upon H2O2 
exposure in this study, again strongly supporting the role of Ca2+ as a positive 
regulator of PAR formation. Thus, it cannot yet be excluded that both Ca2+ and iron 
metal ions contribute to ARTD1 activity and DNA break formation upon H2O2 
treatment. Indeed, Golconda et al. reported both Ca2+ and iron to play a role in the 
formation of DNA breaks upon H2O2 treatment (285). A major consequence of a 
cytosolic Ca2+ rise is the depletion of intracellular Ca2+ stores in the ER and 
lysosomes, leading to Ca2+ overload in the mitochondria and the induction of caspase-
dependent apoptosis (138). Importantly, early hallmarks of apoptosis are 
characterized by DNA fragmentation, which is initiated by a family of caspase-
activated DNases (CADs) (286). Interestingly, early studies have already linked 
accumulation of cytosolic Ca2+ to DNA fragmentation in response to oxidative stress 
(285, 287). Hence, it would be interesting to test whether a Ca2+-dependent nuclease 
might be involved in inducing PAR formation. Inhibition of caspases by Z-VAD 
revealed no significant changes of DNA break induction upon H2O2 exposure, 
suggesting that caspase-dependent DNAases are not playing a crucial role in DNA 
break formation. 
Finally, inhibition of H2O2-induced DNA breaks and PAR formation in presence of 
BAPTA might be two independent processes, as we can currently not determine if the 
induced DNA breaks and PAR formation indeed co-localize.  
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An important aspect for future analysis is the question whether Ca2+ signaling is 
indeed a general regulator of ARTD1 activity, especially considering the versatile role 
of ARTD1 in different cell processes (183). To rule out or identify the crucial 
nuclease, one could perform an unbiased siRNA screen with PAR as a readout upon 
H2O2 exposure, however, also here one would have to consider technical pitfalls of 
such an approach, as has been nicely shown by others (288).  
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